Composition, kit of parts, and, use of an alkoylated amine

Description

155 COMPOSITION, PARTS KIT, AND USE OF AN ALKOCYLATED AMINE

[001] The present invention relates to a composition comprising an antimicrobial agent (a) as defined below and a specific alkoxylated amine (b) as defined below, to the use of an alkoxylated amine (b) as defined below to enhance the antimicrobial activity, in particular the preservative activity, of the antimicrobial agent (a) and to a method for enhancing the antimicrobial activity, in particular the preservative activity, of the antimicrobial agent (a) comprising the use of the antimicrobial agent (a) in combination with said alkoxylated amine (b). TECHNICAL FUNDAMENTALS

[002] Antimicrobial agents, such as those listed below as component (a), are well-established preservatives or biocides in a wide range of application areas. Various products and materials are susceptible to microbial attack or degradation, an attack that not only reduces the economic value of these products or materials but can even pose a health risk to the user. Microbial degradation in aqueous systems can manifest in various ways, such as loss of viscosity, emulsion breakdown, pH change, color change, unpleasant odor, fouling, gas formation, sludge formation, to name just a few easily identifiable indicators. Some of these manifestations also occur in non-aqueous systems, for example, fouling in fuels, heating oils, crude oil, and the like.Antimicrobial agents are incorporated into susceptible products or materials to preserve them, or are used as such or in suitable formulations to treat infected products or materials. Examples of products, materials, and formulations containing antimicrobial agents are compositions and articles for household care, compositions and articles for cleaning or disinfection on a large scale. Petition 870250094721, dated 10 / 16 / 2025, page 177 / 331 / 155 industrial, compositions and articles for personal care, process water, cooling water (e.g., in industrial plants, cooling towers), water in fish or shrimp tanks, water in drinking fountains, fluids for machining metals; water-based raw materials, polymer solutions, polymer dispersions, polymer emulsions, inorganic fluid pastes, organic fluid pastes, surface-active compositions; compositions for treating animal skin, leather, textiles, wood or paper or their precursor materials during papermaking processes; compositions for crop protection; pharmaceutical compositions; paints, glues, adhesives, sealants, dyes, pigments and dispersions thereof, printing inks and the like.

[003] However, some established antimicrobial agents have been found to pose health risks. For example, formaldehyde-releasing antimicrobials have lost acceptance because formaldehyde is classified as carcinogenic, mutagenic, and reproductively toxic. Halogenated organic antimicrobials have also lost ground because they exhibit a certain level of toxic effects, especially when combined with other ingredients commonly found in the formulations they are intended to preserve.

[004] The remaining antimicrobials that are not, or at least are less, hazardous, such as 2-phenoxyethanol, are often not very effective and need to be used in fairly high concentrations to achieve an acceptable antimicrobial effect. In many applications, however, high concentrations are not acceptable; for example, due to formulation problems or bad odor, or because above a certain concentration, these products also become hazardous. Furthermore, in certain circumstances, even high concentrations do not produce the desired effect.

[005] Therefore, at least in certain applications, it is not yet possible to completely forgo more dangerous antimicrobials, but Petition 870250094721, dated 10 / 16 / 2025, page 178 / 331 / 155 very effective. However, it is desirable to reduce their quantity to a minimum.

[006] In general, it is desirable to reduce the amount of antimicrobials, since, intrinsically, they all represent a certain risk, however small, to health or the environment (otherwise, they would not have an antimicrobial effect), but, at the same time, the desired antimicrobial effect should not be compromised.

[007] Consequently, it is necessary to enhance the effect of antimicrobials. Specifically, in the case of non-hazardous or less hazardous but less effective antimicrobials, it is desired to enhance their effect so that they can be applied at low or at least reasonable concentrations. In the specific case of more hazardous but effective antimicrobials, it is desired to enhance their effect so that their concentrations can be minimized to a point that makes their application acceptable.

[008] In compositions containing detergents, the antimicrobial effect of some antimicrobials, especially those with limited activity combined with low water solubility, such as 2-phenoxyethanol, phenoxyisopropanol or benzyl alcohol, is further neutralized by some common detergents, such as detergents with alkyl chains of at least 8 carbon atoms and, in particular, ethoxylated alcohols with at least 8 carbon atoms in the alkyl chain or alkylbenzenesulfonates with at least 10 carbon atoms in the alkyl chain. It would be desirable to reduce this neutralizing effect. SUMMARY OF THE INVENTION

[009] The objective of the present invention is to enhance the effect of certain antimicrobials. A more specific objective is to provide a composition with an enhanced preservative and / or biocidal effect. An additional objective for compositions containing detergents is to reduce the neutralizing effect that some common detergents exert on the antimicrobial effect of certain antimicrobials. Petition 870250094721, dated 10 / 16 / 2025, page 179 / 331 / 155

[0010] The inventors of the present invention have found that certain alkoxylated amines, as defined below, enhance the preservative and / or biocidal effect of certain antimicrobials. In addition to this antimicrobial-enhancing effect, said alkoxylated amines have the advantage of possessing a detergent-enhancing effect, which allows for a reduction in the amount of other detergents that have the potential to reduce the antimicrobial effect of certain antimicrobials, such as 2-phenoxyethanol.

[0011] The present invention therefore relates to a composition comprising (a) at least one antimicrobial agent selected from the group consisting of 2-phenoxyethanol, phenoxyisopropanol, 4,4'-dichloro-2'-hydroxydiphenyl ether, 2-bromo-2-nitropropane-1,3-diol (bronopol), glutaraldehyde, 2,4-dichlorobenzyl alcohol, 1,3,5-tris-(2-hydroxyethyl)-1,3,5-hexahydrotriazine, formic acid and salts thereof, benzoic acid and salts thereof, sorbic acid and salts thereof, lactic acid and salts thereof, isothiazolinones selected from the group consisting of 1,2-benzisothiazol-3(2H)-one (BIT), 2-methyl-2H-isothiazol-3-one (MIT), 2-octyl-2H-isothiazol-3-one (OIT), 5-chloro-2-methyl-2H-isothiazol-3-one (CMIT) and 2-butyl-benzo[d]isothiazol-3-one (BBIT); 3-iodo-2-propynylbutylcarbamate (IPBC), benzyl alcohol, pyridine-2-thiol 1-oxide and salts thereof;2,2-dibromo-2-cyanoacetamide (DBNPA), N(3-aminopropyl)-N-dodecylpropane-1,3-diamine (Diamine), tetrakis(hydroxymethyl)phosphonium sulfate (2:1) (THPS), 2,2-dithiobis[N-methylbenzamide] (DTBMA), 2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB); and mixtures thereof; and (b) an alkoxylated amine of formula (I); NR1R2R3(I) where R1 is -CH2CH2O-An-Bm-H; -CH2CH2O-Bm-An-H or CH2CH2O-Em-nH; in which Petition 870250094721, dated 10 / 16 / 2025, pp. 180 / 331 / 155 A is -CH2CH2O-; B is -CH(Ra)-CH2-O- or -CH2-CH(Ra)-O-; And A and B are randomly assigned; Raé C1-C16-alkyl; m is from 0 to 30; en is from 0 to 15; where the sum of m + n is from 5 to 40; and R2 and R3 independently have one of the meanings of R1, or they are C1-C18-alkyl.

[0012] The invention further relates to the use of an alkoxylated amine (I), as defined above, to enhance the antimicrobial activity, in particular the preservative activity, of the antimicrobial agent, as defined above as component (a).

[0013] The invention also relates to a method for enhancing the antimicrobial activity, in particular the preservative activity, of the antimicrobial agent, as defined above as component (a), comprising the use of the antimicrobial agent (a) in combination with said alkoxylated amine (I).

[0014] The invention further relates to a kit of parts comprising at least two parts, wherein the first part comprises at least one antimicrobial agent, as defined above as component (a); the second part comprises at least one alkoxylated amine (I), as defined above, and optionally at least one organic solvent; and an optional third part comprises at least one organic solvent. DETAILED DESCRIPTION OF THE INVENTION Definitions

[0015] An antimicrobial agent, or simply antimicrobial, is an agent that fights or controls microbes. Unless otherwise specified in Petition 870250094721, dated 10 / 16 / 2025, page 181 / 331 / 155, contrary to the terms of the present invention, the expressions "microbicide" and "biocide" are used as synonyms for antimicrobials.

[0016] Microbes, as defined in the present invention, are unwanted harmful microorganisms and comprise bacteria, fungi (including yeasts and molds), microscopic algae, protozoa, their spores and, although generally not considered living beings, also viruses and prions. “Harmful” means that the microorganism has an unwanted presence or a detrimental effect on humans, their activities or the products they use or produce, or on animals, materials, plants or the environment.

[0017] An antimicrobial effect encompasses a preservative effect as well as a biocidal effect. A preservative or conservation effect, in the terms of the present invention, means that the material or product, as such, comprising an antimicrobial agent, is protected against deterioration by microbial attack. As a consequence, the material or product thus protected has, for example, greater storage stability. By way of example only, an antimicrobial is used in a laundry detergent composition as a preservative to maintain the composition stable during storage, preventing or reducing the proliferation or growth of microbes present in it and thus preventing or reducing the deterioration of the composition's properties, such as the formation of unpleasant odors, changes in viscosity or pH, phase separation, etc.Biocidal effect, as defined in the present invention, means that the composition comprising an antimicrobial agent exerts its antimicrobial effect on a product or material treated with that composition and different from it. Continuing with the example of a laundry detergent composition containing an antimicrobial, that composition exerts a biocidal effect, as defined in the present invention, if the microorganisms present in the laundry treated with it are eliminated or their proliferation or growth is impaired. Petition 870250094721, dated 10 / 16 / 2025, page 182 / 331 / 155, regarding the application of said composition. Another example of a biocidal application is a disinfectant or sanitizing composition that exerts its biocidal effect on materials or products treated with it. The biocidal effect must be rapid, as the microbes present in the treated materials or products must be eliminated or reduced in seconds or minutes, while the preservative effect is a long-term effect, as it must prevail throughout the product's shelf life, which can be years. Many antimicrobials have both preservative and biocidal effects, with the prevalence depending mainly on the concentration of the antimicrobial in the composition.

[0018] Phenoxyisopropanol is 1-phenoxypropan-2-ol. Commercially available phenoxyisopropanol may, however, contain small amounts (i.e., up to 5% by weight) of the 2-phenoxypropan-2-ol isomer; such mixtures also fall within the term “phenoxyisopropanol” as used in the context of the present invention. Phenoxyisopropanol contains a stereogenic center and therefore may be present in the form of the essentially pure S enantiomer, the essentially pure R enantiomer, and mixtures of the two enantiomers, including racemic mixtures. The present invention encompasses both the use of the essentially pure enantiomers and mixtures of the two enantiomers, including racemic mixtures. Generally, however, the racemate is used, as this is its most common commercial form.

[0019] The organic moieties mentioned below are collective terms for individual listings of the individual members of the group. The prefix Cn-Cm indicates in each case the possible number of carbon atoms in the group.

[0020] The term “alkyl”, as used herein, is used in its proper sense and refers to straight (linear) or branched saturated non-cyclic hydrocarbon radicals having the indicated number of carbon atoms. C1-C4-alkyl therefore denotes an alkyl radical with 1 to 4 carbon atoms. Petition 870250094721, dated 10 / 16 / 2025, page 183 / 331 / 155 carbon. Examples are methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, and tert-butyl. C1-C5-alkyl denotes an alkyl radical with 1 to 5 carbon atoms. Examples are, in addition to those mentioned above for C1-C4-alkyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, and other structural isomers thereof. C1-C6-alkyl denotes an alkyl radical with 1 to 6 carbon atoms. Examples include, in addition to those mentioned above for C1-C5-alkyl, n-hexyl 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl and other structural isomers thereof.C1-C8-alkyl denotes an alkyl radical with 1 to 8 carbon atoms. Examples are, in addition to those mentioned above for C1-C6-alkyl, n-heptyl, n-octyl, 2-ethylhexyl and (other) structural isomers thereof. C1-C10-alkyl denotes an alkyl radical with 1 to 10 carbon atoms. Examples are, in addition to those mentioned above for C1-C8-alkyl, n-nonyl, n-decyl, 2-propylheptyl and (other) structural isomers thereof. C1-C16-alkyl denotes an alkyl radical with 1 to 16 carbon atoms. Examples are, in addition to those mentioned above for C1-C10-alkyl, n-ndecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl and structural isomers thereof. C1-C18-alkyl denotes an alkyl radical with 1 to 18 carbon atoms. Examples include, in addition to those mentioned for C1-C16-alkyl, n-heptadecyl, n-octadecyl, and structural isomers thereof.

[0021] C1-C4-hydroxyalkyl denotes a linear or branched C1-C4-alkyl radical, as defined above, in which a hydrogen atom is replaced by an OH group. C1-C8-hydroxyalkyl denotes a linear or branched C1-C8-alkyl radical, as defined above, in which an atom of Petition 870250094721, of 10 / 16 / 2025, p. 184 / 331 / 155 hydrogen is replaced by an OH group. Examples are hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1-hydroxy-n-propyl, 2-hydroxy-n-propyl, 3-hydroxy-n-propyl, 1-hydroxy-1-methyl-ethyl, 2-hydroxy-1-methyl-ethyl, 1-hydroxy-n-butyl, 2-hydroxy-n-butyl, 3-hydroxy-n-butyl, 4-hydroxy-n-butyl and the like.

[0022] Oxo is an =O group. If, for example, in the definition of (C-9), R9 and R10 together form an oxo group, the compound (C-9) is, in that case, a 1,2-dioxolan-2-one substituted at position 4 by R11.

[0023] In terms of the present invention, C1-C4-carboxylic acids are RC(=O)OH compounds, where R is H or C1-Cs-alkyl. Examples are formic acid, acetic acid, propionic acid, butyric acid, and isobutyric acid.

[0024] Unless otherwise indicated, under the terms of the present invention, “ppm” means ppm by weight and corresponds to 1 g of the component per 1,000,000 g of the reference. In other words, 1 ppm corresponds to 0.0001% by weight. Invention Models (Ex)

[0025] The general and preferred Ex forms are summarized in the non-exhaustive list below. Other preferred forms become apparent from the paragraphs following this list.

[0026] E.1. A composition comprising (a) at least one antimicrobial agent selected from the group consisting of 2-phenoxyethanol, phenoxyisopropanol, 4,4'-dichloro-2'-hydroxydiphenyl ether, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde, 2,4-dichlorobenzyl alcohol, 1,3,5-tris-(2-hydroxyethyl)-1,3,5-hexahydrotriazine, formic acid and salts thereof, benzoic acid and salts thereof, sorbic acid and salts thereof, lactic acid and salts thereof, isothiazolinones selected from the group consisting of 1,2-benzisothiazol-3(2H)-one (BIT), 2-methyl-2-isothiazol-3-one (MIT), 2-octyl-2H-isothiazol-3-one (OIT), 5-chloro-2-methyl-2Hisothiazol-3-one (CMIT) and 2-butyl-benzo[d]isothiazol-3-one (BBIT); 3-iodine-2 Petition 870250094721, dated 10 / 16 / 2025, p. 185 / 331 / 155 propynylbutylcarbamate (IPBC), benzyl alcohol, pyridine-2-thiol 1-oxide and salts thereof; 2,2-dibromo-2-cyanoacetamide (DBNPA), N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine (Diamine), tetrakis(hydroxymethyl)phosphonium sulfate (2:1) (THPS), 2,2-dithiobis[N-methylbenzamide] (DTBMA), 2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB); and mixtures thereof; and (b) an alkoxylated amine of formula (I) NR1R2R3(I) where R1 is -CH2CH2O-An-Bm-H; -CHiCHiO-Bm-An-H or CH2CH2O-Em+nH; in which A is -CH2CH2O-; B is -CH(Ra)-CH2-O- or -CH2-CH(Ra)-O-; And A and B are randomly assigned; Raé C1-C16-alkyl; m is from 0 to 30; en is from 0 to 15; where the sum of m + n is from 5 to 40; and R2 and R3 independently have one of the definitions given for R1, or they are C1-C18-alkyl.

[0027] E.2. The composition according to embodiment E.1, wherein the antimicrobial agent is selected from the group consisting of 2-phenoxyethanol, phenoxyisopropanol, 4,4'-dichloro-2'-hydroxydiphenyl ether, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde, benzoic acid and salts thereof and isothiazolinones selected from the group consisting of 1,2-benzisothiazol3(2H)-one (BIT), 2-methyl-2H-isothiazol-3-one (MIT), 2-octyl-2H-isothiazol-3-one (OIT), 5-chloro-2-methyl-2H-isothiazol-3-one (CMIT) and 2-butylbenzo[d]isothiazol-3-one (BBIT); and preferably from the group consisting of 2-phenoxyethanol, phenoxyisopropanol, 4,4'-dichloro 2'-hydroxydiphenyl ether, 2-bromo-2-nitropropane-1,3-diol and 1,2-benzisothiazol-3(2H)one (BIT).

[0028] E.3. The composition according to embodiment E. 2, wherein the antimicrobial agent is selected from the group consisting of 2-phenoxyethanol, 4,4'-dichloro 2'-hydroxydiphenyl ether, benzoic acid and salts thereof and 1,2-benzisothiazol-3(2H)one (BIT).

[0029] E.4. The composition according to embodiment E. 2, wherein the antimicrobial agent is selected from the group consisting of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT).

[0030] E. 5. The composition according to any one of the embodiments E. 3 or E. 4, in which the antimicrobial agent is 2-phenoxyethanol.

[0031] E.6. The composition according to any one of the previous modalities, in which R2 and R3 independently have one of the meanings of R1.

[0032] E.7. The composition according to any one of the previous modalities, in which Raé methylates.

[0033] E.8. The composition according to any of the previous modalities, where m is from 10 to 30 and en is from 3 to 12; or m is from 10 to 25 and en is 0.

[0034] E.9. The composition according to modality E. 8, where m is from 12 to 30 and en is from 4 to 12; or m is from 10 to 20 and en is 0.

[0035] E. 10. The composition according to modality E. 9, where m is 14 to 27 and en is 5 to 10; or m is 15 and en is 0.

[0036] E. 11. The composition according to modality E. 8, where m is 10 to 20 and en is 3 to 8; or m is 10 to 25 and en is 0.

[0037] E. 12. The composition according to modality E. 11, where m is 13 to 15 and en is 4 to 6; or m is 14 to 16 and en is 0.

[0038] E.13. The composition according to modality E. 12, where m is 14 and en is 5; or m is 15 and en is 0. Petition 870250094721, dated 10 / 16 / 2025, p. 187 / 331 / 155

[0039] E. 14. The composition according to any of the above modalities, in which R1é -CHçCHçO-An-Bm-H.

[0040] E. 15. The composition according to any of the embodiments E. 1 to E. 5 and E. 7 to E. 14, wherein one of R2 and R3 has one of the meanings of R1 (and the other is C1-C18-alkyl).

[0041] E.16. The composition according to any of the preceding embodiments, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 100:1 to 1:10000; in particular, of 5:1 to 1:10000.

[0042] E.17. The composition according to embodiment E. 16, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 50:1 to 1:2000; in particular, of 5:1 to 1:2000.

[0043] E.18. The composition according to embodiment E. 17, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 50:1 to 1:1000; in particular, of 5:1 to 1:1000.

[0044] E.19. The composition according to embodiment E. 18, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 50:1 to 1:500; in particular, of 5:1 to 1:500.

[0045] E.20. The composition according to embodiment E. 19, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 20:1 to 1:500; in particular, of 5:1 to 1:500.

[0046] E.21. The composition according to embodiment E. 20, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 10:1 to 1:450; in particular, of 5:1 to 1:450.

[0047] E.22. The composition according to embodiment E. 21, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 2:1 to 1:450.

[0048] E.23. The composition according to any of the above embodiments, wherein the antimicrobial agent is 2-phenoxyethanol, and the Petition 870250094721, dated 10 / 16 / 2025, p. 188 / 331 / 155 2-phenoxyethanol and the alkoxylated amine are present in a total weight ratio of 3:1 to 1:3.

[0049] E.24. The composition according to embodiment E. 23, in which 2-phenoxyethanol and the alkoxylated amine are present in a total weight ratio of 2.5:1 to 1:2.5.

[0050] E.25. The composition according to embodiment E. 24, in which 2-phenoxyethanol and the alkoxylated amine are present in a total weight ratio of 2:1 to 1:2.5.

[0051] E.26. The composition according to embodiment E. 25, in which 2-phenoxyethanol and the alkoxylated amine are present in a total weight ratio of 1.5:1 to 1:2.5.

[0052] E.27. The composition according to embodiment E. 26, wherein 2-phenoxyethanol and the alkoxylated amine are present in a total weight ratio of 1.5:1 to 1:2, for example, 1.3:1 to 1:2 or 1:1 to 1:2.

[0053] E.28. The composition according to any of the embodiments E.1 to E.22, wherein the antimicrobial agent is selected from the group consisting of 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT); and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:10000.

[0054] E.29. The composition according to embodiment E.28, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:2000.

[0055] E.30. The composition according to embodiment E.29, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:1000.

[0056] E.31. The composition according to embodiment E.30, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:500.

[0057] E.32. The composition according to modality E.31, in Petition 870250094721, dated 10 / 16 / 2025, p. 189 / 331 / 155, stating that the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:450.

[0058] E.33. The composition according to embodiment E. 32, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 100:450.

[0059] E.34. The composition according to any of the preceding embodiments, wherein the antimicrobial agent is selected from the group consisting of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT); in the alkoxylated amine of formula (I) R1, R2 and R3 are independently -CH2CH2O-A„-Bm-H, wherein Ra is methyl, m is 10 to 30 and en is 3 to 12; or m is 10 to 20 and en is 0; and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 3:1 to 1:500.

[0060] E.35. The composition according to embodiment E. 34, wherein the antimicrobial agent is selected from the group consisting of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT); in the alkoxylated amine of formula (I), R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, wherein Ra is methyl, m is 14 to 27 and en is 5 to 10; or m is 15 and en is 0; and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 2:1 to 1:450.

[0061] E.36. The composition according to either embodiment E. 34 or E. 35, wherein the antimicrobial agent is 2-phenoxyethanol; in the alkoxylated amine of formula (I) R1, R2 and R3 are independently CH2CH2O-An-Bm-H, where Ra is methyl, m is 10 to 30 and en is 3 to 12; or m is 10 to 20 and en is 0; and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 3:1 to 1:5.

[0062] E.37. The composition according to modality E. 36, where m is 13 to 15 and en is 4 to 6; or m is 14 to 16 and en is 0.

[0063] E.38. The composition according to modality E. 37, in Petition 870250094721, dated 10 / 16 / 2025, p. 190 / 331 / 155 that m is 14 and en is 5; or m is 15 and en is 0.

[0064] E.39. The composition according to any of the embodiments E. 36 to E. 38, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 3:1 to 1:3.

[0065] E.40. The composition according to embodiment E. 39, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 2.5:1 to 1:2.5.

[0066] E.41. The composition according to embodiment E. 40, wherein the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 2:1 to 1:2.5, preferably 1.5:1 to 1:2.5; for example, 1.5:1 to 1:2 or 1.3:1 to 1:2 or 1:1 to 1:2.

[0067] E.42. The composition according to either embodiment E. 34 or E. 35, wherein the antimicrobial agent is selected from the group consisting of 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT); in the alkoxylated amine of formula (I), R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, where Ra is methyl, m is 10 to 20 and en is 3 to 8; and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:500.

[0068] E.43. The composition according to modality E. 42, where m is 13 to 15 and en is 4 to 6.

[0069] E.44. The composition according to modality E. 43, where m is 14 and en is 5.

[0070] E.45. In the composition according to any of the embodiments E. 42 to E. 44, the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:450.

[0071] E.46. The composition according to embodiment E. 45, in which the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 100:450.

[0072] E.47. The composition according to any of the Petition 870250094721, dated 10 / 16 / 2025, p. 191 / 331 / 155 previous embodiments, wherein the composition further comprises (c) at least one organic solvent selected from the group consisting of (c.1) carboxamides of formula (C-1) wherein R4 is hydrogen or C1-C8-alkyl; R5 is C1-C8-alkyl; and R6 is C1-C8-alkyl or C1-C8-hydroxyalkyl; (c.2) carboxylic esters of formula (C-2) where R6 is C1-C8-alkyl or C1-C8-hydroxyalkyl; and R7 is C1-C10-alkyl; (c.3) Cs-C8-alkanols; (c.4) C3-C8-alkanediols; (c.5) C1-C8-alkylmonoethers of C2-C8-alkanediols; (c.6) diethylene glycol, dipropylene glycol, a polyethylene glycol with up to 10 repeating units or a polypropylene glycol with up to 10 repeating units; (c.7) C1-C8-alkyl monoethers of diethylene glycol or dipropylene glycol; (c.8) lactones of formula (C-8) Petition 870250094721, dated 10 / 16 / 2025, p. 192 / 331 / 155 where R8 is C1-C5-alkyl; (c.9) dioxolanes of formula (C-9) in what R9 and R10 are, independently, C1-C4-alkyl or together form an oxo group; and R11 is C1-C4-alkyl or C1-C4-hydroxyalkyl; and (c.10) mono-, di- or triesters of glycerol with C1-C4 carboxylic acids.

[0073] E.48. The composition according to embodiment E. 47, wherein the organic solvent of component (c) is selected from the group consisting of (c. 1) the carboxamide of formula (C-1), wherein R4 and R5 are methyl, and R6 is 1-hydroxyethyl; (c.5) Cs-C5-alkylmonoethers of C2-Cs-alkanediols; (c.7) C1-C6-alkyl monoethers of diethylene glycol or dipropylene glycol; and (c.8) the lactone of formula (C-8), where R8 is methyl.

[0074] E.49. The composition according to embodiment E.48, in which the organic solvent of component (c) is selected from the group consisting of (c.1) the carboxamide of formula (C-1), in which R4 and R5 are Petition 870250094721, dated 10 / 16 / 2025, p. 193 / 331 / 155 methyl, and R6 is 1-hydroxyethyl; (c.5) 1-butoxy-propan-2-ol; (c.7) diethylene glycol mono-n-butyl ether; and (c.8) the lactone of formula (C-8), where R8 is methyl.

[0075] E. 50. The composition according to any of the embodiments E. 47 to 49, in which the antimicrobial agent and the organic solvent of component (c) are present in a total weight ratio of 10:1 to 1:10.

[0076] E.51. The composition according to embodiment E.50, in which the antimicrobial agent and the organic solvent of component (c) are present in a total weight ratio of 5:1 to 1:5.

[0077] E.52. The composition according to embodiment E.51, in which the antimicrobial agent and the organic solvent of component (c) are present in a total weight ratio of 3:1 to 1:3.

[0078] E.53. The composition according to embodiment E.52, in which the antimicrobial agent and the organic solvent of component (c) are present in a total weight ratio of 2:1 to 1:2.

[0079] E.54. The composition according to embodiment E.53, in which the antimicrobial agent and the organic solvent of component (c) are present in a total weight ratio of 2:1 to 1:1.

[0080] E.55. A composition according to any of the preceding embodiments, which is selected from the group consisting of antimicrobial concentrates, compositions for household care, compositions for cleaning or disinfection on an industrial scale, compositions for personal care, process water, cooling water, water in fish or shrimp tanks, water in drinking fountains, fluids for metal machining; water-based raw materials, polymer solutions, polymer dispersions, polymer emulsions, inorganic fluid pastes, organic fluid pastes, surface-active compositions; compositions for treatment of Petition 870250094721, dated 10 / 16 / 2025, page 194 / 331 / 155 animal skin; compositions for treating leather; compositions for treating textiles during the manufacturing process; compositions for treating wood; compositions for treating paper or precursor material during papermaking processes; compositions for crop protection; pharmaceutical compositions; inks, glues, adhesives, sealants, dyes, pigments and dispersions thereof, inks and wet wipes.

[0081] E.56. Kit of parts comprising at least two parts, wherein the first part comprises at least one antimicrobial agent as defined in any of the embodiments E.1 to E.6; the second part comprises an alkoxylated amine as defined in any of the embodiments E.1 and E.6 to E.15 and, optionally, at least one organic solvent; and an optional third part comprises at least one organic solvent; wherein the first part does not comprise an alkoxylated amine as defined in any of the embodiments E.1 and E.6 to E.15; wherein the second part does not comprise any antimicrobial agent as defined in any of the embodiments E.1 to E.5; wherein the optional third part does not comprise any antimicrobial agent as defined in any of the embodiments E.1 to E.5, nor an alkoxylated amine as defined in any of the embodiments E.1 and E.6 to E.15; and wherein the first and second parts contain at least one antimicrobial agent as defined in any of the embodiments E.1 to E.5 and the alkoxylated amine as defined in any of the embodiments E.1 and E.6 to E.15 in amounts such that, when the first and second parts are mixed, the resulting total weight ratio is as defined in any of the embodiments E.16 to E.22.

[0082] E.57. The use of an alkoxylated amine, as defined in Petition 870250094721, dated 10 / 16 / 2025, p. 195 / 331 / 155 any of the embodiments E. 1 and E. 6 to E. 15, to enhance the antimicrobial activity, in particular the preservative activity, of the antimicrobial agent, as defined in any of the embodiments E. 1 to E. 5.

[0083] E. 58. The use, according to embodiment E. 57, of an alkoxylated amine, as defined in any of embodiments E. 1 and E. 6 to E. 15, to enhance the antimicrobial activity, in particular the preservative activity, of 2-phenoxyethanol.

[0084] E. 59. Use in accordance with any of the modalities E. 57 or E. 58 to enhance the antimicrobial activity, in particular the preservative activity, of the antimicrobial agent in an aqueous liquid composition for household care.

[0085] E.60. Use in accordance with any of the modalities E. 57 to E. 59, wherein the antimicrobial agent, as defined in any of the embodiments E. 1 to E. 5, and the alkoxylated amine, as defined in any of the embodiments E. 1 and E. 6 to E. 15, are used in a weight ratio as defined in any of the embodiments E. 16 to E. 22.

[0086] E.61. Use in accordance with any of the modalities E. 57 to E. 59, wherein the antimicrobial agent, the alkoxylated amine, and their weight ratios are as defined in any of the embodiments E. 34 to E. 46.

[0087] Unless otherwise specified, the remarks below concerning suitable and preferred antimicrobial agents, alkoxylated amines (I), weight ratios in which they are used and compositions in which they are used apply both to the compositions of the inventions and to the use and method of the invention.

[0088] The antimicrobial agent is, inter alia, selected from formic acid and its salts, benzoic acid and its salts, sorbic acid and its salts, lactic acid and its salts. Suitable salts of these acids are alkali metal salts, such as lithium, sodium or potassium salts; Petition 870250094721, dated 10 / 16 / 2025, page 196 / 331 / 155 alkaline earth metal salts, such as magnesium and calcium salts, and ammonium salts, such as salts containing an ammonium cation of the formula [NRaRbRcRd]+, wherein Ra, Rb, Rc and Rd, independently of each other, are selected from the group consisting of hydrogen, C1-C4-alkyl and C1-C4-alkoxy. Preferably, alkali metal salts are used, in particular sodium or potassium salts.

[0089] The antimicrobial agent is preferably selected from the group consisting of 2-phenoxyethanol, phenoxyisopropanol, 4,4'-dichloro-2'-hydroxydiphenyl ether (diclosan), 2-bromo-2-nitropropane-1,3-diol (bronopol), glutaraldehyde, benzoic acid and salts thereof and isothiazolinones selected from the group consisting of 1,2-benzisothiazol-3(2H)-one (BIT), 2-methyl-2H-isothiazol-3-one (MIT), 2-octyl-2H-isothiazol-3-one (OIT), 5-chloro-2-methyl-2H-isothiazol-3-one (CMIT) and 2-butyl-benzo[d]isothiazol-3-one (BBIT); and more preferably from the group consisting of 2-phenoxyethanol, phenoxyisopropanol, 4,4'-dichloro 2'-hydroxydiphenyl ether, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde, benzoic acid and salts thereof and 1,2-benzisothiazol-3(2H)one (BIT), and more preferably from 2-phenoxyethanol, 4,4'-dichloro 2'-hydroxydiphenyl ether (diclosan), benzoic acid and salts thereof and 1,2-benzisothiazol-3(2H)one (BIT).

[0090] In a more preferred alternative embodiment, the antimicrobial agent is selected from the group consisting of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol (bronopol), glutaraldehyde and 1,2-benzisothiazol3(2H)-one (BIT).

[0091] In one specific embodiment, the antimicrobial agent is 2-phenoxyethanol.

[0092] The antimicrobial agents of component (a) are known in the art and are commercially available or can be prepared by known methods.

[0093] Alkoxylated amines (I) are also known in the art and Petition 870250094721, of 10 / 16 / 2025, p. 197 / 331 / 155 are commercially available, for example, BASF's Plurafac® LF 1430, or can be prepared by standard organic chemistry methods. To obtain, for example, compounds (I) in which R2 and R3 have one of the meanings of R1 and Ra is methyl, triethanolamine N(CH2CH2OH)3 is typically reacted with the necessary amounts of propylene oxide (PO) and / or ethylene oxide (EO). To obtain alkoxylated amines (I) where R1, R2 and R3 are -CH2CH2O-An-Bm-H or -CH2CH2O-Bm-An-H and where neither m nor n are 0, i.e., where both repeating units A and B are present and arranged in blocks, triethanolamine is first reacted with EO and then with PO to give compounds (I) where R1, R2 and R3 are CH2CH2O-An-Bm-H; or triethanolamine is first reacted with PO and then with EO to give compounds (I) in which R1, R2 and R3 are -CHiCHiO-BmAn-H.To obtain alkoxylated amines (I) where R1, R2 and R3 are -CH2CH2OEm+nH and where neither m nor n is 0, i.e., compounds (I) with a random distribution of repeating units A and B, triethanolamine is reacted with a mixture of EO and PO containing EO and PO in an amount corresponding to the desired m values. To obtain compounds where n is 0, triethanolamine is reacted only with the necessary amount of PO. To obtain compounds where m is 0, triethanolamine is reacted only with the necessary amount of EO. Alkoxylated amines in which one or both R2 and R3 are C1-C18-alkyl can be obtained analogously by the reaction of a C1-C18-alkyl-diethanolamine (if only one of R2 and R3 is C1-C18-alkyl) with PO and / or EO as described above, or by the reaction of a di-(C1-C18alkyl)-ethanolamine (if both R2 and R3 are C1-C18-alkyl) with PO and / or EO as described above.To obtain alkoxylated amines (I) in which Ra is different from methyl, corresponding alkylene oxides are used instead of PO, such as butylene oxide, pentylene oxide, etc.

[0094] To obtain compounds (I) in which R1, as well as one of R2 and R3 is -CH2CH2O-An-Bm-H and the other of R2 and R3 is C1-C18-alkyl, is Petition 870250094721, dated 10 / 16 / 2025, p. 198 / 331 / 155 alternatively it is possible to react a C1-C18-alkylamine with the required amount of ethylene oxide (EO) and then, if m is not 0, with the required amount of propylene oxide (if Raem B is methyl) or another suitable precursor of B (if Rafor is different from methyl), such as butylene oxide, pentylene oxide, etc. To obtain compounds (I) in which R1, as well as one of R2 and R3 is -CH2CH2Ü-Bm-An-H and the other of R2 and R3 is C1-C18-alkyl, it is alternatively possible to react a C1-C18-alkylamine with the required amount of propylene oxide (if Raem B is methyl) or another suitable precursor of B (if Rafor is different from methyl), such as butylene oxide, pentylene oxide, etc., and then, if n is not 0, with the required amount of ethylene oxide (EO).To obtain compounds (I) in which R1, as well as one of R2 and R3 is -CH2CH2O-Em+nH and where neither m nor n are 0, i.e., compounds (I) with a random distribution of repeating units A and B, and the other of R2 and R3 is C1-C18-alkyl, it is alternatively possible to react a C1-C18alkylamine with a mixture of EO and PO containing EO and PO (or another suitable precursor of B (if Rafor is different from methyl), such as butylene oxide, pentylene oxide, etc.) in an amount corresponding to the desired men. To obtain compounds (I) in which R1 is -CH2CH2O-An-Bm-H and both R2 and R3 are C1-C18-alkyl, it is alternatively possible to react a di(C1-C18-alkyl)-amine with the required amount of ethylene oxide (EO) and then, if m is not 0, with the required amount of propylene oxide (if Raem B is methyl) or another suitable precursor of B (if Rafor is different from methyl), such as butylene oxide, pentylene oxide, etc.To obtain compounds (I) in which R1 is -CH2CH2O-Bm-An-H and both R2 and R3 are C1-C18-alkyl, it is alternatively possible to react a di-(C1-C18-alkyl)-amine with the required amount of propylene oxide (if Raem B is methyl) or another suitable precursor of B (if Ra is different from methyl), such as butylene oxide, pentylene oxide, etc., and then, if n is not 0, with the required amount of ethylene oxide (EO). To obtain compounds (I) in which R1 is Petition 870250094721, 10 / 16 / 2025, p. 199 / 331 / 155. CH2CH2Ü-Em+nH e where neither m nor n are 0, i.e. compounds (I) with a random distribution of repeating units A and B, and both R2 and R3 are C1-C18-alkyl, it is alternatively possible to react a di-(C1-C18-alkyl)amine with a mixture of EO and PO containing EO and PO (or another suitable precursor of B (if Rafor is different from methyl), such as butylene oxide, pentylene oxide, etc.) in an amount corresponding to the desired men.

[0095] As becomes evident from the synthesis methods described above, by which alkoxylated amines (I) are typically prepared using EO and / or PO or other alkylene oxide for alkoxylation, men are generally average values, since the degrees of alkoxylation are, in general, statistical averages which, for a specific product, may be a whole number or a fraction. By way of example, in an alkoxylated amine (I) in which R1m is 14 and n is 5, some of the R1 radicals may contain more than 14 B units or less than 14 B units and / or more than 5 A units or less than 5 A units, the average number m of repeating B units being 14 and the average number n of repeating A units being 5.

[0096] In a preferred embodiment, R2 and R3 independently have one of the meanings of R1.

[0097] In another preferred embodiment, one of R2 and R3 has one of the meanings of R1 (and the other is C1-C18-alkyl).

[0098] More preferably, however, R2 and R3 independently have one of the meanings of R1.

[0099] Preferably, in the B units, Raé methyl, B being, therefore, preferably derived from PO.

[00100] Preferably, m is 10 to 30 (on average) and en is 3 to 12 (on average); or m is 10 to 25 (on average) and en is 0. More preferably, m is 13 to 30 (on average) and en is 4 to 10 (on average); or m is 14 to 16 (on average) and en is 0. In a specific modality, m is 14 to 27 (on average) and en is 5 to 10 (on average); or m is 15 (on average) and en is 0. In a modality Petition 870250094721, dated 10 / 16 / 2025, p. 200 / 331 / 155 specific, m is 14 (on average) en is 5 (on average); or m is 15 (on average) en is 0.

[00101] Preferably, R1e -CH2CH2O-An-Bm-H. Preferably, n, me Raem B have the preferred meanings above.

[00102] More preferably, R1, R2 and R3 are -CHgCHçO-An-Bm-H. Even more preferably, R1, R2 and R3 are -CH2CH2O-An-Bm-H, where Raem B is methyl, m is 10 to 30 (on average) and en is 3 to 12 (on average); or m is 10 to 25 (on average) and en is 0. In particular, R1, R2 and R3 are -CH2CH2O-An-Bm-H, where Raem B is methyl, m is 13 to 30 (on average) and en is 4 to 10 (on average); or m is 14 to 16 (on average) and en is 0. Specifically, R1, R2 and R3 are -CH2CH2OAn-Bm-H, where Raem B is methyl, m is 14 to 27 (on average) and en is 5 to 10 (on average); or m is 15 (on average) and en is 0.

[00103] In a specific embodiment, R1, R2, and R3 are -CH2CH2O-An-Bm-H, where Raem B is methyl, m is 10 to 20 (on average), en is 3 to 8 (on average); or m is 10 to 25 (on average), en is 0. More specifically, R1, R2, and R3 are -CH2CH2O-An-Bm-H, where Raem B is methyl, m is 13 to 15 (on average), en is 4 to 6 (on average); or m is 14 to 16 (on average), en is 0. Very specifically, R1, R2, and R3 are -CH2CH2O-An-Bm-H, where Raem B is methyl, m is 14 (on average), en is 5 (on average); or m is 15 (on average), en is 0.

[00104] The antimicrobial agent and the alkoxylated amine are preferably present in a total weight ratio of 100:1 to 1:10000 (e.g., 5:1 to 1:10000), more preferably 50:1 to 1:2000 (e.g., 5:1 to 1:2000), even more preferably 50:1 to 1:1000 (e.g., 5:1 to 1:1000), particularly preferably 50:1 to 1:500, in particular 20:1 to 1:500, more particularly 10:1 to 1:500, even more particularly 5:1 to 1:500, specifically 5:1 to 1:450, very specifically 2:1 to 1:450.

[00105] In a specific embodiment, the antimicrobial agent is 2-phenoxyethanol, and 2-phenoxyethanol and the alkoxylated amine are present in a Petition 870250094721, dated 10 / 16 / 2025, p. 201 / 331 / 155 total weight ratio of 3:1 to 1:5, preferably 3:1 to 1:3, more preferably 2.5:1 to 1:2.5, even more preferably 2:1 to 1:2.5, in particular 1.5:1 to 1:2.5, more particularly 1.5:1 to 1:2, specifically 1.3:1 to 1:2 and very specifically 1:1 to 1:2.

[00106] In another specific embodiment, the antimicrobial agent is selected from the group consisting of 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT), and said antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:500, preferably 1:1 to 1:450 and more preferably 1:100 to 1:450.

[00107] In a particularly preferred embodiment, the antimicrobial agent is selected from the group consisting of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT); in the alkoxylated amine of formula (I) R1, R2 and R3 are independently -CHiCHiO-An-Bm-H, where Ra is methyl, m is 10 to 30 and n is 3 to 12; or m is 10 to 20 and n is 0; and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 3:1 to 1:500; wherein specifically in the alkoxylated amine of formula (I) R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, wherein Ra is methyl, m is 14 to 27 and en is 5 to 10; or m is 15 and en is 0; and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 2:1 to 1:450.

[00108] In a particular embodiment, the antimicrobial agent is 2-phenoxyethanol; in the alkoxylated amine of formula (I) R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, where Ra is methyl, m is 10 to 30 and n is 3 to 12; or m is 10 to 20 and n is 0; and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 3:1 to 1:5, preferably 3:1 to 1:3, more preferably 2.5:1 to 1:2.5, even more preferably 2:1 to 1:2.5, in particular 1.5:1 to 1:2.5, specifically 1.5:1 to 1:2, more specifically 1.3:1 to 1:2 and much Petition 870250094721, dated 10 / 16 / 2025, p. 202 / 331 / 155 specifically from 1:1 to 1:2.

[00109] More particularly, the antimicrobial agent is 2-phenoxyethanol; in the alkoxylated amine of formula (I) R1, R2 and R3 are independently -CHçCHçO-An-Bm-H, where Ra is methyl, m is 13 to 15 and en is 4 to 6; or m is 14 to 16 and en is 0; and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 2:1 to 1:5, preferably 2:1 to 1:3, more preferably 1.5:1 to 1:2.5 and even more preferably 1:1 to 1:2.

[00110] Specifically, the antimicrobial agent is 2-phenoxyethanol; in the alkoxylated amine of formula (I), R1, R2 and R3 are independently CHiCHiO-An-Bm-H, where Ra is methyl, m is 14 and en is 5; or m is 15 and en is 0; and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 2:1 to 1:5, preferably 2:1 to 1:3, more preferably 1.5:1 to 1:2.5 and even more preferably 1:1 to 1:2.

[00111] In another specific embodiment, the antimicrobial agent is selected from the group consisting of 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT); in the alkoxylated amine of formula (I) R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, where Ra is methyl, m is 10 to 20 and en is 3 to 8; and said antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:500, preferably 1:1 to 1:450, and more preferably 1:100 to 1:450.

[00112] More particularly, the antimicrobial agent is selected from the group consisting of 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT); in the alkoxylated amine of formula (I), R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, wherein Ra is methyl, m is 13 to 15 and en is 4 to 6; and said antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:500, preferably 1:1 to 1:450 and, more preferably, 1:100 to 1:450.

[00113] Specifically, the antimicrobial agent is selected from Petition 870250094721, of 10 / 16 / 2025, p. 203 / 331 / 155 group consisting of 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT); in the alkoxylated amine of formula (I), R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, where Ra is methyl, m is 14 and en is 5; and said antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:500, preferably 1:1 to 1:450 and, more preferably, 1:100 to 1:450.

[00114] In a preferred embodiment, the composition further comprises at least one organic solvent. This is obviously different from components (a) and (b). The organic solvent is preferably selected from the group consisting of C1-C8-alkanols, C2-C8-alkanediols, C1-C8-alkyl monoethers of C2-C8-alkanediols, polyetherpolyols, C1-C8-alkyl monoethers of polyetherpolyols, 5-, 6- or 7-membered lactones which may be substituted with one or more C1-C12-alkyl groups; 5-, 6- or 7-membered cyclic carbonates which may be substituted with one or more C1-C12-alkyl groups; Aliphatic esters, carboxamides, dioxolanes that may be substituted by one or more C1-C4-alkyl and / or C1-C4-hydroxyalkyl groups, aliphatic, alicyclic or heterocyclic amine-N-oxides and mixtures of the solvents mentioned above.

[00115] It should be noted that, in this context, organic solvents are not limited to “typical” solvents, i.e., organic compounds with solvation properties that are liquid at 25°C, but also include compounds with solvation properties that have a melting point above, at most, 50°C, and also compounds that exert their solvation properties only when mixed with water, such as the aliphatic, alicyclic or heterocyclic amine-N-oxides mentioned above, which would be more correctly termed solubilizers.

[00116] C1-C8-alkanols are R-OH compounds, where R is a linear or branched C1-C8 alkyl group. Examples include methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, isobutanol, tert-butanol, 1-pentanol, 1 Petition 870250094721, dated 10 / 16 / 2025, page 204 / 331 / 155 hexanol, 1-heptanol, 1-octanol, 2-ethylhexanol and (other) structural isomers of the last four 1-alkanols mentioned.

[00117] C2-C8-alkanediols are HO-A-OH compounds, where A is a C2-C8 linear or branched alkanedi-yl (or C2-C8 alkylene), in which the two OH groups are not geminal bonded (i.e., they are not bonded to the same carbon atom). Examples include ethylene glycol (1,2-ethanediol), propylene glycol (1,2-propanediol), 1,3-propanediol, 1,2-butanediol, 1,4-butanediol, 1,2-pentanediol, 1,5-pentanediol, 1,2-hexanediol, 1,6-hexanediol, 1,2-heptanediol, 1,2-octanediol, and the like.

[00118] C1-C8-Alkyl monoethers of C2-C8-alkanediols are compounds RO-A-OH, where A is as defined for the alkanediols above and R is C1-C8 alkyl. Examples include ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol mono-n-propyl ether, ethylene glycol monoisopropyl ether, ethylene glycol mono-n-butyl ether (butyl glycol), ethylene glycol monosec-butyl ether, ethylene glycol monoisobutyl ether, ethylene glycol monoterc-butyl ether, ethylene glycol monopentyl ether, ethylene glycol monohexyl ether, ethylene glycol monoheptyl ether, ethylene glycol monooctyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol mono-n-propyl ether, propylene glycol monoisopropyl ether, propylene glycol monon-butyl ether, propylene glycol monosec-butyl ether, ether propylene glycol monoisobutyl ether, propylene glycol mono-tert-butyl ether, propylene glycol monopentyl ether, propylene glycol monohexyl etherpropylene glycol monoheptyl ether, propylene glycol monooctyl ether, 1,3-propanediol monomethyl ether, 1,3-propanediol monoethyl ether, 1,3-propanediol mono-n-propyl ether, 1,3-propanediol monoisopropyl ether, 1,3-propanediol mono-n-butyl ether, 1,3-propanediol monosec-butyl ether, 1,3-propanediol monoisobutyl ether, 1,3-propanediol mono-tert-butyl ether, 1,3-propanediol monopentyl ether, ether, Petition 870250094721, dated 10 / 16 / 2025, page 205 / 331 / 155 monohexyl ether of 1,3-propanediol, monoheptyl ether of 1,3-propanediol, monooctyl ether of 1,3-propanediol and the like.

[00119] Polyetherpolyols are formally the etherification products of alkanediols and therefore HO-A-[OA]n-OH compounds, wherein each A is independently an alkylene group, usually a C2-C3 alkylene group, such as 1,2-ethylene, 1,2-propylene or 1,3-propylene, and en is from 1 to 100. Examples are polyethylene glycol, generally with a molecular weight of 106 to approximately 4500 (the term polyethylene glycol therefore includes diethylene glycol, triethylene glycol and other ethylene glycol oligomers), and polypropylene glycol, generally with a molecular weight of 134 to approximately 6000 (the term polypropylene glycol therefore includes dipropylene glycol, tripropylene glycol and other propylene glycol oligomers).

[00120] C1-C8-Alkyl monoethers of polyetherpolyols are ROA-[OA]n-OH compounds, where A and n are as defined for the polyetherpolyols above and R is C1-C8-alkyl.Examples include polyethylene glycol monomethyl ether, polyethylene glycol monoethyl ether, polyethylene glycol mono-n-propyl ether, polyethylene glycol mono-n-butyl ether, and the like.

[00121] Examples of 5, 6 or 7 membered lactones that can be substituted by one or more C1-C12-alkyl groups are γ-butyrolactone, γ-valerolactone, γ-octalactone, γ-nonalactone, δ-valerolactone, δ-decanolactone, δ-dodecanolactone and ε-caprolactone which may contain one or more C1-C12-alkyl substituents.

[00122] Examples of 5-, 6-, or 7-membered cyclic carbonates that can be substituted with one or more C1-C12-alkyl groups are ethylene carbonate, propylene carbonate, and butylene carbonate, which may contain one or more C1-C12-alkyl substituents.

[00123] Examples of suitable aliphatic esters are ethyl acetate, propyl acetate, butyl acetate, methylpropionate, ethyl propionate and other esters described below in context with the solvent (C-2). Petition 870250094721, dated 10 / 16 / 2025, page 206 / 331 / 155

[00124] Examples of suitable carboxamides are carboxamides of formula RC(=O)-NR'R'', wherein R is hydrogen, C1-C12-alkyl which may contain one or more hydroxyl groups, or C2-C12-alkenyl, and R' and R'', independently of each other, are hydrogen or C1-C12-alkyl which may contain one or more hydroxyl groups, or R' and R'' form, together with the nitrogen atom to which they are attached, a saturated 6-membered heterocyclic ring which may contain an additional heteroatom as a ring member selected from among O and N as a ring member. Examples of such rings are presented above. Preferably, the ring is morpholin-4-yl, i.e., morpholinyl linked through the ring nitrogen atom to RC(=O)-.Specific examples of carboxamide solvents are N,N-dimethylformamide, N,N-diethylformamide, N,N-dimethylacetamide, N,N-dimethyloctanamide, N,N-dimethylnonanamide, N,N-dimethyldecanamide, N,N-dimethyllactamide, octanylmorpholine and other carboxamides described below in context with solvent (C-1).

[00125] Examples of suitable dioxolanes that can be substituted with one or more C1-C4-alkyl and / or C1-C4-hydroxyalkyl groups are presented below in the context of the solvent (C-9).

[00126] Examples of suitable aliphatic, alicyclic or heterocyclic amine-N-oxides are N,N-dimethyl-N-ethylamine N-oxide, N,N,N-triethylamine N-oxide, N,N-dimethyl-N-cyclohexylamine N-oxide, N,N-dimethyl-N-ethanolamine (DMEAO) N-oxide and N-methylmorpholine N-oxide.

[00127] More preferably, the solvent is selected from the group consisting of C1-C8 alkanols, C2-C8 alkanediols, C1-C8 alkyl monoethers of C2C8 alkanediols, 5-, 6- or 7-membered lactones which may contain one or more C1-C12 alkyl groups and mixtures thereof. Among the C1-C8 alkanols, preference is given to C1-C4 alkanols, in particular C2-C3 alkanols (i.e., ethanol, n-propanol, isopropanol or a mixture thereof) and, specifically, n-propanol. Among the C2-C8 alkanediols, preference is Petition 870250094721, dated 10 / 16 / 2025, page 207 / 331 / 155, refers to C2-C4 alkanediols, in particular to C2-C3 alkanediols, such as ethylene glycol, 1,2-propanediol and 1,3-propanediol, and specifically to 1,2-propanediol (propylene glycol). Among the C1-C8 alkyl monoethers of C2-C8 alkanediols, preference is given to C1-C6 alkyl monoethers of C2-C4 alkanediols and in particular to C1-C4 alkyl monoethers of a C2-C3 alkanediol, such as C1-C4 alkyl monoethers of ethylene glycol or propylene glycol, specific examples being ethylene glycol mono-n-propyl ether, ethylene glycol mono-n-butyl ether (also called butylglycol), propylene glycol mono-n-propyl ether, propylene glycol mono-n-butyl ether and mixtures thereof. Among 5-, 6-, or 7-membered lactones that may contain one or more C1-C12-alkyl groups, preference is given to γ-butyrolactone, γ-valerolactone, γ-octalactone, γ-nonalactone, ε-caprolactone, and mixtures thereof.

[00128] In particular, the solvent is a C2-C8-alkanediol, more preferably a C2-C4-alkanediol, in particular a C2-C3-alkanediol, such as ethylene glycol, 1,2-propanediol and 1,3-propanediol, and specifically 1,2-propanediol (propylene glycol).

[00129] In another specific embodiment, the solvent is a C1-C8 alkanol, more preferably a C1-C4 alkanol, and in particular a C2-C3 alkanol (i.e., ethanol, n-propanol, isopropanol or a mixture thereof), specifically ethanol.

[00130] In particular, however, the composition further comprises (c) at least one organic solvent (which is obviously different from components (a) and (b)) selected from the group consisting of (c.1) carboxamides of formula (C-1) Petition 870250094721, dated 10 / 16 / 2025, pages 208 / 331 / 155 in which R4 is hydrogen or C1-C5-alkyl; R5 is C1-C5-alkyl; and R6 is C1-Cs-alkyl or C1-Cs-hydroxyalkyl; (c.2) carboxylic esters of formula (C-2) where R6 is C1-C5-alkyl or C1-C5-hydroxyalkyl; and R7é Ci-Cio-alkyla; (c.3) C3-Cs-alkanols; (c.4) C3-Cs-alkanediols; (c.5) C1-Cs-alkylmonoethers of C2-Cs-alkanediols; (c.6) diethylene glycol, dipropylene glycol, a polyethylene glycol with up to i0 repeating units or a polypropylene glycol with up to i0 repeating units; (c.7) C1-C5-alkyl monoethers of diethylene glycol or dipropylene glycol; (cs) lactones of the formula (Cs) wherein Rsé Ci-C5-alkyl; (c.9) dioxolanes of formula (C-9) Petition 870250094721, dated 10 / 16 / 2025, page 209 / 331 / 155 in which R9 and R10 are, independently, C1-C4 alkyl or together form an oxo group; and R11 is C1-C4-alkyl or C1-C4-hydroxyalkyl; and (c.10) mono-, di- or triesters of glycerol with C1-C4 carboxylic acids.

[00131] Examples of carboxamides of formula (C-1) are Nmethylacetamida, N,N-dimethylacetamida, N-ethylacetamida, N,N-diethylacetamida, N-etil-N-metilaacetamida, N-propylacetamida, N,N-dipropylacetamida, Nmetil-N-propylacetamida, N-ethyl-N-propylacetamida, N-isopropylacetamida, N,N-di-isopropylacetamida, N-metil-N-isopropylacetamida, N-etil-Nisopropylacetamida, Nn-butilacetamida, N,N-di-n-butilacetamida, Nn-butilN-metilaacetamida, Nn-butil-N-ethylacetamida, Nn-butil-N-propylacetamida, Nn-butil-N-isopropylacetamida, N-metilpropanamida, N,Ndimethylpropanamida, N-etilpropanamida, N,N-diethylpropanamida, N-ethyl-N-methylpropanamide, N-propylpropanamide, N,N-dipropylpropanamide, N-methylN-propylpropanamide, N-ethyl-N-propylpropanamide, N-isopropylpropanamide, N,N-di-isopropylpropanamide, N-methyl-N-isopropylpropanamide, N-ethyl-Nisopropylpropanamide, Nn-butylpropanamide, N,N-di-n-butylpropanamide, Nn-butyl-N-methylpropanamide, Nn-butyl-N-ethylpropanamide, Nn-butyl-N-propylpropanamide,Nn-butyl-N-isopropylpropanamida, N-methyl-lactamida (CH3CH(OH)C(O)N(H)CH3), N,N-dimetil-lactamida, N-etil-lactamida, N,Ndietil-lactamida, N-metil-N-etil-lactamida, N-propil-lactamida, N,N-dipropillactamida, N-metil-N-propil-lactamida, N, Petition: 870250094721, on 16 / 10 / 2025, p. 210 / 331 / 155 isopropil-lactamida, N,N-di-isopropil-lactamida, N-metil-N-isopropillactamida, N-etil-N-isopropil-lactamida and semelhantes.

[00132] Examples of carboxylic acids with the formula (C-2) are methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate, n-butyl acetate, n-hexyl acetate, 2-ethylhexyl acetate, methyl propionate, ethyl propionate, propyl propionate, isopropyl propionate, n-butyl propionate, n-hexyl propionate, 2-ethylhexyl propionate, methyl lactate, ethyl lactate, propyl lactate, isopropyl lactate, n-butyl lactate, n-hexyl lactate, 2-ethylhexyl lactate and the like.

[00133] C3-C8-Alkanols (c.3) are R-OH compounds where R is a linear or branched C3-C8-alkyl group, as defined above. Examples are n-propanol, isopropanol, n-butanol, sec-butanol, isobutanol, tert-butanol, 1-pentanol, 1-hexanol, 1-heptanol, 1-octanol, 2-ethylhexanol and (other) structural isomers of the last four 1-alkanols mentioned.

[00134] C3-C8-Alkanediols (c.4) are HO-A-OH compounds, wherein A is a linear or branched C3-C8-alkanedi-yl (or C3-C8-alkylene) group, in which the two OH groups are not geminal bonded (i.e., they are not bonded to the same carbon atom). Examples are propylene glycol (1,2-propanediol), 1,3-propanediol, 1,2-butanediol, 1,4-butanediol, 1,2-pentanediol, 1,5-pentanediol, 1,2-hexanediol, 1,6-hexanediol, 1,2-heptanediol, 1,2-octanediol and the like.

[00135] C1-C8-Alkyl monoethers of C2-C8-alkanediols (c.5) are RO-A-OH compounds, wherein A is 1,2-ethylene (-CH2CH2-) or is as defined for the C3-C8-alkanediols above, and R is C1-C8-alkyl. Examples are ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol mono-n-propyl ether, ethylene glycol monoisopropyl ether, ethylene glycol mono-n-butyl ether (butyl glycol), ethylene glycol monosec-butyl ether, ethylene glycol monoisobutyl ether, ethylene glycol monoterc-butyl ether, ethylene glycol monopentyl ether, ethylene glycol monohexyl ether Petition 870250094721, dated 10 / 16 / 2025, page. 211 / 331 / 155 ethylene glycol, ethylene glycol monoheptyl ether, ethylene glycol monooctyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol mono-n-propyl ether, propylene glycol monoisopropyl ether, propylene glycol mono-n-butyl ether, propylene glycol monosec-butyl ether, propylene glycol monoisobutyl ether, propylene glycol monotert-butyl ether, propylene glycol monopentyl ether, propylene glycol monohexyl ether, propylene glycol monoheptyl ether, propylene glycol monooctyl ether, 1,3-propanediol monomethyl ether, 1,3-propanediol monoethyl ether 1,3-propanediol mono-n-propyl ether, 1,3-propanediol monoisopropyl ether, 1,3-propanediol mono-n-butyl ether, 1,3-propanediol mono-sec-butyl ether, 1,3-propanediol monoisobutyl ether, 1,3-propanediol mono-tertbutyl ether, monopentyl ether of 1,3-propanediol,1,3-propanediol monohexyl ether, 1,3-propanediol monoheptyl ether, 1,3-propanediol monooctyl ether and the like.

[00136] Polyethylene glycols with up to 10 repeating units are oligomers or polymers of formula HO-A-[OA]n-OH, where A is a 1,2-ethylene (-CH2-CH2-) group and n is from 2 to 9.

[00137] Polypropylene glycols with up to 10 repeating units (classified in (c.6)) are oligomers or polymers of formula HO-A-[OA]n-OH, wherein A is a 1,2-propylene group (-CH(CH3)-CH2- or -CH2CH(CH3)-, and en is from 2 to 9.

[00138] C1-Cs-Alkyl monoethers of diethylene glycol (classified in (c.7)) are RO-CH2CH2-O-CH2CH2-OH compounds, where R is C1-C8-alkyl. Examples are diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol mono-n-propyl ether, diethylene glycol monoisopropyl ether, diethylene glycol mono-n-butyl ether (also called butyldiglycol), diethylene glycol monosec-butyl ether, diethylene glycol monoisobutyl ether, diethylene glycol mono-tert-butyl ether Petition 870250094721, dated 10 / 16 / 2025, page 212 / 331 / 155 diethylene glycol, diethylene glycol monopentyl ether, diethylene glycol monohexyl ether, diethylene glycol monoheptyl ether, diethylene glycol monooctyl ether and structural isomers thereof.

[00139] C1-C8-Alkyl monoethers of dipropylene glycol (classified in (c.7)) are compounds RO-CH(Ra)CH(Rb)-O-CH(Rc)CH(Rd)-OH, wherein R is C1-C8-alkyl, one of Rae Rb is H and the other is methyl, and one of Rc and Rd is H and the other is methyl. Examples include dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol mono-n-propyl ether, dipropylene glycol monoisopropyl ether, dipropylene glycol mono-n-butyl ether, dipropylene glycol monosec-butyl ether, dipropylene glycol monoisobutyl ether, dipropylene glycol mono-tert-butyl ether, dipropylene glycol monopentyl ether, dipropylene glycol monohexyl ether, dipropylene glycol monoheptyl ether, dipropylene glycol monooctyl ether, and structural isomers thereof.

[00140] Examples of lactones with the formula (C-8) are γ-valerolactone (R8= methyl; also known as γ-pentalactone), γ-caprolactone (R8= ethyl; also known as γ-hexalactone), γ-heptalactone (R8= n-propyl), γ-octalactone (R8= n-butyl) and γ-nonalactone (R8= n-pentyl).

[00141] Examples of dioxolanes of formula (C-9) are propylene carbonate (4-methyl-1,3-dioxolan-2-one; R9 and R10 together form an oxo group =O, R11= methyl), 4-ethyl-1,3-dioxolan-2-one (R9 and R10 together form an oxo group =O, R11= ethyl), isopropyldenglycerol (R9, R10= methyl, R11= hydroxymethyl) and the like.

[00142] Examples of mono-, di- or triesters of glycerol with C1-C4-carboxylic acids (c. 10) are glycerol monoacetate, glycerol diacetate and glycerol triacetate.

[00143] In a preferred embodiment of solvents (C-1), R6 is C1-C5-hydroxyalkyl, more preferably C1-C4-hydroxyalkyl, even more preferably C1-C2-hydroxyalkyl, specifically 1-hydroxyethyl. In Petition 870250094721, dated 10 / 16 / 2025, page 213 / 331 / 155 another preferred embodiment of solvents (C-1), R6 is C1-C4-alkyl or C1-C4-hydroxyalkyl, more preferably C1-C2-alkyl or C1-C2-hydroxyalkyl, specifically methyl or 2-hydroxyethyl.

[00144] R4 is preferably hydrogen or C1-C4-alkyl, more preferably hydrogen or C1-C2-alkyl, even more preferably C1-C2-alkyl (i.e., methyl or ethyl), specifically methyl.

[00145] R5 is preferably C1-C4-alkyl, more preferably C1-C2-alkyl (i.e., methyl or ethyl), specifically methyl.

[00146] Specifically, the solvent (c.1) with formula (C-1) is N,N-dimethyl-lactamide.

[00147] In a preferred embodiment of solvents (C-2), R6 is C1-C8-hydroxyalkyl, more preferably C1-C4-hydroxyalkyl, even more preferably C1-C2-hydroxyalkyl, specifically 1-hydroxyethyl. In another preferred embodiment of solvents (C-2), R6 is C1-C4-alkyl or C1-C4-hydroxyalkyl, more preferably C1-C2-alkyl or C1-C2-hydroxyalkyl, specifically methyl or 2-hydroxyethyl.

[00148] R7 is preferably C1-C10-alkyl, more preferably C1C10-alkyl, in particular C8-alkyl, specifically 2-ethylhexyl.

[00149] Specifically, the solvent (c.2) with formula (C-2) is 2-ethylhexyl-lactate.

[00150] The solvent (c.3) is preferably selected from C3-C4 alkanols, specifically n-propanol and n-butanol.

[00151] The solvent (c.4) is preferably selected from C4-C6 alkanediols, in particular from C5-alkanediols, specifically from 1,2-pentanediol and neopentyl glycol.

[00152] The solvent (c.5) is preferably selected from C1-C6 alkyl monoethers of C2-C3 alkanediols, more preferably C2-C5 alkyl monoethers of C2-C3 alkanediols, in particular C3-C4 alkyl monoethers of C2-C3 alkanediols, specifically 1-butoxy-propan-2-ol, (ether n Petition 870250094721, dated 10 / 16 / 2025, page 214 / 331 / 155 butyl propylene glycol), 1-butoxy-ethan-2-ol (butyl glycol; n-butyl ether of ethylene glycol) or 1-propoxy-propan-2-ol (n-propyl ether of propylene glycol).

[00153] The solvent (c.6) is preferably selected from diethylene glycol, dipropylene glycol, a polyethylene glycol (PEG) with a number average molecular weight of up to 200 or a polypropylene glycol (PPG) with a number average molecular weight Mn of up to 200, more preferably from dipropylene glycol or a polyethylene glycol with a number average molecular weight of up to 200, specifically dipropylene glycol. The number average molecular weight is determined by gel permeation chromatography using PEG standards.

[00154] The solvent (c.7) is preferably selected from C1-C-alkyl monoethers of diethylene glycol or dipropylene glycol, specifically from diethylene glycol mono-n-butyl ether, diethylene glycol mono-n-hexyl ether (hexyldiglycol) or dipropylene glycol monomethyl ether.

[00155] In solvents (c.8) of formula (C-8), R8 is preferably linear C1C4-alkyl, specifically methyl.

[00156] The solvent (c.9) is preferably selected from propylene carbonate (4-methyl-1,3-dioxolan-2-one; R9 and R10 together form an oxo group; R11 is methyl) or isopropylidene glycerol (2,2-dimethyl-4-(hydroxymethyl)-1,3dioxolan; R9 and R10 are methyl; R11 is hydroxymethyl).

[00157] The solvent (c.10) is preferably selected from glycerol monoacetate, glycerol diacetate and glycerol triacetate and is specifically glycerol triacetate (triacetin).

[00158] The organic solvent (c) is preferably selected from the group consisting of (c.1) carboxamide of formula (C-1), wherein R4 and R5 are methyl, and R6 is 1-hydroxyethyl (i.e., N,N-dimethyl-lactamide); (c.5) C3-C5-alkylmonoethers of C2-C3-alkanediols, in particular 1-butoxy-propan-2-ol; Petition 870250094721, dated 10 / 16 / 2025, page 215 / 331 / 155 (c.7) Ci-C-alkyl monoethers of diethylene glycol or dipropylene glycol, in particular, diethylene glycol mono-n-butyl ether; (c.8) lactone of formula (C-8), wherein R8 is methyl (i.e., γvalerolactone); and mixtures thereof.

[00159] In particular, the organic solvent is selected from the group consisting of N,N-dimethyl-lactamide, 1-butoxy-propan-2-ol, mono-n-butyl diethylene glycol ether (also called butyldiglycol), γvalerolactone and mixtures thereof.

[00160] The presence of solvent (c) is particularly beneficial if the antimicrobial agent is 2-phenoxyethanol. However, solvents can also be used when other antimicrobials are used.

[00161] The presence of solvent (c) does not preclude the presence of other organic solvents, such as those listed above.

[00162] The antimicrobial agent and the organic solvent of component (c) are preferably present in a total weight ratio of 10:1 to 1:10, more preferably 5:1 to 1:5, even more preferably 3:1 to 1:3, in particular 2:1 to 1:2, specifically 2:1 to 1:1.

[00163] In another preferred embodiment, the composition comprises water.

[00164] In another preferred embodiment, the composition comprises water and an organic solvent.

[00165] The ideal relative and absolute amounts of components (a) and (b), the presence, nature and amounts of optionally present solvents and water depend on the nature of the composition.

[00166] The composition of the invention may be a concentrate comprising the antimicrobial (a), the alkoxylated amine (I) and, optionally, a carrier, such as a diluent, for example, an organic solvent and / or water; or it may be an intermediate composition, i.e., a composition Petition 870250094721, dated 10 / 16 / 2025, page 216 / 331 / 155 that is not yet the ready-to-use composition for the end user, but already includes a portion of the other components (i.e., components other than the antimicrobial (a), the alkoxylated amine (I) and the optional carrier) of the final ready-to-use composition; or it may be a ready-to-use composition, i.e., a composition that is used as such and does not require further dilution or the addition of other substances.

[00167] Antimicrobials find application in a vast field. In principle, any system or material containing water lacking intrinsic protection (intrinsic protection may, for example, be present in systems containing a sufficiently high amount of alcohol and / or surfactant to prevent microbial infestation, etc.) is prone to microbial attack / infestation.

[00168] Examples of such systems, materials or products that require antimicrobial protection and / or that exert an antimicrobial action are compositions for household care (such as compositions for washing clothes, for example, detergents or fabric softeners; compositions for washing dishes; cleaning compositions, etc.), compositions for cleaning or disinfecting on an industrial scale (as opposed to domestic care carried out on a distinctly smaller scale), compositions for personal care (including cosmetics), process water, cooling water (e.g., in industrial plants, cooling towers), water in fish or shrimp tanks, water in drinking fountains, fluids for machining metals; water-based raw materials, polymer solutions, polymer dispersions, polymer emulsions, inorganic fluid pastes, organic fluid pastes, surface-active compositions; compositions for treating animal skin; compositions for treating leather; compositions for treating textiles during the manufacturing process; compositions for treating wood; compositions for treating paper or precursor material during the process. Petition 870250094721, dated 10 / 16 / 2025, page 217 / 331 / 155 paper manufacturing processes; compositions for crop protection; pharmaceutical compositions; inks, glues, adhesives, sealants, dyes, pigments and dispersions thereof, paints, wet wipes (for personal care, for household care, etc.) and similar products.

[00169] The composition of the invention is therefore preferably selected from the group consisting of antimicrobial concentrates, compositions for household care, compositions for cleaning or disinfection on an industrial scale, compositions for personal care, process water, cooling water, water in fish or shrimp tanks, water in drinking fountains, fluids for metal machining; water-based raw materials, polymer solutions, polymer dispersions, polymer emulsions, inorganic fluid pastes, organic fluid pastes, surface-active compositions; compositions for treating animal skin; compositions for treating leather; compositions for treating textiles during the manufacturing process; compositions for treating wood; compositions for treating paper or precursor material during papermaking processes; compositions for crop protection; pharmaceutical compositions;paints, glues, adhesives, sealants, dyes, pigments and dispersions thereof, inks and wet wipes.

[00170] Household cleaning compositions and industrial-scale cleaning or disinfection compositions (also called industrial and institutional cleaning or I&I cleaning) largely overlap, with the difference that I&I compositions are adapted for large-scale use and are therefore often more aggressive (e.g., being more concentrated and / or having a significantly higher or lower pH than the respective household cleaning composition) and / or are less “pleasant,” for example, in terms of odor, appearance, or touch. Furthermore, they are suitable for clean-in-place (CIP), which is an automated cleaning method for the internal surfaces of pipes, vessels, Petition 870250094721, dated 10 / 16 / 2025, page 218 / 331 / 155 equipment, filters and associated connections, among others, without the need for extensive disassembly.

[00171] Examples of compositions for household care and I&I are dishwashing compositions (in liquid or gel form), laundry compositions (in liquid or gel form; for example, laundry detergents, fabric softeners, rinsing compositions, bleaching compositions, stain removal compositions and the like), surface cleaning compositions (also called hard surface cleaners; for example, glass, floor, countertop, bathroom (bedroom) cleaning compositions, toilets, sinks, kitchens, appliances and furniture; multi-purpose cleaning products;sanitary cleaning products), non-cosmetic deodorants (e.g., air and / or surface deodorizers), disinfectants (e.g., spray air disinfectants, and spray, liquid and paste / gel surface disinfectants), surface protection and / or polishing compositions, carpet shampoos, descaling agents and compositions for wet wipes (e.g., for cleaning floors, furniture, bathroom surfaces, etc.).

[00172] Personal care compositions are used to cleanse, wash, disinfect, nourish, care for, protect, or beautify the human body (and therefore also include cosmetics). Examples include creams, lotions, ointments, other o / w or w / o emulsions, liquid or gel-like soaps, shampoos, makeup and other decorative cosmetics, and compositions for wet wipes (e.g., for cleaning the diaper area). More specific examples are preparations for washing and cleansing the skin in the form of soaps, syndets, washing gels, soap-free detergents or washing pastes, bath preparations, e.g., bubble baths, milks, oils, bath preparations; skin care preparations, e.g., skin emulsions, multi-emulsions, powders, sprays, or Petition 870250094721, dated 10 / 16 / 2025, page 219 / 331 / 155 skin oils; cosmetic preparations, for example, facial makeup in the form of day creams or powder creams, facial powders (loose or pressed), rouge or cream makeup, eye care products, for example, eyeshadow preparations, mascara, eyeliners, eye creams or eye area treatment creams; lip care preparations, for example, lipsticks, lip glosses, lip liner, nail care products, such as nail polishes, nail polish removers, nail hardeners or cuticle removers; foot care preparations, for example, foot washes, foot powders, foot creams or balms, special deodorants and antiperspirants or callus removal products;Protective preparations against light, such as sunscreens, lotions, creams or oils, sunscreens or tropical products, pre-tanning preparations or after-sun preparations; preparations for tanning the skin, for example, self-tanning creams; depigmenting preparations, for example, preparations for whitening the skin or preparations for lightening the skin; insect repellents, for example, insect repellent oils, lotions, sprays or sticks; deodorants, such as deodorant sprays, deodorant aerosols, pump sprays, deodorant gels, sticks or roll-ons, also water-free deodorant aerosols or sticks; antiperspirants, for example, antiperspirant sticks, creams or roll-ons; Preparations for cleaning and caring for blemished skin, for example, synthetic detergents (solid or liquid), peeling preparations or exfoliants or peeling masks;Preparations for chemical hair removal (depilation), for example, liquid depilatory products, depilatory products in cream or paste form, depilatory products in gel or aerosol foam form; shaving preparations, for example, shaving soaps, foaming shaving creams, non-foaming shaving creams, foams and gels, pre-shave preparations for dry shaving, aftershave or aftershave lotions; preparations of; Petition 870250094721, dated 10 / 16 / 2025, page 220 / 331 / 155 fragrances, for example, fragrances (cologne, eau de toilette, perfume water, toilet perfume, perfume), perfumed oils or perfumed creams;Cosmetic preparations for hair treatment, for example, hair washing products in the form of shampoos and conditioners, hair care products, for example, pre-treatment preparations, hair tonics, styling creams, styling gels, pomades, hair rinses, treatment packs, intensive hair treatments, hair structuring preparations, for example, hair curling preparations for permanent waves (hot waves, soft waves, cold waves), hair straightening preparations, liquid hair fixing preparations, hair mousses, fixatives, bleaching preparations, for example, hydrogen peroxide solutions, bleaching shampoos, bleaching creams, bleaching powders, bleaching pastes or oils, temporary, semi-permanent or permanent hair dyes, preparations containing self-oxidizing dyes or natural hair dyes, such as henna or chamomile;Anti-dandruff preparations in the form of shampoos, conditioners, hair tonics, styling creams or gels, or treatment packs; oral care preparations such as toothpastes, gels, mouthwashes, and sprays; disinfectants for the mouth or skin.

[00173] Process water is, for example, process water used in the food, feed, pharmaceutical or cosmetic industries (cooling and process water), or process water used in paper production, wood treatment, cooling water towers, air scrubbers, air conditioners, printing fluids or oil production.

[00174] Crop protection compositions, which are often also called plant protection compositions, are compositions that are effective against various harmful microorganisms, harmful invertebrate pests or undesirable plants relevant to agriculture, for example, harmful fungi, harmful invertebrate pests, such Petition 870250094721, dated 10 / 16 / 2025, pp. 221 / 331 / 155, such as harmful insects, arachnids, nematodes or mollusks, and weeds that cause damage to agricultural plants, plant propagation materials such as seeds, or harvested crops. Examples of crop protection compositions are fungicidal, insecticidal, acaricidal, nematicidal, molluscicidal, or herbicidal compositions. The term also encompasses plant growth regulator compositions. Plant growth regulators are phytopharmaceutical products used to influence plant growth and are used, for example, to increase the stability of cereals by shortening stem length, thus reducing or preventing lodging, to improve rooting of cuttings, reducing plant height in horticulture, preventing the germination of potatoes, and the like.The term also encompasses compositions used in the protection of materials to combat various harmful microorganisms and invertebrate pests, such as compositions for treating sawn timber or the surrounding area of ​​timber against termites, or compositions for treating mosquito nets against harmful insects such as Anopheles mosquitoes and the like. Antimicrobial concentrate

[00175] In a preferred embodiment, the composition is an antimicrobial concentrate. Preferably, the antimicrobial concentrate comprises: (a) 0.01 to 99.9% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.1 to 99.99% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 0 to 99.8% by weight, relative to the total weight of the composition, of one or more organic solvents, preferably as defined above, the solvent most preferably comprising a solvent Petition 870250094721, dated 10 / 16 / 2025, page 222 / 331 / 155 selected from solvents (c.1) to (c.10); (d) 0 to 20% by weight, relative to the total weight of the composition, of at least one additional additive; and (e) 0 to 99.8% by weight, relative to the total weight of the composition, of water.

[00176] The term “concentrate” is used in this context also for compositions in which components (a) and (b) do not constitute the major part (and therefore do not form a concentrate in the proper sense). However, it indicates that components other than (a), (b) and optional diluents (d) and (e), if present, do not predominate. Furthermore, the term indicates that the composition may consist only of components (a) and (b). Preferably, however, at least one diluent (d) or (e) or mixtures thereof are present to ensure easier handling.

[00177] If the antimicrobial agent is 2-phenoxyethanol, phenoxyisopropanol, formic acid or a salt thereof, benzoic acid or a salt thereof, sorbic acid or a salt thereof, lactic acid or a salt thereof, or N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine (diamine), it is preferably contained in an amount of 0.1 to 99.9% by weight, relative to the total weight of the composition.

[00178] The suitable and preferred components (a) and (b) and their suitable and preferred weight ratios are those mentioned above.

[00179] Other additives (c) are, for example, agents that stabilize the concentrate, such as emulsifiers and / or hydrotropic agents, activity enhancers other than component (b) and pH modifiers.

[00180] Any emulsifiers commonly used in such systems may be used. Some non-limiting examples are carboxylic acids and their salts, alkyl phosphates or phosphoric acid esters, ethoxylated and / or propoxylated fatty acids, ethoxylated and / or propoxylated polyethylene glycols, fatty alcohols. Petition 870250094721, dated 10 / 16 / 2025, page 223 / 331 / 155 ethoxylated and / or propoxylated fatty acid monoglycerides, sucrose esters of fatty acids, sorbitol esters of fatty acids, sorbitan esters of fatty acids, glucose esters of fatty acids, ethoxylated and / or propoxylated derivatives of listed fatty acid polyol esters, fatty acid sulfates and sulfonates, ethoxylated amines, ethoxylated amides, polysiloxane / polyalkyl / polyether copolymers and derivatives, poly(oxyethylene)-poly(oxypropylene) block polymers, zwitterionic surfactants having at least one quaternary ammonium group and at least one carboxylate and / or sulfonate group in the molecule.

[00181] Hydrotropic agents are compounds that solubilize hydrophobic compounds in aqueous solution by means other than micellar solubilization. Similar to surfactants, hydrotropes often (but not necessarily) consist of a hydrophilic part and a hydrophobic part, but unlike surfactants, the hydrophobic part is usually too small to cause spontaneous self-aggregation. Examples are aromatic salts of sulfonic acids, such as alkali metal, alkaline earth metal, or ammonium salts of p-toluenesulfonic acid (e.g., sodium, potassium, calcium, or ammonium p-tosylate), of xylenesulfonic acids (e.g., sodium, potassium, calcium, or ammonium salts of o-, m-, or p-xylenesulfonates), or of cumenesulfonic acids, usually of p-cumenesulfonic acid (e.g., sodium, potassium, calcium, or ammonium salts of p-cumenesulfonate); Adenosine triphosphate (ATP); and urea.

[00182] Examples of activity enhancers other than component (b) are ethylhexylglycerin (3-(2-ethylhexyloxy)propane-1,2-diol) and polyethyleneimines (PEI). Further details are provided below in the context of household care compositions.

[00183] pH modifiers are acids, bases, and also buffers.

[00184] Acids can be inorganic or organic. Acids Petition 870250094721, dated 10 / 16 / 2025, page 224 / 331 / 155 Suitable inorganic acids are, for example, sulfuric acid, hydrochloric acid and phosphoric acid, wherein sulfuric acid is generally preferred. Suitable organic acids are, for example, unsubstituted, saturated, C1-C6 aliphatic mono-, di- and tricarboxylic acids, such as formic acid, acetic acid, propanoic acid, oxalic acid, succinic acid and glutaric acid; saturated, saturated, C1-C6 aliphatic mono-, di- and tricarboxylic acids containing one or more OH groups, such as lactic acid, tartaric acid and citric acid; unsaturated, C1-C6 aliphatic mono-, di- and tricarboxylic acids, such as sorbic acid; Aromatic carboxylic acids, such as benzoic acid, salicylic acid, and mandelic acid; and sulfonic acids, such as methanesulfonic acid or toluenesulfonic acid.

[00185] Suitable bases are, in particular, inorganic bases, such as the carbonates mentioned below in the context of the sequestrant, for example, sodium or potassium carbonate; other alkali metal hydroxides and alkaline earth flours, such as NaOH or KOH.

[00186] Suitable buffering agents are typical systems such as hydrogen phosphate / dihydrogen phosphate buffer, carbonate / hydrogen carbonate buffer, acetic acid / acetate buffer, or Tris buffer. In addition, most of the acids mentioned above, which are weak and whose anion is not a strong salt, also have buffering capacity.

[00187] Suitable organic solvents (c) are those mentioned above. Preferred organic solvents are therefore C1-C8-alkanols, C2-C8-alkanediols, C1-C8-alkyl monoethers of C2-C8-alkanediols, polyetherpolyols, C1-C8-alkyl monoethers of polyetherpolyols, 5-, 6- or 7-membered lactones which may be substituted by one or more C1-C12-alkyl groups; 5-, 6- or 7-membered cyclic carbonates which may be substituted by one or more C1-C12-alkyl groups; aliphatic esters, carboxamides, dioxolanes as defined above, aliphatic or alicyclic amine-N-oxides and mixtures of the solvents mentioned above. Examples of such groups of solvents Petition 870250094721, dated 16 / 10 / 2025, p. 225 / 331 / 155, is mentioned above. More preferably, the solvent (c) is selected from C1-C8 alkanols, C2-C8 alkanediols, C1-C8 alkyl monoethers of C2-C8 alkanediols, 5-, 6- or 7-membered lactones which may contain one or more C1-C12 alkyl groups and mixtures thereof. Among the C1-C8 alkanols, preference is given to C1-C4 alkanols, in particular C2-C3 alkanols (i.e., ethanol, n-propanol, isopropanol or a mixture thereof) and, specifically, n-propanol. Among the C2-C8 alkanediols, preference is given to the C2-C4 alkanediols, in particular the C2-C3 alkanediols, such as ethylene glycol, 1,2-propanediol and 1,3-propanediol, and specifically to 1,2-propanediol (propylene glycol).Among the C1-C8 alkyl monoethers of C2-C8 alkanediols, preference is given to C1-C-alkyl monoethers of C2-C4 alkanediols and in particular to C1-C4 alkyl monoethers of a C2-C3 alkanediol, such as C1-C4 alkyl monoethers of ethylene glycol or propylene glycol, specific examples being ethylene glycol mono-n-propyl ether, ethylene glycol mono-n-butyl ether (also called butylglycol), propylene glycol mono-n-propyl ether, propylene glycol mono-n-butyl ether and mixtures thereof. Among 5-, 6-, or 7-membered lactones that may contain one or more C1-C12-alkyl groups, preference is given to γ-butyrolactone, γ-valerolactone, γ-octalactone, γ-nonalactone, ε-caprolactone, and mixtures thereof.

[00188] In particular, the solvent is a C2-C8-alkanediol, more preferably a C2-C4-alkanediol, in particular a C2-C3-alkanediol, such as ethylene glycol, 1,2-propanediol and 1,3-propanediol, and specifically 1,2-propanediol (propylene glycol).

[00189] In another specific embodiment, the solvent is a C1-C8 alkanol, more preferably a C1-C4 alkanol, and in particular a C2-C3 alkanol (i.e., ethanol, n-propanol, isopropanol or a mixture thereof), specifically n-propanol.

[00190] In another specific embodiment, the solvent comprises Petition 870250094721, dated 10 / 16 / 2025, page 226 / 331 / 155 less one of the solvents (c.1) to (c.10) as defined above and, if desired, also another organic solvent. More particularly, the solvent comprises N,N-dimethyl-lactamide, 1-butoxy-propan-2-ol, mono-n-butyl diethylene glycol ether, γ-valerolactone or a mixture of two or more of these solvents and, if desired, also a C2-C3-alkanol (i.e., ethanol, n-propanol, isopropanol or a mixture thereof) and / or a C2-C3alkanediol, such as ethylene glycol, 1,2-propanediol and 1,3-propanediol, and specifically 1,2-propanediol (propylene glycol).

[00191] In one specific embodiment, the antimicrobial concentrate comprises: (a) 1 to 99.9% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.1 to 99% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 0 to 98.9% by weight, in relation to the total weight of the composition, of one or more organic solvents, preferably as defined above, the solvent comprising more preferably a solvent selected from solvents (c.1) to (c.10); and (d) 0 to 15% by weight, in relation to the total weight of the composition, of at least one additional additive; (e) 0 to 98.9% by weight, relative to the total weight of the composition, of water.

[00192] In another specific embodiment, the antimicrobial concentrate comprises: (a) 5 to 90% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 10 to 95% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different Petition 870250094721, dated 10 / 16 / 2025, page 227 / 331 / 155 alkoxylated amines (I), as defined above; (c) 0 to 85% by weight, in relation to the total weight of the composition, of one or more organic solvents, preferably as defined above, the solvent comprising more preferably a solvent selected from solvents (c.1) to (c.10); and (d) 0 to 10% by weight, in relation to the total weight of the composition, of at least one additional additive; (e) 0 to 85% by weight, relative to the total weight of the composition, of water. Compositions for Home Care and I&I

[00193] Examples of compositions for household care and I&I are listed above. Among these, preference is given to dishwashing compositions, laundry compositions, surface cleaning compositions and carpet shampoos.

[00194] Thus, in another preferred embodiment, the composition of the invention is selected from the group consisting of dishwashing compositions, laundry compositions, surface cleaning compositions and carpet shampoos. Such compositions preferably comprise: (a) 0.001 to 7% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.001 to 7% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 0 to 15% by weight, relative to the total weight of the composition, of at least one organic solvent, preferably as defined above, the solvent most preferably comprising a solvent selected from solvents (c.1) to (c.10); (d) 0.1 to 40% by weight, in relation to the total weight of Petition 870250094721, dated 10 / 16 / 2025, page 228 / 331 / 155 composition, of one or more surfactants; (e) 0 to 6 by weight, relative to the total weight of the composition, of at least one enzyme; (f) 0 to 20% by weight, in relation to the total weight of the composition, of at least one sequestrant; (g) 0 to 8% by weight, in relation to the total weight of the composition, of at least one antifoaming agent and / or foam stabilizer; (h) 0 to 50% by weight, relative to the total weight of the composition, of an additional additive; and (i) 10 to 99.898% by weight, relative to the total weight of the composition, of water; where components (a) to (i) add up to 100% by weight.

[00195] The suitable and preferred components (a) and (b) and their suitable and preferred weight ratios are those mentioned above.

[00196] Suitable organic solvents (c) are those mentioned above. Preferred organic solvents are therefore C1-Cs-alkanols, C2-C8-alkanediols, C1-Cs-alkyl monoethers of C1-Cs-alkanediols, polyetherpolyols, C1Cs-alkyl monoethers of polyetherpolyols, 5-, 6- or 7-membered lactones which may be substituted by one or more C1-C12-alkyl groups; 5-, 6- or 7-membered cyclic carbonates which may be substituted by one or more C1-C12-alkyl groups; aliphatic esters, carboxamides, aliphatic or alicyclic amine-N-oxides and mixtures of the solvents mentioned above. Examples of these groups of solvents are mentioned above. More preferably, the solvent (c) is selected from C1-C8-alkanols, C2-C8-alkanediols, C1-C8-alkyl monoethers of C2-C8-alkanediols, 5, 6 or 7 membered lactones which may contain one or more C1-C12-alkyl groups and mixtures thereof.Among the C1-Cs alkanols, preference is given to C1-C4 alkanols, in particular to C2-C3 alkanols (i.e., ethanol, n-propanol, isopropanol, or a mixture thereof) and, specifically, n-propanol. Petition 870250094721, dated 10 / 16 / 2025, pp. 229 / 331 / 155 Among the C2-Cs alkanediols, preference is given to C2-C4 alkanediols, in particular to C1-Cs alkanediols, such as ethylene glycol, 1,2-propanediol and 1,3-propanediol, and specifically to 1,2-propanediol (propylene glycol). Among the C1-C5 alkyl monoethers of C1-C5 alkanediols, preference is given to C1-C6 alkyl monoethers of C2-C4 alkanediols and in particular to C1-C4 alkyl monoethers of a C2-C3 alkanediol, such as C1-C4 alkyl monoethers of ethylene glycol or propylene glycol, specific examples being ethylene glycol monon-propyl ether, ethylene glycol mono-n-butyl ether (also called butylglycol), propylene glycol mono-n-propyl ether, propylene glycol mono-n-butyl ether and mixtures thereof. Among 5-, 6-, or 7-membered lactones that may contain one or more C1-C12-alkyl groups, preference is given to γ-butyrolactone, γ-valerolactone, γ-octalactone, γ-nonalactone, ε-caprolactone, and mixtures thereof.

[00197] In particular, the solvent is a C2-Cs-alkanediol, more preferably a C2-C4-alkanediol, in particular a C2-C3-alkanediol, such as ethylene glycol, 1,2-propanediol and 1,3-propanediol, and specifically 1,2-propanediol (propylene glycol).

[00198] In another specific embodiment, the solvent is a C1-Csalkanol, more preferably a C1-C4-alkanol, and in particular a C2-C3alkanol (i.e., ethanol, n-propanol, isopropanol or a mixture thereof), specifically n-propanol.

[00199] In another specific embodiment, the solvent comprises at least one of the solvents (c.1) to (c.10) as defined above and, if desired, also another organic solvent. More particularly, the solvent comprises N,N-dimethyl-lactamide, 1-butoxy-propan-2-ol, mono-n-butyl diethylene glycol ether, γ-valerolactone or a mixture of these solvents and, if desired, also a C2-C3-alkanol (i.e., ethanol, n-propanol, isopropanol or a mixture thereof) and / or a C2-C3-alkanediol, such as ethylene glycol, 1,2-propanediol and 1,3-propanediol, and specifically 1,2-propanediol (propylene glycol).

[00200] The surfactants (or surfactant compounds) of component (d) may be anionic, cationic, nonionic or amphoteric (zwitterionic).

[00201] Anionic surfactants are, for example, of the sulfate, sulfonate or carboxylate type, or mixed forms thereof. Examples are alkylbenzenesulfonates, alkyl sulfates, alkyl ether sulfates, olefin sulfonates, fatty acid salts, alkyl and alkenyl ether carboxylates or an alpha-sulfonic fatty acid salt or an ester thereof.

[00202] More specific examples are alkylbenzenesulfonates with 10 to 20 carbon atoms in the alkyl radical (e.g., sodium dodecylbenzene sulfonate), alkyl sulfates with 8 to 18 carbon atoms in the alkyl radical (e.g., sodium lauryl sulfate), alkyl ether sulfates with 8 to 18 carbon atoms in the alkyl radical (e.g., sodium laureth sulfate; SLES), and fatty acid salts derived from oils or fats, e.g., palm oil or tallow, with 8 to 18 carbon atoms in the alkyl portion (therefore containing, inter alia, sodium oleate, linolate, palmitate, myristate, stearate, etc.). The countercation is preferably an alkali metal cation, especially sodium or potassium, specifically sodium. Preferred carboxylates are alkali metal sarcosinates with the formula RCON(R')CH2COO-M+ where R' is C9-C17-alkyl or C9-C17-alkenyl, R' is C1-C4-alkyl and M+ is an alkali metal cation, especially Na+.

[00203] Cationic surfactants are, for example, ammonium salts, such as Cs-C16-dialkyldimethylammonium halides, dialkoxydimethylammonium halides, or imidazolinium salts with a long-chain alkyl radical.

[00204] Non-ionic surfactants are, for example, a primary or secondary alcohol ethoxylate, especially an ethoxylated C8-C20 aliphatic alcohol with an average of 1 to 20 moles of ethylene oxide per alcohol group. Preference is given to C10-C15 primary and secondary aliphatic alcohols. Petition 870250094721, dated 10 / 16 / 2025, page 231 / 331 / 155 ethoxylated with an average of 1 to 10 mol of ethylene oxide per alcohol group. Non-ethoxylated nonionic surfactants, for example, alkyl polyglycosides, glycerol monoethers and polyhydroxyamides (glucamide), may also be used.

[00205] Amphoteric surfactants are, for example, derivatives of secondary or tertiary amines, for example, C6-C18-alkyl betaines (e.g., cocoamidopropyl betaine; disodium cocoamphodiacetate (DSCADA)) or C6C15-alkyl sulfobetaines, or amine oxides, such as alkyldimethylamine oxides.

[00206] Examples of enzymes from component (e) are those typically used in compositions for laundry, dishwashing or cleaning products.

[00207] Enzyme, in this context, means catalytically active proteins that are characterized by an amino acid sequence. Variants of an enzyme can be described by a certain sequence identity of an amino acid sequence of the variant when compared to a respective initial sequence. For the calculation of sequence identities, in a first step, a global alignment of pairwise sequences must be produced, which means that two sequences must be aligned along their entire length, normally using the Needleman and Wunsch algorithm (J. Mol. Biol. (1979) 48, p. 443-453). Preferably, the “NEEDLE” program (The European Molecular Biology Open Software Suite (EMBOSS)) is used for the purposes of the present invention, using the standard program parameters (gap open=10.0, gap extend=0.5 and matrix=EBLOSUM62).In a second step, the % identity is calculated: % identity = (identical residues / length of the alignment region showing the respective sequence of this invention along its entire length) * 100.

[00208] The enzymes are preferably selected from hydrolases, Petition 870250094721, dated 10 / 16 / 2025, pp. 232 / 331 / 155, such as proteases, esterases, glycosidases, lipases, DNases, amylases, cellulases, mannanases, other glycosyl hydrolases, and mixtures of the enzymes mentioned above. All these hydrolases contribute to the dissolution and removal of dirt from stains / residues containing proteins, greases, or starch. Oxidoreductases can also be used for bleaching. Particularly suitable are active enzymatic ingredients obtained from bacterial or fungal strains, such as Bacillus subtilis, Bacillus licheniformis, Streptomyceus griseus, and Humicola insolens.

[00209] Preferred hydrolases are selected from the group of enzymes that act on ester linkages (esterases) (EC 3.1), glycosylases (EC 3.2), and peptidases (EC 3.4). Enzymes that act on ester linkages (EC 3.1) are, for example, lipases and DNases. Glycosylases (EC 3.2) are, for example, amylases, cellulases, and mannanases. Peptidases are, for example, proteases.

[00210] Suitable hydrolases are, for example, α-glucosidases (EC number 3.2.1.20), proteases (e.g., Ovozyme® (from Novozymes); EC number 3.2.1.20), amylases [e.g., Purastar® (from Genencor), Termamyl® (from Novozymes), Stainzyme® (from Novozymes), Duramyl® (from Novozymes)], mannanases [e.g., Purabrite® (from Genencor), Mannastar® (from Genencor), Mannaway® (from Novozymes)] and cellulases [e.g., Carezyme® (from Novozymes), Celluzyme® (from Novozymes), endolase, Puradax® (from Genencor)]. Suitable amylases include especially α-amylases (EC number 3.2.1.1), isoamylases, pullulanases, and pectinases. The cellulases used are preferably cellobiohydrolases, endoglucanases, and β-glucosidases, also called cellobiases, or mixtures thereof. Since different types of cellulase differ in their CMCase and Avicelase activities, it is possible to establish the desired activities through controlled mixtures of cellulases.

[00211] Suitable lipases include, for example, Lipex and Lipolase. Examples of lipolytically active enzymes are the well-known cutinases. Petition 870250094721, dated 10 / 16 / 2025, pp. 233 / 331 / 155

[00212] Peroxidases or oxidases have also proven suitable in some cases.

[00213] In one aspect, the enzymes comprise at least one protease (EC 3.4). In a preferred embodiment, at least one protease is selected from serine proteases (EC 3.4.21), more preferably from subtilisins (EC 3.4.21.62). At least one subtilisin may have SEQ ID NO:22, as described in EP 1921147 (which may be referred to as BLAP WT here), or be a variant thereof that is at least 80% identical to SEQ ID NO:22, as described in EP 1921147, and that has proteolytic activity. In one embodiment, a subtilisin is at least 80% identical to SEQ ID NO:22, as described in EP 1921147, and is distinguished by having the amino acid glutamic acid (E), or aspartic acid (D), or asparagine (N), or glutamine (Q), or alanine (A), or glycine (G), or serine (S) at position 101 (according to BPN' numbering), preferably R101E.

[00214] In one embodiment, at least one subtilisin is at least 80% identical to SEQ ID NO:22, as described in EP 1921147, with the mutations (according to BPN' numbering) S3T + V4I + V205I. In one embodiment, at least one subtilisin is at least 80% identical to SEQ ID NO:22, as described in EP 1921147, with the mutations (according to BPN' numbering) S3T + V4I + R101E + V205I. In one embodiment, at least one subtilisin is at least 80% identical to SEQ ID NO:22, as described in EP 1921147, with the mutation (according to BPN' numbering) S3T + V4I + V199M + V205I + L217D. In one embodiment, at least one subtilisin has an amino acid sequence that is at least 80% identical to SEQ ID NO:22, as described in EP 1921147, with the mutations S3T + V4I + S9R + A15T + V68A + D99S + R101S + A103S + I104V + N218D (according to BPN numbering). At least one subtilisin has an amino acid sequence that is at least 80% identical to SEQ ID NO:22. Petition 870250094721, dated 10 / 16 / 2025, p. 234 / 331 / 155 as described in EP 1921147 and with the R101E mutation along with one or more selected substitutions from the group consisting of S156D, L262E, Q137H, S3T, R45E,D,Q, P55N, T58W,Y,L, Q59D,M,N,T, G61D,R, S87E, G97S, A98D,E,R, S106A,W, N117E, H120V,D,K,N, S125M, P129D, E136Q, S144W, S161T, S163A,G, Y171L, A172S, N185Q, V199M, Y209W, M222Q, N238H, V244T, N261T,D and L262N,Q,D (as described in WO 2016 / 096711 and in accordance with BPN numbering).

[00215] In one aspect, the enzymes comprise at least one amylase, preferably at least one alpha-amylase (EC 3.2.1.1). Preferably, the enzymes comprise at least one alpha-amylase selected from hybrid amylases. In one embodiment, the enzymes comprise at least one hybrid amylase at least 95% identical to SEQ ID NO: 23 of WO 2014 / 183920. In one embodiment, the enzymes comprise at least one hybrid amylase 95% identical to SEQ ID NO: 30 of WO 2014 / 183921.

[00216] In one aspect, the detergent formulations comprise at least one lipase, preferably at least one triacylglycerol lipase (EC 3.1.1.3).

[00217] Preferably, the enzymes comprise at least one triacylglycerol lipase from Thermomyces lanuginosus. In one embodiment, said lipase is at least 80% identical to amino acids 1-269 of SEQ ID NO:2 of US5869438. In one embodiment, said lipase comprises at least the amino acid substitutions T231R and N233R. In one embodiment, the enzymes comprise at least one lipase comprising T231R and N233R and one or more of the following amino acid substitutions, when compared to amino acids 1-269 of SEQ ID NO:2 of US5869438: Q4V, V60S, A150G, L227G, P256K.

[00218] In one embodiment, the enzymes comprise at least one lipase that is at least 95% identical to the complete polypeptide sequence of Petition 870250094721, dated 10 / 16 / 2025, p. 235 / 331 / 155 amino acids 1-269 of SEQ ID NO:1 of document WO 2015 / 01009, preferably comprising at least N11K / A18K / G23K / K24A / V77I / D130A / V154I / V187T / T189Q amino acid substitutions or N11K / A18K / G23K / K24A / L75R / V77I / D130A / V154I / V187T / T189Q.

[00219] In one aspect, the enzymes comprise at least one cellulase, preferably at least one beta-1,4-glucanase (EC 3.2.1.4), also called endoglucanase herein. In one embodiment, the enzymes comprise at least one endoglucanase from Humicola insolens DSM 1800 at least 80% identical to the amino acid sequence described in Figure 14A-E of WO 91 / 17244, preferably to the sequence according to amino acids 20-434. Preferably, the so-called endoglucanase has one or more substitutions at positions selected between 182, 223 and 231, more preferably selected between P182S, A223V and A231V. In one embodiment, the enzymes comprise at least one endoglucanase that is at least 80% identical to a polypeptide according to SEQ ID NO: 2 of WO 95 / 02675. In another embodiment, the enzymes comprise at least one endoglucanase from Bacillus sp. that is at least 80% identical to the amino acid sequence from position 1 to position 773 of SEQ ID NO: 2 of WO 2004 / 053039.In one embodiment, the enzymes comprise at least one endoglucanase from Thielavia terrestris that is at least 80% identical to the amino acid sequence from position 1 to position 299 of SEQ ID NO:4 of document WO 2004 / 053039.

[00220] In one aspect, the enzymes comprise at least one mannanase, preferably at least one beta-mannanase (EC 3.2.1.78). In one embodiment, the enzymes comprise at least one beta-mannanase selected from the GH5 family of mannanases. In one embodiment, the enzymes comprise at least one beta-mannanase at least 90% identical to SEQ ID NO:12 of WO 2018 / 184767. In one embodiment, the enzymes comprise at least one beta-mannanase at least 90% identical to Petition 870250094721, dated 10 / 16 / 2025, pp. 236 / 331 / 155 SEQ ID NO:16 of WO 2018 / 184767. In one embodiment, the enzymes comprise at least one beta-mannanase that is at least 90% identical to SEQ ID NO:20 of WO 2018 / 184767. Preferably, the enzymes comprise at least one mannanase that is 95% identical to a polypeptide sequence of SEQ ID NO:20 of WO 2018 / 184767 having at least one substitution selected from A101V, E405G, and Y459F. In one embodiment, the enzymes comprise at least one beta-mannanase originating from Trichoderma organisms, such as those described in WO 93 / 24622. Preferably, at least one beta-mannanase is 80% identical to SEQ ID NO:1 of WO 2008 / 009673. More preferably, the betamannanase according to SEQ ID NO: 1 of document WO 2008 / 009673 comprises at least one substitution selected from S3R, S66P, N113Y, V181H, L207F, A215T and F274L.

[00221] In one aspect, the detergent formulations comprise at least one DNase. In one embodiment, the enzymes comprise at least one DNase at least 80% identical to SEQ ID NO: 1-24 and SEQ ID NO: 27-28 of WO 2019 / 081724 and WO 2019 / 081721. Preferably, the enzymes comprise at least one DNase comprising one or both of the motifs selected from SEQ ID NO: 25 and SEQ ID NO: 26 of WO 2019 / 081724. In one embodiment, the enzymes comprise at least one DNase comprising one or more motifs selected from SEQ ID NO: 73, SEQ ID NO: 74 and SEQ ID NO: 75 of WO 2017 / 060493.

[00222] If the composition is a dishwashing composition, it preferably comprises at least one protease and / or amylase. More preferably, it comprises a mixture of enzymes. Preference is given, for example, to enzyme mixtures comprising or consisting of the following enzymes: - protease and amylase, Petition 870250094721, dated 10 / 16 / 2025, pp. 237 / 331 / 155 - protease and lipase (or lipolytically active enzymes), - protease and cellulase, - protease and mannanase, - amylase, cellulase, and lipase (or lipolytically active enzymes), - protease, amylase, and lipase (or lipolytically active enzymes), - protease, lipase (or lipolytically active enzymes), and cellulase, - protease, lipase (or lipolytically active enzymes) and mannanase, - protease, amylase, lipase (or lipolytically active enzymes) and mannanase.

[00223] Liquid formulations for automatic dishwashing generally comprise at least one subtilisin protease, as described herein, in amounts of about 0.10% to 0.25% by weight, more preferably about 0.12% to 0.21% by weight, all relative to the total weight of the detergent formulation.

[00224] Liquid formulations for automatic dishwashing generally comprise at least one alpha-amylase, as described herein, in amounts of about 0.002% to 0.015% by weight, more preferably 0.004% to 0.01% by weight, all relative to the total weight of the detergent formulation.

[00225] Liquid formulations for hand dishwashing generally comprise at least one subtilisin protease, as described herein, in amounts of about 0.005% to 0.15% by weight, more preferably about 0.01% to 0.1% by weight, all relative to the total weight of the detergent formulation.

[00226] Liquid formulations for hand dishwashing generally comprise at least one alpha-amylase, as described herein, in amounts of about 0.001% to 0.015% by weight, more preferably Petition 870250094721, dated 10 / 16 / 2025, pp. 238 / 331 / 155, from 0.002% to 0.015% by weight, all in relation to the total weight of the detergent formulation.

[00227] Liquid formulations for hand dishwashing generally comprise at least one triacylglycerol lipase, as described herein, in amounts of about 0.001% to 0.005% by weight, more preferably 0.001% to 0.002% by weight, all relative to the total weight of the detergent formulation.

[00228] Liquid formulations for hand dishwashing generally comprise at least one endoglucanase, as described herein, in amounts of about 0.001% to 0.01% by weight, more preferably 0.002% to 0.009% by weight, all relative to the total weight of the detergent formulation.

[00229] Liquid formulations for hand dishwashing generally comprise at least one beta-mannanase, as described herein, in amounts of about 0.0005% to 0.005% by weight, more preferably 0.0005% to 0.002% by weight, all relative to the total weight of the detergent formulation.

[00230] Similar preferences apply to surface cleaning compositions.

[00231] If the composition is a composition for washing clothes, it preferably comprises at least one of amylases, lipases, proteases and cellulases. More preferably, it comprises a mixture of enzymes. Some illustrative mixtures are: - protease and amylase, - protease and cellulase, - cellulase and amylase, - amylase, cellulase, and lipase (or lipolytically active enzymes), - protease, amylase, and lipase (or lipolytically active enzymes), - protease, lipase (or lipolytically active enzymes) and Petition 870250094721, dated 10 / 16 / 2025, pp. 239 / 331 / 155 cellulase, - protease, lipase (or lipolytically active enzymes) and mannanase, - protease, amylase, lipase (or lipolytically active enzymes) and mannanase.

[00232] Liquid formulations for washing clothes generally comprise at least one subtilisin protease, as described herein, in amounts of about 0.005% to 0.15% by weight, more preferably about 0.01% to 0.1% by weight, all relative to the total weight of the detergent formulation.

[00233] Liquid formulations for laundry generally comprise at least one alpha-amylase, as described herein, in amounts of about 0.001% to 0.015% by weight, more preferably 0.002% to 0.015% by weight, all relative to the total weight of the detergent formulation.

[00234] Liquid formulations for washing clothes generally comprise at least one triacylglycerol lipase, as described herein, in amounts of about 0.001% to 0.005% by weight, more preferably 0.001% to 0.002% by weight, all relative to the total weight of the detergent formulation.

[00235] Liquid formulations for washing clothes generally comprise at least one endoglucanase, as described herein, in amounts of about 0.001% to 0.01% by weight, more preferably 0.002% to 0.009% by weight, all relative to the total weight of the detergent formulation.

[00236] Liquid formulations for laundry generally comprise at least one beta-mannanase, as described herein, in amounts of about 0.0005% to 0.005% by weight, more preferably 0.0005% to 0.002% by weight, all relative to the total weight of the formulation. Petition 870250094721, dated 10 / 16 / 2025, pp. 240 / 331 / 155 detergent.

[00237] Enzymes can be adsorbed onto carriers to protect them from premature decomposition.

[00238] If the composition includes one or more enzymes, it may also contain enzyme stabilizers (for more details, see component (h)).

[00239] Enzymes or enzyme packets suitable for such compositions are commercially available. Examples are the Lavergy® brand from BASF.

[00240] Sequestrants (f), also called builders, structural substances, framework substances, complexing agents, chelating agents, chelating agents or softeners, bind alkaline earth metals and other water-soluble metal salts without precipitating. They help break down dirt, disperse dirt components, separate dirt and, in some cases, have a washing effect themselves. Many of the sequestrants listed below are multifunctional, meaning that the substances have additional functions such as dispersing activity or anti-graying properties.

[00241] Suitable sequestrants may be of an organic or inorganic nature. Examples include aluminosilicates, carbonates, phosphates and polyphosphates, polycarboxylic acids, polycarboxylates, hydroxycarboxylic acids, phosphonic acids, for example, hydroxyalkylphosphonic acids, phosphonates, aminopolycarboxylic acids and salts thereof, and polymeric compounds containing carboxylic acid groups and salts thereof.

[00242] Suitable inorganic sequestrants are, for example, crystalline or amorphous aluminosilicates with ion-exchange properties, such as zeolites. Suitable crystalline silicates as sequestrants are, for example, disilicates or sheet silicates, for example, 5-Na2Si2O5 or BPetition 870250094721, 10 / 16 / 2025, page 241 / 331 / 155 NaiSiiOs (SKS 6 or SKS 7). Suitable inorganic carbonate-based scavenging substances are carbonates and bicarbonates. These can be used in the form of their alkali metal, alkaline earth metal, or ammonium salts. Phosphates commonly used as inorganic scavengers are alkali metal orthophosphates and / or polyphosphates, for example, pentasodium triphosphate.

[00243] Suitable organic sequestrants are, for example, C4-C30-di-, -tri- and -tetracarboxylic acids, for example, succinic acid, propanetricarboxylic acid, butanetetracarboxylic acid, cyclopentanetetracarboxylic acid and alkyl- and alkenylsuccinic acids with C2-C20-alkyl or -alkenyl radicals. Suitable organic sequestrants are also hydroxycarboxylic acids and polyhydroxycarboxylic acids (sugar acids). These include C4-C20-hydroxycarboxylic acids, for example, malic acid, tartaric acid, glutonic acid, mucic acid, lactic acid, glutaric acid, citric acid, tartronic acid, glucoheptonic acid, lactobionic acid and sucrose mono-, di- and tricarboxylic acids. Among these, preference is given to citric acid and its salts. Suitable organic sequestrants also include phosphonic acids, for example, hydroxyalkylphosphonic acids or aminophosphonic acids, and salts thereof.These include, for example, phosphonobutanetricarboxylic acid (2-phosphinobutane-1,2,4-tricarboxylic acid; PBTC), aminotris-methylenephosphonic acid (N[CH2PO(OH)2]s), aminotris(methylenephosphonate), sodium salt (ATMP; N[CH2PO(ONa)2]3), ethylenediaminetetra(methylenephosphonic) acid (EDTMPA), hexamethylenediamine(tetramethylenephosphonic acid), hexamethylenediamine(tetramethylenephosphonate), potassium salt (CioH(28x)N2KxO12P4 (x=6)), bis(hexamethylene)triamine(pentamethylenephosphonic acid) ((HO2)POCH2N[(CH2)2N[CH2PO(OH)2]2]2), diethylenetriamine-penta(methylenephosphonic acid) (DTPMP; (HO)2POCH2N[CH2CH2N[CH2PO(OH)2]2]2), diethylenetriaminepenta(methylenephosphonate), sodium salt (<7I I(28-xN3NaxOi5P5. Petition 870250094721, of 10 / 16 / 2025, page 242 / 331 / 155 (x=7)); tetramethylenetriaminepentaphosphonic acid, hydroxyethylamine diphosphonic acid, 2-hydroxyethyliminobis(methylenephosphonic) acid (HOCHiCH2N[CH2PO(OH)2]2), morpholinomethanediphosphonic acid, 1-hydroxy-C1- to C10-alkyl-1,1-diphosphonic acids such as 1-hydroxyethane-1,1-diphosphonic acid (HEDP; CH2C(OH)[PO(OH)2]2). Suitable organic sequestrants are, in addition, polyaspartic acids. Polyaspartic acid includes salts of polyaspartic acids. Salt-forming cations can be monovalent or multivalent, examples being sodium, potassium, magnesium, calcium, ammonium, and the ammonium salt of mono-, di-, and triethanolamine. Such polymers can be copolymers, in particular of (a) L- or Daspartic acid (preferably L-aspartic acid), (b) a carboxylic acid, and (c) a diamone or an amino alcohol. Such copolymers generally comprise 70–95 mol% of (a), 5–30 mol% of (b), and 2–20 mol% of (c).The molar ratio of the carboxyl-containing compound (b) to the diamine or amino alcohol (c) is preferably between 5:1 and 1:1.5 or between 3:1 and 1:1.2, and more preferably between 3:1 and 1:1 or 2:1 and 1:1.Suitable organic sequestrants are additionally aminopolycarboxylic acids, such as nitrilotriacetic acid (NTA), dipropionic nitrilomonoacetic acid, nitrilotripropionic acid, β-alaninediacetic acid (β-ADA), ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentacetic acid, 1,3-propylenediaminetetraacetic acid, 1,2-propylenediaminetetraacetic acid, N-(alkyl)ethylenediaminotriacetic acid, N(hydroxyalkyl)ethylenediaminotriacetic acid, ethylenediaminotriacetic acid, cyclohexylene-1,2-diaminotetraacetic acid, iminodisuccinic acid, ethylenediaminodisuccinic acid, serinodiacetic acid, isoserinodiacetic acid, L-asparaginediacetic acid, L-glutaminediacetic acid, methylglycinodiacetic acid (MGDA), and the salts of the aminopolycarboxylic acids mentioned above. Suitable organic sequestrants are, additionally, polymeric compounds containing carboxylic acid groups, such as... Petition 870250094721, dated 10 / 16 / 2025, page 243 / 331 / 155 acrylic acid homopolymers. The term "acrylic acid homopolymer" also includes polymers in which some or all of the carboxylic acid groups are present in the neutralized form. Suitable polymeric compounds containing carboxylic acid groups are also oligomaleic acids. Suitable polymeric compounds containing carboxylic acid groups are also terpolymers of unsaturated C4-C8 dicarboxylic acids. Suitable unsaturated C4-C8 dicarboxylic acids in this context are, for example, maleic acid (or maleic anhydride), fumaric acid, itaconic acid, aconitic acid, mesaconic acid, methylenemalonic acid, and citraconic acid.Suitable polymeric compounds containing carboxylic acid groups are also homopolymers of monoethylenically unsaturated C3-C8 monocarboxylic acids, for example, acrylic acid, methacrylic acid, crotonic acid, 2-ethylacrylic acid, 2-phenylacrylic acid, cinnamic acid, vinylacetic acid and sorbic acid; copolymers of dicarboxylic acids, for example, of maleic acid and acrylic acid; terpolymers of maleic acid, acrylic acid and a vinyl ester of a C1-C3 carboxylic acid; and copolymers of maleic acid with C2-C8 olefins.

[00244] Antifoaming agents and / or foam stabilizers (g) are, for example, soaps, paraffins and silicone oils.

[00245] Other additives (h) are, for example, hydrotropic agents, acids, bases, buffering agents, enzyme stabilizers, bleaching agents, corrosion inhibitors, colorants, fragrances, thickeners, activity enhancers other than component (b), and inorganic salts.

[00246] Hydrotropic agents are compounds that solubilize hydrophobic compounds in aqueous solution by means other than micellar solubilization. Similar to surfactants, hydrotropes often (but not necessarily) consist of a hydrophilic part and a hydrophobic part, but, unlike surfactants, the hydrophobic part is usually too small to cause self-aggregation. Petition 870250094721, dated 10 / 16 / 2025, page 244 / 331 / 155 spontaneous. Examples are aromatic salts of sulfonic acid, such as alkali metal salts, alkaline earth metal salts or ammonium salts of p-toluenesulfonic acid (e.g., sodium, potassium, calcium or ammonium p-tosylate), of xylenesulfonic acids (e.g., sodium, potassium, calcium or ammonium salts of o-, m- or p-xylenesulfonates) or of cumenesulfonic acids, generally of p-cumenesulfonic acid (e.g., sodium, potassium, calcium or ammonium salts of p-cumenesulfonate); adenosine triphosphate (ATP); and urea.

[00247] Acids can be inorganic or organic. Suitable inorganic acids are, for example, sulfuric acid, hydrochloric acid and phosphoric acid, wherein sulfuric acid is generally preferred. Suitable organic acids are, for example, unsubstituted, saturated aliphatic C1-C6-mono-, di- and tricarboxylic acids, such as formic acid, acetic acid, propanoic acid, oxalic acid, succinic acid and glutaric acid; saturated aliphatic C1-C6-mono-, di- and tricarboxylic acids containing one or more OH groups, such as lactic acid, tartaric acid and citric acid; unsaturated aliphatic C1-C6-mono-, di- and tricarboxylic acids, such as sorbic acid; aromatic carboxylic acids, such as benzoic acid, salicylic acid and mandelic acid; and sulfonic acids, such as methanesulfonic acid or toluenesulfonic acid.Organic acids primarily serve to adjust the pH of the composition, but some of them, for example, di- and tricarboxylic acids, can also act as sequestrants.

[00248] Suitable bases are, in particular, inorganic bases, such as the carbonates mentioned in the context of the sequestrant, for example, sodium or potassium carbonate; other hydroxides of alkali metals and alkaline earth metals, such as NaOH or KOH.

[00249] Suitable buffering agents are typical systems, such as hydrogen phosphate / dihydrogen phosphate buffer, buffer of Petition 870250094721, dated 10 / 16 / 2025, pp. 245 / 331 / 155 carbonate / bicarbonate, acetic acid / acetate buffer or Tris buffer. Furthermore, most of the acids mentioned above, which are weak and whose anion is not a strong salt, also have buffering capacity.

[00250] If the composition comprises one or more enzymes, it may also comprise enzyme stabilizers, for example, calcium propionate, sodium formate, boric acid or salts thereof, boronic acids and salts thereof, polyols, peptide aldehydes and / or antioxidants.

[00251] Suitable boronic acids are, for example, aromatic and heteroaromatic boronic acids, such as benzeneboronic acid (BBA; also called phenylboronic acid (PBA)), 4-formylphenylboronic acid (4-FPBA), 2-FPBA, 3-FPBA, 4-carboxyphenylboronic acid (4-CPBA), 4-(hydroxymethyl)-phenylboronic acid (4HMPBA), p-tolylboronic acid (p-TBA), (2-acetamidophenyl)boronic acid, 2-bromophenylboronic acid, 3-bromophenylboronic acid, 4-bromophenylboronic acid, 2-chlorophenylboronic acid, 3-chlorophenylboronic acid, 4-chlorophenylboronic acid, 2,4-dichlorophenylboronic acid, 3,5-dichlorophenylboronic acid, acid 4-fluorophenylboronic acid, 3-chloro-4-fluorophenylboronic acid, 1,3,5-trimethylphenylboronic acid,3,5-bis(trifluoromethyl)phenylboronic acid, 4-methoxyphenylboronic acid, 4-(methylthio)phenylboronic acid, 3-aminophenylboronic acid, 4-(trimethylsilyl)phenylboronic acid, 4,4-biphenyldiboronic acid, 1-naphthylboronic acid, 2-naphthylboronic acid, 6-hydroxy-2-naphthaleneboronic acid, 9-anthraceneboronic acid, 2-furanylboronic acid, 3-furanylboronic acid, 2-thienylboronic acid, 3-thienylboronic acid, 5-chlorothiopheneboronic acid, 3-bromothiopheneboronic acid, 5-bromothiopheneboronic acid, 5-methyl-2-thienylboronic acid, 4-methylthiopheneboronic acid, dimethylthiopheneboronic acid, 3-methoxy-2-thiophenoboronic acid, 2-benzofuranylboronic acid, 4-dibenzofuranboronic acid, 1-benzothiophene-2-boronic acid, dibenzothiopheneboronic acid, 1-tiantrenylboronic acid and 2-benzothiophenic acid, Petition 870250094721, dated 10 / 16 / 2025, page 246 / 331 / 155 tiantenilboronic acid. Other examples are p-methylphenylethylboronic acid, diphenylboronic acid anhydride, and octylboronic acid. Mixtures of two or more different boronic acids are also suitable. Suitable salts of the boronic acids mentioned above are, for example, alkali metal salts, such as sodium or potassium salts, alkaline earth metal salts, such as magnesium and calcium salts, and ammonium salts.

[00252] Suitable polyols are, for example, polyols containing 2 to 6 hydroxyl groups, such as ethylene glycol, propylene glycol, 1,2-propanediol, 1,2-butanediol, 1,2-pentanediol, hexylene glycol, glycerol, sorbitol, mannitol, erythriol, glucose, fructose and lactose.

[00253] Peptide aldehydes are C-terminal reduced oligopeptides (i.e., in which the C(O)OH group is reduced to an aldehyde group [CH(O)]). Suitable peptide aldehydes are, for example, di-, tri- or tetrapeptide aldehydes and aldehyde analogs (any of the form B1-BO-R wherein R is H, CH3, CX3, CHX2 or CH2X (wherein X = halogen), BO is a single amino acid residue including one with an optionally substituted aliphatic or aromatic side chain; and B1 represents one or more (e.g., 1, 2 or 3) amino acids, optionally comprising an N-terminal protecting group, or is a protease inhibitor of the protein type, such as RASI, BASI, WASI (bifunctional alpha-amylase / subtilisin inhibitors of rice, barley and wheat) or CI2 or SSI.

[00254] A suitable bleaching agent is hydrogen peroxide.

[00255] In addition, as mentioned above, some enzymes have bleaching properties.

[00256] Colorants can be added to achieve a specific aesthetic appearance, but they can also be used as shading colorants to reduce or prevent the (auto)oxidation of composition components, especially unsaturated organic compounds, triggered by UV or visible light (for example, if the container in which the Petition 870250094721, dated 10 / 16 / 2025, page 247 / 331 / 155. The composition is maintained to allow the transmission of UV or visible light) and / or catalysis of transition metal ions (if present). If used as shading dyes, they generally impart a violet or blue color. Shading dyes are particularly useful in laundry compositions, such as laundry detergents or fabric softeners, where they can help prevent yellowing of fabrics.

[00257] Examples of shading dyes include direct dyes (also known as substantive dyes; water-soluble dyes with an affinity for fibers, which are absorbed directly; generally azo dyes), for example, direct violet 7, direct violet 9, direct violet 11, direct violet 26, direct violet 31, direct violet 35, direct violet 40, direct violet 41, direct violet 51 and direct violet 99; in addition, direct violet 66; acid dyes, such as azine dyes, for example, acid blue 98, acid violet 50 and acid blue 59, acid violet 50 and acid blue 98 being preferred; or non-azine dyes, for example, acid violet 17, acid black 1 and acid blue 29; hydrophobic dyes (dyes that do not contain water-solubilizing charged groups;generally selected from the groups of disperse and solvent dyes, in particular anthraquinone and monoazo blue and violet dyes), for example, solvent violet 13, disperse violet 27, disperse violet 26, disperse violet 28, disperse violet 63 and disperse violet 77; basic dyes (organic dyes that have a net positive charge and deposit on cotton), for example, triarylmethane basic dyes, methane basic dyes, anthraquinone basic dyes, basic blue 16, basic blue 65, basic blue 66, basic blue 67, basic blue 71, basic blue 159, basic violet 19, basic violet 35, basic violet 38, basic violet 48; basic blue 3, basic blue 75, basic blue 95, basic blue 122, basic blue 124, basic blue 141; Reactive dyes (dyes that contain an organic group capable of reacting with cellulose and binding the dye to the cellulose by covalent bonding, depositing itself on the cotton), for example, reactive blue 19, reactive blue; Petition 870250094721, dated 10 / 16 / 2025, pp. 248 / 331 / 155 163, reactive blue 182, reactive blue 96; and dye conjugates (formed by the bonding of direct, acidic or basic dyes to polymers or particles by means of physical forces).

[00258] Fragrances can be of natural or synthetic origin; their nature is generally not critical. By way of example only, natural aromatic substances include extracts of flowers (lilies, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, cumin, juniper), fruit peel (bergamot, lemons, oranges), roots (apple, angelica, celery, cardamom, water cane, iris, calamus), wood (pine, sandalwood, guaiacum wood, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme), needles and branches (firs, pines, Scots pines, mountain pines), resins and balsams (galbanum, elemi, benzoin, myrrh, frankincense, opoponax). Animal-based raw materials are also considered, for example, civet and castoreum.Also, by way of example only, synthetic aromatic substances are, for instance, products of the ester, ether, aldehyde, ketone, alcohol, or hydrocarbon type. Examples of ester-type aromatic compounds include benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethylmethylphenylglycinate, allylcyclohexyl propionate, styralyl propionate, and benzyl salicylate.Ethers include, for example, benzyl ethyl ether; aldehydes include, for example, linear alkanals having 8 to 18 hydrocarbon atoms, citral, citronellal, citronellyl oxyacetaldehyde, cyclamaldehyde, hydroxycitronellal, lilial, and bourgeonal; ketones include, for example, ionones, isomethyl ionone, and methyl cedryl ketone; alcohols include, for example, anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenyl ethyl alcohol, and terpineol; and hydrocarbons include mainly terpenes and balsams. It is preferable... Petition 870250094721, dated 10 / 16 / 2025, pp. 249 / 331 / 155, however, use mixtures of various aromatic substances that, together, produce an attractive fragrance. Ethereal oils of relatively low volatility, which are mainly used as aroma components, are also suitable as essential oils, for example, sage oil, chamomile oil, clove oil, lemon balm oil, cinnamon leaf oil, linden flower oil, juniper oil, vetiver oil, frankincense oil, galbanum oil, lablanum oil, and lavender oil.Preference is given to the use of bergamot oil, dihydromyrcenol, lilial, liral, citronellol, phenyl ethyl alcohol, hexyl cinnamaldehyde, geraniol, benzyl acetone, cyclamen aldehyde, linalool, boisambrene forte, ambroxan, indole, hedione, sandelice, lemon oil, tangerine oil, orange oil, allyl amyl glycolate, ciclovertal, lavender oil, muscat sage oil, amanhecer, bourbon geranium oil, cyclohexyl salicylate, vertofix coeur, iso-E-Super, Fixolide NP, evernil, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romillat, irotyl and floramat alone or in mixtures with each other.

[00259] Additional examples include alpha-hexyl cinnamaldehyde, 2-phenoxyethyl isobutyrate (Phenirat1), dihydromyrcenol (2,6-dimethyl-7-octen2-ol), methyl dihydrojasmonate (preferably with a cis isomer content greater than 60% by weight) (Hedione9, Hedione HC9), 4,6,6,7,8,8-hexamethyl1,3,4,6,7,8-hexahydrocylopenta[g]benzopyran (Galaxolide3), tetrahydrolinalool (3,7-dimethyloctan-3-ol), ethyl linalool, benzyl salicylate, 2-methyl3-(4-tert-butylphenyl)propanal (Lilial2), cinnamic alcohol, acetate of 4,7-methane-3a,4,5,6,7,7a-hexahydro-5-indenyl and / or 4,7-methane-3a,4,5,6,7,7a-hexahydro-6-indenyl acetate (Herbaflorat1), citronellol, citronellyl acetate, tetrahydrogeraniol, vanillin, linalyl acetate, styryl acetate (1-phenylethyl acetate), octahydro-2,3,8,8-tetramethyl-2-acetonefetone and / or 2-acetyl-1,2,3,4,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene (Iso E Super3), hexyl salicylate, 4-tert-butylcyclohexyl acetate (Oryclone1), 2-tert-Petition 870250094721,of 16 / 10 / 2025, p. 250 / 331 / 155 butylcyclohexyl (Agrumex HC1), alpha-ionone (4-(2,2,6-trimethyl-2-cyclo-hexen1-yl)-3-buten-2-one), n-alpha-methylionone, alpha-isomethylionone, coumarin, acetate, terpinyl alcohol, 2-phenyl 4-(4-hydroxy-4-methylpentyl)-3-cyclohexenocarboxaldehyde (Lyral3), alpha-amylcinamaldehyde, ethylene braszylate, (E)e / ou (Z)-3-methylcyclopentadecene-5-one (Muscenone9), 15-pentadecene-11olideo / ou 15-pentadecene-12-olide (Globalide1), 15-cyclopentadecanolide (Macrolide1), 1-(5,6,7,8-tetra-hydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)ethanone (Tonalide10), 2-isobutyl-4-methyltetra-hydro-2H-pyran-4-ol (Florol9), 2-ethyl-4(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol (Sandolene1), cis-3hexenyl acetate, trans-3-hexene acetate, trans-2-cis-6-nonadienol, 2,4-dimethyl-3cyclo-hexenocarboxaldehyde (Vertocitral1), 2,4,4,7-tetramethyl-oct-6-en-3-one (Claritone1), 2,6-dimethyl-5-heptenal (Melonal2), boropyl-propyl(33) (Florhydral2), 2-methyl-3-(3,4-(methylenedioxyphenyl)propanal (Helional3), 3-(4-ethylphenyl)-2,2-dimethylpropanal (Florazon1), 7-methyl-2H-1,5-benzodioxepin-3(4H)-one (Calone19515), 3,3,5-trimethylcyclohexyl acetate (preferably with a cis isomer content of 70% by weight or more) and 2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-ol (Ambrinol S1).

[00260] If trade names have been specified above, they refer to the following sources: 1 Trade name of Symrise GmbH, Germany; USA; 2 Trade name of Givaudan AG., Switzerland; 3 Trade name of International Flavors & Fragrances Inc., 5 Trade name of Danisco Seillans SA, France; 9 Trade name of Firmenich SA, Switzerland; 10 Trade name of PFW Aroma Chemicals BV, Netherlands.

[00261] Fragrances may optionally be incorporated into encapsulated form. Petition 870250094721, dated 10 / 16 / 2025, pp. 251 / 331 / 155

[00262] Thickeners are used to impart the desired viscosity to the composition of the invention.

[00263] Any known thickener (rheology modifier) ​​is suitable in principle, provided it does not exert any adverse effect on the effectiveness of the composition. Suitable thickeners may be of natural or synthetic origin.

[00264] Thickeners of natural origin are mainly derived from polysaccharides. Examples include xanthan gum, gellan gum, locust bean flour, guar flour or gum, carrageenan, agar, tragacanth gum, gum arabic, alginates, modified starches such as hydroxyethyl starch, starch phosphate esters or starch acetates, dextrins, pectins and cellulose derivatives such as carboxymethylcellulose, hydroxyethylcellulose, hydrophobically modified hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose and the like. Other examples include bacterial cellulose, i.e., any type of cellulose produced by the fermentation of a bacterium of the genus Acetobacter, such as CELLULON® (CPKelco, USA), including materials called microfibrillated cellulose or cross-linked bacterial cellulose; and non-bacterial cellulose, such as cellulosic fibers extracted from vegetables, fruits or wood, like Avicel® from FMC, Citri-Fi from Fiberstar or Betafib from Cosun.

[00265] Thickeners of natural origin are also inorganic thickeners, such as polysilicic acids and clay minerals, such as sheet silicates, and also the silicates mentioned for the reinforcing agents. More specific examples are listed in the following table. Most are derived from smectite clays and silica derivatives.

[00266] Examples of synthetic thickeners are polyacrylic and polymethacrylic compounds, such as (partially) crosslinked acrylic acid homopolymers, for example, acrylic acid homopolymers that have been crosslinked with an allylic ether of sucrose or pentaerythritol, or Petition 870250094721, dated 10 / 16 / 2025, page. 252 / 331 / 155 with propylene (carbomers), for example, the Carbopol® trademarks of BF Goodrich (e.g., Carbopol® 676, 940, 941, 934 and the like) or the Polygel® trademarks of 3V Sigma (e.g., Polygel® DA), copolymers of ethylenically unsaturated mono- or dicarboxylic acids, for example, terpolymers of acrylic acid, methacrylic acid or maleic acid with methyl acrylate or ethyl acrylate and a (meth)acrylate derived from long-chain ethoxylated alcohols, for example, the Acusol® trademarks of Rohm & Haas (e.g., Acusol® 820 or 1206A), copolymers of two or more monomers selected from acrylic acid, methacrylic acid and their C1-C4-alkyl esters, for example, copolymers of methacrylic acid, butyl acrylate and methyl methacrylate or of butyl acrylate and methyl methacrylate, for example, the Rohm & Haas brands Aculyn® and Acusol® (for example, Aculyn® 22, 28 or 33 and Acusol® 810, 823 and 830),or crosslinked high molecular weight acrylic acid copolymers, for example, C10-C30-alkyl acrylate copolymers with one or more comonomers selected from acrylic acid, methacrylic acid and their C1-C4-alkyl esters, said copolymers having been crosslinked with an allylic ether of sucrose or pentaerythritol (for example, Carbopol® ETD 2623, Carbopol® 1382 or Carbopol® AQUA 30 from Rohm & Haas).

[00267] Suitable thickeners are also phospholipids, such as alkylated phosphatidylcholine, phosphobetaines or quaternary alkylphosphate compounds.

[00268] Examples of synthetic thickeners are also reaction products of maleic acid polymers with ethoxylated long-chain alcohols, for example, the Surfonic L series from Texaco Chemical Co. or Gantrez AN-119 from ISP; polyethylene glycols, polyamides, polyimines and polycarboxylic acids.

[00269] Examples of synthetic thickeners are, in addition, dibenzylidene polyol acetal derivatives (DBPA derivatives). These may comprise a dibenzylidene sorbitol acetal derivative (DBS). The said Petition 870250094721, dated 10 / 16 / 2025, page 253 / 331 / 155 A derivative of DBS may be selected from the group consisting of: 1,3:2,4-dibenzylidene sorbitol; 1,3:2,4-di(p-methylbenzylidene) sorbitol; 1,3:2,4-di(p-chlorobenzylidene) sorbitol; 1,3:2,4-di(2,4-dimethyldibenzylidene) sorbitol; 1,3:2,4-di(p-ethylbenzylidene) sorbitol; 1,3:2,4-di(3,4-dimethyldibenzylidene) sorbitol; and mixtures thereof.

[00270] Suitable thickeners are, moreover, di-starch gelling agents, for example, selected from those with a molecular weight of about 150 g / mol to about 1,500 g / mol, or even from about 500 g / mol to about 900 g / mol. Such di-starch gelling agents may comprise at least two nitrogen atoms, wherein at least two of these nitrogen atoms form starch functional substitution groups. The starch groups may be different or identical. Examples are compounds of the formula Ra-C(=O)-NHL-C(=O)-Rb, wherein Ra and R are terminal groups with amino function or terminal groups with starch function, and L is a linking moiety with a molecular weight of 14 to 500 g / mol. Rae Rb may comprise a pH-adjustable group, wherein the pH-adjustable starch gelling agent may have a pKa of about 1 to about 30, or even of about 2 to about 10. The pH-adjustable group may comprise a pyridine. L may comprise a carbon chain comprising between 2 and 20 carbon atoms.L may comprise a pH-adjustable group. The pH-adjustable group may be a secondary amine.

[00271] Examples of synthetic thickeners are also non-polymeric crystalline structuring agents with a hydroxyl function. Said compound may comprise a crystallizable glyceride that can be pre-emulsified to aid dispersion in the final liquid detergent formulation. The crystallizable glycerides may comprise hydrogenated castor oil or “HCO” or its derivatives, provided they are capable of crystallizing in the liquid formulation.

[00272] Mixtures of the aforementioned thickeners are also suitable.

[00273] Suitable activity enhancers, other than Petition 870250094721, dated 10 / 16 / 2025, page 254 / 331 / 155 component (b), are, in particular, the PEI.

[00274] EIPs are ethylenediamine polymers and can be characterized by repeating groups of the empirical formula -[CH2-CH2-NH]n-, where n ranges from approximately 10 to 100,000, for example, from 10 to 15,000. EIPs can be linear or branched (branched forms are not correctly reflected in the formula above; however, the formula should also symbolize branched forms), where branching can result in dendrimers, star-shaped polymers, hyperbranched polymers, and other branched forms. Branched polyethyleneimines can be characterized by their degree of branching (DB). The DB can be determined, for example, by 13C NMR spectrometry and is defined as follows: DB = D + T / (D + T + L) where D represents the fraction of tertiary amino groups, L (linear) represents the fraction of secondary amino groups, and T (terminal) represents the fraction of primary amino groups. Preferably, DB ranges from 0.1 to 0.95, more preferably from 0.25 to 0.90, in particular from 0.30 to 0.80, and specifically from 0.5 to 0.8.

[00275] Preferably, the PEIs used in the present compositions have a weight-average molecular mass (Mw) of 500 to 1,000,000 g / mol, more preferably 600 to 75,000 g / mol and, in particular, 800 to 25,000 g / mol, as determined by gel permeation chromatography (GPC with PEG or PMMA standard; specifically with multi-angle light scattering detector (MALS) of the respective polyalkyleneimine intermediate, with 1.5 wt% aqueous formic acid as eluent and crosslinked polyhydroxyethyl methacrylate as stationary phase).

[00276] In a specific embodiment, the PEIs used in the present compositions are grafted with ethylene oxide (EO) and / or propylene oxide (PO). Typically, the PEI is grafted with 5 to 100 moles of oxide. Petition 870250094721, dated 10 / 16 / 2025, page 255 / 331 / 155 of alkylene per mole of PEI.

[00277] If present, PEI is typically contained in the home care or I&I composition in an amount of 0.001 to 10% by weight, preferably 0.001 to 1% by weight, relative to the total weight of the composition.

[00278] Suitable PEIs are commercially available, for example, under the BASF brand names Lupasol® and Sokolan® HP.

[00279] Suitable inorganic salts are, for example, sodium chloride and calcium chloride.

[00280] In a specific embodiment, the composition of the invention is a dishwashing composition. Dishwashing compositions preferably comprise: (a) 0.001 to 7% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.001 to 7% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 0 to 15% by weight, relative to the total weight of the composition, of at least one organic solvent, preferably as defined above, the solvent most preferably comprising a solvent selected from solvents (c.1) to (c.10); (d) 0.1 to 40% by weight, relative to the total weight of the composition, of one or more surfactants; (e) 0 to 6% by weight, relative to the total weight of the composition, of at least one enzyme; (f) 0 to 20% by weight, in relation to the total weight of the composition, of at least one sequestrant; (g) 0 to 8% by weight, in relation to the total weight of the composition, of at least one antifoaming agent and / or foam stabilizer; Petition 870250094721, dated 10 / 16 / 2025, page 256 / 331 / 155 (h) 0 to 50% by weight, in relation to the total weight of the composition, of an additional additive; and (i) 10 to 99.898% by weight, in relation to the total weight of the composition, of water; where components (a) to (i) add up to 100% by weight.

[00281] These dishwashing compositions are in liquid or gel form and are suitable for both machine and hand washing. As a general rule, compositions for hand dishwashing should be adapted so as not to present any risk to the user. For example, the amount of acids and / or bases optionally present is such that the resulting pH does not harm the user's skin.

[00282] The suitable and preferred components (a) to (h) are those listed above.

[00283] Dishwashing compositions may additionally comprise, as component (h), anti-graying polymers and scale inhibitors or dispersers.

[00284] More particularly, the composition of the invention is a dishwashing composition comprising: (a) 0.001 to 5% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.01 to 7% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 0 to 5% by weight, relative to the total weight of the composition, of at least one organic solvent, preferably as defined above, the solvent comprising more preferably a solvent selected from solvents (c.1) to (c.10); (d) 5 to 25% by weight, in relation to the total weight of the composition, of one or more surfactants; Petition 870250094721, dated 10 / 16 / 2025, page 257 / 331 / 155 (e) 0 to 6% by weight, in relation to the total weight of the composition, of at least one enzyme; (f) 0 to 20% by weight, in relation to the total weight of the composition, of at least one sequestrant; (g) 0 to 8% by weight, in relation to the total weight of the composition, of at least one antifoaming agent and / or foam stabilizer; (h) 0 to 50% by weight, relative to the total weight of the composition, of an additional additive; and (i) 10 to 94.989% by weight, relative to the total weight of the composition, of water; where components (a) to (i) add up to 100% by weight.

[00285] In a specific embodiment, the antimicrobial agent (a) is 2-phenoxyethanol, and this is contained in an amount of 0.1 to 5% by weight, for example, 0.1 to 2% by weight, relative to the total weight of the composition; and the alkoxylated amine (b) is contained in an amount of 0.1 to 7% by weight.

[00286] In another specific embodiment, the composition of the invention is a composition for washing clothes. Compositions for washing clothes preferably comprise: (a) 0.001 to 7% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.001 to 7% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 0 to 15% by weight, relative to the total weight of the composition, of at least one organic solvent, preferably as defined above, the solvent most preferably comprising a solvent selected from solvents (c.1) to (c.10); (d) 0.1 to 40% by weight, relative to the total weight of the composition, of one or more surfactants; Petition 870250094721, dated 10 / 16 / 2025, page 258 / 331 / 155 (e) 0 to 6% by weight, in relation to the total weight of the composition, of at least one enzyme; (f) 0 to 20% by weight, in relation to the total weight of the composition, of at least one sequestrant; (g) 0 to 8% by weight, in relation to the total weight of the composition, of at least one antifoaming agent and / or foam stabilizer; (h) 0 to 50% by weight, relative to the total weight of the composition, of an additional additive; and (i) 10 to 99.898% by weight, relative to the total weight of the composition, of water; where components (a) to (i) add up to 100% by weight.

[00287] These laundry compositions are in liquid or gel form and are suitable for both machine and hand washing. As a general rule, compositions for hand washing of clothes should be adapted so as not to present any risk to the user. For example, the amount of acids and / or bases optionally present is such that the resulting pH does not harm the user's skin.

[00288] The suitable and preferred components (a) to (h) are those listed above.

[00289] Examples of compositions for washing clothes include laundry detergents, fabric softeners, rinse aids, bleaches and stain removers.

[00290] Laundry detergents may additionally contain, as component (h), dye transfer inhibitors, anti-graying polymers, anti-soiling polymers, anti-redeposition agents, anti-shrinkage agents, anti-wrinkle agents, ironing aids, skin-beneficial agents, antistatic agents, processing aids such as electrolytes, pearlescent agents, opacifiers, sunscreens and / or antioxidants. Petition 870250094721, dated 10 / 16 / 2025, pp. 259 / 331 / 155

[00291] The terms anti-graying and anti-redeposition agents are often used interchangeably. Suitable examples of such agents are the PEIs mentioned above in grafted (alkoxylated) or ungrafted form, other alkyleneimine polymers, such as polypropyleneimine (PPI), also in grafted or ungrafted form, other ethoxylated hexamethylenediamine polymers that are quaternized and – optionally, but preferably – sulfated, and the GP graft polymer comprising as a graft base a polyether and, as graft side chains, copolymers comprising at least one comonomer (CM), as described below.

[00292] Ethoxylated hexamethylenediamine polymers preferably contain, on average, 10 to 50, more preferably 15 to 40, and even more preferably 20 to 30 EO (ethoxylate) groups per NH group, resulting in an average molecular weight Mw in the range of 2,000 to 10,000 g / mol, more preferably 3,000 to 8,000, and even more preferably 4,000 to 6,000. In a preferred embodiment, the ethoxylated hexamethylenediamine is quaternized and also sulfated, preferably containing 2 cationic ammonium groups and 2 anionic sulfate groups.

[00293] In the GP graft polymer, the side chains comprise at least one comonomer (CM) selected from CH2=CH-OC(O)-Ra(CM-Ia) CH2=CH-CH2-OC(O)-Ra(CM-Ib) CH2=CZ-CO-ORb(CM-Ic) where Ra is selected from C1-C21-alkyl, e.g., methyl, n-propyl, n-pentyl, n-heptyl, n-nonyl, iso-nonyl, n-undecyl, ntridecyl, n-pentadecyl, n-heptadecyl or n-nonadecyl, Rbé selected from C2-C20-alkyl, preferably with an even number of carbon atoms, for example, ethyl, n- and isopropyl, n-hexyl, isohexyl, sec-hexyl, n-heptyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl or isodecyl, n-CpI G, n-C14H29, Petition 870250094721, dated 10 / 16 / 2025, page 260 / 331 / 155 C16H33 or n-Ci8H37, and Z is selected between hydrogen and methyl, with hydrogen being preferred.

[00294] In the GP graft polymer, the polyethers have at least 5 ether groups per mole and, if present, only hydroxyl groups, for example, one, two or three hydroxyl groups per molecule. Such hydroxyl groups may be primary or secondary hydroxyl groups, with primary hydroxyl groups being preferred. The polyethers are preferably polyethylene glycols, for example, with an average molecular weight Mn in the range of 500 to 25,000 g / mol, preferably from 1,000 to 15,000 g / mol and, even more preferably, from 1,500 to 10,000 g / mol, for example, from 1,500 to 4,000 g / mol or from 4,000 to 6,000 g / mol or from 5,000 to 8,000 g / mol. Alternatively, the polyethers are preferably polypropylene glycols, for example, with an average molecular weight of Mn in the range of 500 to 20,000 g / mol, preferably from 2,000 to 10,000 g / mol and even more preferably from 4,000 to 9,000 g / mol.Alternatively, the polyethers are copolymers of ethylene glycol and propylene glycol units, for example, random copolymers and, preferably, block copolymers, for example, diblock copolymers and triblock copolymers. Preferably, the ethylene glycol and propylene glycol copolymers are block copolymers. The polyethylene glycols, polypropylene glycols and EO-PO block copolymers may be uncapped or end-capped with C1-C20-alkyl or C3-C20-2-hydroxyalkyl.

[00295] Other examples of anti-graying agents are carboxymethylcellulose (CMC), starch ether sulfonic acid salts, cellulose ether sulfonic acid salts, cellulose sulfuric acid ester acid salts, starch sulfuric acid ester acid salts, methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, methylhydroxyethylcellulose, methylcarboxymethylcellulose, ethylhydroxyethylcellulose, and mixtures thereof. Petition 870250094721, dated 10 / 16 / 2025, pp. 261 / 331 / 155

[00296] Other examples of anti-graying agents are polyalkylene oxide polymers (ethylene oxide, propylene oxide and / or butylene oxide polymers) grafted with methyl acrylate, ethyl acrylate, methyl methacrylate and / or ethyl methacrylate.

[00297] In fabric softeners, at least part of the detergent (c) described above is replaced by a softening agent.

[00298] Suitable softening agents are quaternary ammonium salts, especially quaternary ammonium or quaternary ammonium esters (esterquats). Quats are [NR1R2R3R4]+X- compounds, wherein R1, R2, R3 and R4 are alkyl groups, wherein at least one, usually two, is / are long-chain alkyl and the others are usually methyl or ethyl, and X- is a counter-anion, such as chloride. Examples are DSDMAC (diestearyl dimethyl ammonium chloride, also called DODMAC (dioctadecyl dimethyl ammonium chloride)), TDMAC (dimethyl ammonium tallow chloride), DHTDMAC (di(hydrogenated tallow alkyl) dimethyl ammonium chloride) and DDAC-C10 (didecyldimethyl ammonium chloride). Quaternary ammonium esters are derivatives of alkanolamines in which at least one alkanol group is esterified with a fatty acid.Typically, quaternary ammonium esters are derived from methyltriethanolammonium salts, in which 1, 2, or 3 of the OH groups are esterified with a fatty acid, and from dimethyldiethanolammonium salts, in which 1 or 2 OH groups are esterified with a fatty acid. Quaternary ammonium esters are preferred.

[00299] More specifically, the composition of the invention is a composition for washing clothes comprising: (a) 0.001 to 5% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.01 to 7% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; Petition 870250094721, dated 10 / 16 / 2025, page 262 / 331 / 155 (c) 0 to 5% by weight, in relation to the total weight of the composition, of at least one organic solvent, preferably as defined above, the solvent comprising more preferably a solvent selected from solvents (c.1) to (c.10); (d) 4 to 30% by weight, in relation to the total weight of the composition, of one or more surfactants; (e) 0 to 6% by weight, relative to the total weight of the composition, of at least one enzyme; (f) 0 to 20% by weight, in relation to the total weight of the composition, of at least one sequestrant; (g) 0 to 8% by weight, in relation to the total weight of the composition, of at least one antifoaming agent and / or foam stabilizer; (h) 0 to 50% by weight, relative to the total weight of the composition, of an additional additive; and (i) 10 to 95.989% by weight, relative to the total weight of the composition, of water; wherein components (a) to (i) add up to 100% by weight.

[00300] In a specific embodiment, the antimicrobial agent (a) is 2-phenoxyethanol, and this is contained in an amount of 0.1 to 5% by weight, for example, 0.1 to 2% by weight, relative to the total weight of the composition; and the alkoxylated amine (b) is contained in an amount of 0.1 to 7% by weight.

[00301] In a specific embodiment, the composition of the invention is a surface cleaning composition. Surface cleaning compositions preferably comprise: (a) 0.001 to 7% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.001 to 7% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; Petition 870250094721, dated 10 / 16 / 2025, page 263 / 331 / 155 (c) 0 to 15% by weight, in relation to the total weight of the composition, of at least one organic solvent, preferably as defined above, the solvent comprising more preferably a solvent selected from solvents (c.1) to (c.10); (d) 0.1 to 40% by weight, relative to the total weight of the composition, of one or more surfactants; (e) 0 to 6% by weight, relative to the total weight of the composition, of at least one enzyme; (f) 0 to 20% by weight, in relation to the total weight of the composition, of at least one sequestrant; (g) 0 to 8% by weight, in relation to the total weight of the composition, of at least one antifoaming agent and / or foam stabilizer; (h) 0 to 50% by weight, relative to the total weight of the composition, of an additional additive; and (i) 10 to 99.898% by weight, relative to the total weight of the composition, of water; where components (a) to (i) add up to 100% by weight.

[00302] These surface cleaning compositions are available in liquid or gel form and are suitable for manual use. Naturally, surface cleaning compositions for domestic use must be adapted so as not to present any risk to the user. For example, the amount of acids and / or bases optionally present is such that the resulting pH does not harm the user's skin.

[00303] The suitable and preferred components (a) to (h) are those listed above.

[00304] Surface cleaning compositions may additionally comprise, as component (h), anti-graying polymers and scale inhibitors or dispersers.

[00305] More specifically, the composition of the invention is a Petition 870250094721, dated 10 / 16 / 2025, pp. 264 / 331 / 155 surface cleaning composition. (a) 0.001 to 5% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.001 to 5% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 0 to 8% by weight, relative to the total weight of the composition, of at least one organic solvent, preferably as defined above, the solvent comprising more preferably a solvent selected from solvents (c.1) to (c.10); (d) 0.1 to 30% by weight, relative to the total weight of the composition, of one or more surfactants; (e) 0 to 3% by weight, relative to the total weight of the composition, of at least one enzyme; (f) 0 to 10% by weight, in relation to the total weight of the composition, of at least one sequestrant; (g) 0 to 4% by weight, in relation to the total weight of the composition, of at least one antifoaming agent and / or foam stabilizer; (h) 0 to 25% by weight, relative to the total weight of the composition, of an additional additive; and (i) 10 to 99.898% by weight, relative to the total weight of the composition, of water; wherein components (a) to (i) add up to 100% by weight.

[00306] Even more particularly, the composition of the invention is a surface cleaning composition comprising: (a) 0.001 to 5% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.01 to 5% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different Petition 870250094721, dated 10 / 16 / 2025, page 265 / 331 / 155 alkoxylated amines (I), as defined above; (c) 0 to 5% by weight, relative to the total weight of the composition, of at least one organic solvent, preferably as defined above, the solvent comprising more preferably a solvent selected from solvents (c.1) to (c.10); (d) 0.1 to 25% by weight, relative to the total weight of the composition, of one or more surfactants; (e) 0 to 3% by weight, relative to the total weight of the composition, of at least one enzyme; (f) 0 to 10% by weight, in relation to the total weight of the composition, of at least one sequestrant; (g) 0 to 4% by weight, in relation to the total weight of the composition, of at least one antifoaming agent and / or foam stabilizer; (h) 0 to 25% by weight, relative to the total weight of the composition, of an additional additive; and (i) 10 to 99.739% by weight, relative to the total weight of the composition, of water; where components (a) to (i) add up to 100% by weight.

[00307] In a specific embodiment, the antimicrobial agent (a) is 2-phenoxyethanol, and this is contained in an amount of 0.1 to 5% by weight, for example, 0.1 to 2% by weight, relative to the total weight of the composition; and the alkoxylated amine (b) is contained in an amount of 0.1 to 7% by weight.

[00308] In a particular embodiment, the I&I or home care composition is a refill concentrate. Refill concentrates contain all the ingredients of the ready-to-use final product, but the water is essentially absent (“essentially” considering that some of the ingredients may contain some residual water) or contained in much smaller quantities than in the ready-to-use final product. The end user simply places the concentrated refill in a container. Petition 870250094721, dated 10 / 16 / 2025, page 266 / 331 / 155 appropriate and add the indicated amount of water.

[00309] Such refill concentrates preferably comprise: (a) 0.01 to 10% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.01 to 10% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different N-alkoxylated amines (I), as defined above; (c) 0 to 30% by weight, in relation to the total weight of the composition, of at least one organic solvent, the solvent most preferably comprising a solvent selected from solvents (c.1) to (c.10); (d) 0.1 to 60% by weight, relative to the total weight of the composition, of one or more surfactants; (e) 0 to 10% by weight, relative to the total weight of the composition, of at least one enzyme; (f) 0 to 10% by weight, in relation to the total weight of the composition, of at least one sequestrant; (g) 0 to 10% by weight, in relation to the total weight of the composition, of at least one antifoaming agent and / or foam stabilizer; (h) 0 to 50% by weight, relative to the total weight of the composition, of an additional additive; and (i) 0 to 20% by weight, relative to the total weight of the composition, of water; where components (a) to (i) add up to 100% by weight.

[00310] In a specific embodiment, the antimicrobial agent (a) is 2-phenoxyethanol, and this is contained in an amount of 0.1 to 10% by weight, relative to the total weight of the composition; and the alkoxylated amine (b) is contained in an amount of 0.1 to 10% by weight. Crop protection compositions

[00311] The combination of the antimicrobial agent and the alkoxylated amine Petition 870250094721, of 10 / 16 / 2025, page 267 / 331 / 155 (I) in crop protection compositions generally serves for the preservation of said composition. Crop protection compositions that require preservation generally contain water.

[00312] Examples of such compositions are, for example, solutions, emulsions, suspensions, pastes, capsules, and mixtures thereof. Examples of composition types are suspensions (e.g., SC, OD, FS), emulsifiable concentrates (e.g., EC), emulsions (e.g., EW, EO, ES, ME), capsules (e.g., CS, ZC), pastes, as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g., GF). These and other composition types are defined in the “Catalogue of pesticide formulation types and international coding system”, Technical Monograph No. 2, 6th edition. May 2008, CropLife International.

[00313] The compositions are prepared in a known manner, as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.

[00314] Suitable auxiliaries include solvents, liquid carriers, surfactants, dispersants, emulsifiers, wetting agents, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, food stimulants, compatibilizers, antifreeze agents, antifoaming agents, colorants, adhesion agents and binders.

[00315] Suitable solvents and liquid carriers are water and organic solvents, such as fractions of mineral oil with medium to high boiling points, for example, kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, for example, toluene, paraffin, tetrahydronaphthalene, alkylated naphthalenes; alcohols, for example, ethanol, propanol, butanol, benzyl alcohol, cyclohexanol; glycols; Petition 870250094721, dated 10 / 16 / 2025, pp. 268 / 331 / 155 DMSO; ketones, e.g. cyclohexanone; esters, for example lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, for example, N-methyl-pyrrolidone, dimethyl amides of fatty acids; and mixtures thereof.

[00316] Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes and mixtures thereof. These surfactants can be used as emulsifiers, dispersants, solubilizers, wetting agents, penetration enhancers, protective colloids or adjuvants. Examples of surfactants are listed in McCutcheon's, Vol. 1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International or North American edition).

[00317] Suitable anionic surfactants are alkaline, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates and mixtures thereof. Examples of sulfonates are alkylaryl sulfonates, diphenyl sulfonates, alpha-olefin sulfonates, lignin sulfonates, fatty acid and oil sulfonates, ethoxylated alkylphenol sulfonates, alkoxylated arylphenol sulfonates, condensed naphthalene sulfonates, dodecyl and tridecylbenzene sulfonates, naphthalene and alkylnaphthalene sulfonates, sulfosuccinates or sulfosuccinamates. Examples of sulfates are fatty acid and oil sulfates, ethoxylated alkylphenol sulfates, alcohol sulfates, ethoxylated alcohol sulfates, or fatty acid ester sulfates. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates and carboxylated alcohols or alkylphenol ethoxylates.

[00318] Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids, or fatty acid esters that have been alkoxylated. Petition 870250094721, dated 10 / 16 / 2025, p. 269 / 331 / 155 with 1 to 50 equivalents. Ethylene oxide and / or propylene oxide may be used for alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters, or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters, or alkylpolyglucosides. Examples of polymeric surfactants are vinylpyrrolidone polymers or copolymers, vinyl alcohols, or vinyl acetate.

[00319] Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetaines and imidazolines. Suitable block polymers are AB or A-BA type block polymers comprising polyethylene oxide and polypropylene oxide blocks, or ABC type block polymers comprising alkanol, polyethylene and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkaline salts of polyacid or polyacrylic acid cell polymers. Examples of polybases are polyvinylamines or polyethyleneamines.

[00320] Suitable adjuvants are compounds that have negligible or even non-existent pesticidal activity and that improve the biological performance of the ionic polymeric compound containing imidazolium groups in the target. Examples include surfactants, mineral or vegetable oils, and other auxiliaries. Additional examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.

[00321] Suitable thickeners are polysaccharides (e.g., xanthan gum, carboxymethylcellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates. Petition 870250094721, dated 10 / 16 / 2025, pp. 270 / 331 / 155

[00322] Suitable antifreeze agents are ethylene glycol, propylene glycol, urea and glycerin.

[00323] Suitable anti-foaming agents are silicones, long-chain alcohols and fatty acid salts.

[00324] Suitable dyes (e.g., red, blue, or green) are pigments with low water solubility and water-soluble dyes. Examples include inorganic dyes (e.g., iron oxide, titanium oxide, iron hexacyanoferrate) and organic dyes (e.g., alizarin, azo, and phthalocyanine dyes).

[00325] Suitable tackifying agents or binders are polyvinylpyrrolidones, polyvinyl acetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes and cellulose ethers.

[00326] Crop protection compositions naturally contain at least one active agent suitable for combating harmful microorganisms, invertebrate pests or weeds, for example, at least one fungicide, insecticide, acaricide, nematicide, molluscicide and / or herbicide; or for regulating plant growth.

[00327] Examples of fungicidally active substances include: • acidalines, such as benalaxyl, metalaxyl, ofurace or oxadixyl; • Amine derivatives, such as aldimorph, dodine, dodemorph, fenpropimorph, fenpropidim, guazatine, iminoctadine, spiroxamine, or tridemorph; • anilinopyrimidines, such as pyrimethanil, mepanipyrim or cyprodinil; • antibiotics, such as cycloheximide, griseofulvin, kasugamycin, natamycin, polyoxin and streptomycin; • azoles, such as bitertanol, bromoconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, Petition 870250094721, dated 10 / 16 / 2025, p. 271 / 331 / 155 flusilazole, flutriafol, hexaconazole, imazalil, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prochloraz, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole or triticonazole; • 2-methoxybenzophenones, such as those described in EP-A 897 904 by general formula (I), for example, metraphenone; • dicarboximides, such as iprodione, miclozolim, procymidone or vinclozolin; • dithiocarbamates, such as ferbam, nabam, maneb, mancozeb, metam, metiram, propineb, polycarbamate, thioram, ziram or zineb; • heterocyclic compounds, such as anilazine, benomyl, boscalid, carbendazim, carboxine, oxycarboxin, cyazofamide, dazomet, dithianone, famoxadone, fenamidone, fenarimol, fuberidazole, flutolanil, furametpyr, isoprothiolane, mepronil, nuarimol, picobenzamide, probenazole, proquinazide, pyrifenox, pyroquilone, quinoxifen, siltiofam, thiabendazole, thifluzamide, thiophanate-methyl, tiadinil, tricyclazole or triporin; • Nitrophenyl derivatives, such as binapacryl, dinocap, dinobutone or isopropyl nitrothalic; • Phenylpyrroles, such as fenpiclonil or fludioxonil; • Unclassified fungicides, such as acibenzolar-S-methyl, bentiavalicarb, carpropamide, chlorothalonil, cyflufenamide, cymoxanil, diclomezine, diclocimet, dietofencarb, edifenfos, etaboxam, fenhexamide, fentin acetate, fenoxanil, ferimzone, fluaziname, fosetyl, fosetyl-aluminum, iprovalicarb, hexachlorobenzene, metrafenone, pencicuron, propamocarb, phthalide, tolclofos-methyl, quintozene or zoxamide; • strobilurins, such as those described in document WO 03 / 075663 by general formula (I), for example, azoxystrobin, dimoxystrobin, fluoxastrobin, cresoxim-methyl, metominostrobin, orisastrobin, Petition 870250094721, dated 10 / 16 / 2025, page 272 / 331 / 155 picoxystrobin, pyraclostrobin and trifloxystrobin; • Sulfenic acid derivatives, such as captafol, captan, diclofluanide, folpet or tolylfluanide; • cinnamamides and analogous compounds, such as dimethomorph, flumetover or flumorph; • 6-aryl-[1,2,4]triazol[1,5-a]pyrimidines, such as those described, for example, in documents WO 98 / 46608, WO 99 / 41255 or WO 03 / 004465, in each case by the general formula (I); • Amide fungicides, such as cyflufenamide and (Z)-N-[α(cyclopropylmethoximino)-2,3-difluoro-6-(difluoromethoxy)benzyl]-2-phenylacetamide.

[00328] Examples of herbicides include: • 1,3,4-thiadiazoles, such as butidazole and ciprazole; • amides, such as alidochlor, benzoylprop-ethyl, bromobutide, chlorthiamide, dimepiperate, dimethenamid, diphenamide, ethobenzanide, flamprop-methyl, fosamine, isoxaben, metazachlor, monalide, naptalam, pronamide or propanil; • aminophosphoric acids, such as bilaphos, buminaphos, ammonium glufosinate, glyphosate or sulfosate; • aminotriazoles, such as amitrol, or anilides, such as anilophos or mephenacet; • aryloxyalkanoic acids, such as 2,4-D, 2,4-DB, clomeprop, dichlorprop, dichlorprop-P, fenoprop, fluroxypyr, MCPA, MCPB, mecoprop, mecoprop-P, napropamide, naproanilide or triclopyr; • Benzoic acids, such as chloramben or dicamba; • benzothidiazinones, such as bentazone; • Bleaching agents, such as clomazone, diflufenicam, fluorochloridone, flupoxam, fluridone, pyrazolate or sulcotrione; • carbamates, such as carbetamide, chlorbufam, chlorprofam, Petition 870250094721, dated 10 / 16 / 2025, page 273 / 331 / 155 desmedifam, fenmedifam or vernolato; • quinolinocarboxylic acids, such as quinclorac or quinmerac; • dichloropropionic acids, such as dalapon; • dihydrobenzofurans, such as etofumesate; • dihydrofuran-3-ones, such as flurtamone; • dinitroanilines, such as benefim, butralin, dinitramine, etalfluralin, flucoralin, isopropaline, nitraline, oryzalin, pendimethalin, prodiamine, profluralin or trifluralin; • dinitrophenols, such as bromophenoxim, dinoseb, dinoseb acetate, dinoterb, DNOC or minoterb acetate; • Diphenyl ethers, such as acifluorfen sodium, aclonifene, bifenox, chlornitrofen, difenoxuron, ethoxyfen, fluorodifen, fluoroglycophenoethyl, fomesafen, furiloxyfen, lactofen, nitrofen, nitrofluorfen or oxyfluorfen; • dipyridyls, such as ciperquat, diphenzoquat methylsulfate, diquat or paraquat dichloride; • Imidazoles, such as isocarbamide; • Imidazolinones, such as imazametapyr, imazapyr, imazaquin, imazethabenz-methyl, imazethapyr, imazapic, or imazamox; • oxadiazoles, such as metazol, oxadiargil or oxadiazone; • oxiranes, such as tridiphane; • phenols, such as bromoxynil or ioxynil; • phenoxyphenoxypropionic acid esters, such as clodinafop, cyalofop-butyl, diclofop-methyl, fenoxaprope-ethyl, fenoxaprop-P-ethyl, fenthiaprope-ethyl, fluazifop-butyl, fluazifop-P-butyl, haloxyfop-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, isoxapirifop, propaquizafop, quizalofop-ethyl, quizalofop-P-ethyl or quizalofop-P-tefuryl; Petition 870250094721, dated 10 / 16 / 2025, page 274 / 331 / 155 • phenylacetic acids, such as chlorfenac; • Phenylpropionic acids, such as chlorfenprop-methyl; • active substances of PPI (PPI = incorporated pre-plant), such as benzofenap, flumiclorac-pentyl, flumioxazine, flumipropine, flupropacil, pyrazoxifen, sulfentrazone or thidiazimine; • pyrazoles, such as nipiraclofen; • pyridazines, such as chloridazone, maleic hydrazide, norflurazone, or pyridate; • pyridinecarboxylic acids, such as clopyralid, dithiopyr, picloram or thiazopyr; • pyrimidyl ethers, such as pyrithiobacic acid, pyrithiobac sodium, KIH-2023 or KIH-6127; • sulfonamides, such as flumetsulam or metossulam; • triazolecarboxamides, such as triazophenamide; • Uracils, such as bromacil, lenacil, or terbacil; • In addition, benazoline, benfuresate, bensulide, benzofluor, bentazone, butamiphos, cafenstrole, chlorthal-dimethyl, cinmethylline, diclobenil, endothal, fluorbentranil, mefluidide, perfluidone, piperophos, topramezone, and prohexadione-calcium; • sulfonylureas, such as amidosulfuron, azimsulfuron, bensulfuron-methyl, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, etametsulfuron-methyl, flazasulfuron, halosulfuron-methyl, imazosulfuron, metsulfuron-methyl, nicosulfuron, primisulfuron, prosulfuron, pyrazosulfuron-ethyl, rimsulfuron, sulfometuron-methyl, tifensulfuron-methyl, triasulfuron, tribenuron-methyl, triflulsulfuron-methyl or tritosulfuron; • Plant protection active substances of the cyclohexenone type, such as aloxidim, clethodim, chlorproxidim, cycloxidim, sethoxidim and tralcoxidim. Particularly preferred active herbicidal substances of the type Petition 870250094721, dated 10 / 16 / 2025, pp. 275 / 331 100 / 155 cyclohexenone are: tepraloxidim (cf. AGROW, n° 243, 11.3.95, page 21, caloxidim) and 2-(1-[2-{4-chlorphenoxy}propyloximino]butyl)-3-hydroxy-5-(2Htetrahydrothiopyran-3-yl)-2-cyclohexen-1-one, and the sulfonylurea type is: N-(((4methoxy-6-[trifluoromethyl]-1,3,5-triazin-2-yl)amino)carbonyl)-2(trifluoromethyl)benzenesulfonamide.

[00329] Examples of insecticides include: • organophosphates, such as acephate, azinphos-methyl, chlorpyrifos, chlorfenvinphos, diazinon, dichlorvos, dimethylvinphos, dioxabenzophos, dicrotophos, dimethoate, disulfoton, ethion, EPN, fenitrothion, fenthion, isoxation, malathion, methamidophos, metidathion, methyl parathion, mevinphos, monocrotophos, oxidemeton-methyl, paraoxon, parathion, phentoate, phosalone, phosmet, phosfamidone, phorate, phoxim, pirimiphos-methyl, profenophos, prothionphos, pirimiphos-ethyl, pyraclophos, pyridafenthion, sulprophos, triazophos, trichlorfon, tetrachlorvinphos or vamidothion; • carbamatos, such as alanicarbe, benfuracarbe, bendiocarbe, carbaryl, carbofuran, carbosulfan, fenoxicarbe, furatiocarbe, indoxacarbe, methiocarbo, methomyl, oximil, pirimicarbe, propoxur, tiodicarbe or triazamate; piretroides, such as bifenthrin, cyfluthrin, cycloprothrin, cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, cyhalothrin, lambda-cyhalothrin, permethrin, silafluofeno, taufluvalinato, tefluthrin, tralometrine, alpha-cypermethrin ou zeta-cypermethrin; Arthropod growth regulators: a) inhibitors of chitin synthesis, for example, benzoylureas, such as chlorfluazuron, diflubenzuron, flucicloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron, buprofezin, diphenol, hexthiazox, ethoxazole or clofentezine; b) ecdysone antagonists, such as halofenozide, methoxyfenozide or tebufenozide; c) juvenile hormone analogs, such as pyriproxyfen, methoprene or fenoxycarb; d) inhibitors of lipid biosynthesis, Petition 870250094721, dated 10 / 16 / 2025, pp. 276 / 331 101 / 155 such as spirodiclofen; neonicotinoids, such as flonicamide, clothianidin, dinotefuran, imidacloprid, thiamethoxam, nitenpyram, nitiazine, acetamiprid or thiacloprid; Additional unclassified insecticides, such as abamectin, acequinocil, acetamiprid, amitraz, azadirachtin, bensultap, bifenazate, cartap, chlorfenapyr, chlordimeform, cyromazine, diafenthiuron, dinotefuran, diphenolan, emamectin, endosulfan, etiprole, phenazaquine, fipronil, formetanate, formetanate hydrochloride, gamma-HCH, hydramethylnon, imidacloprid, indoxacarb, isoprocarb, metolcarb, pyridab, pimetrozine, spinosad, tebufenpyrad, thiamethoxam, thiocyclam, XMC and xylylcarb; • N-phenylsemicarbazones, such as those described in document EP-A 462 456 by general formula (I), especially compounds of general formula (A) R2 (A) wherein R2 and R3 represent, independently of each other, hydrogen, halogen, CN, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl or C1-C4 haloalkoxy and R4 represents C1-C4 alkoxy, C1-C4 haloalkyl or C1-C4 haloalkoxy, for example, compound IV, wherein R2 represents 3-CF3, R3 represents 4-CN and R4 represents 4-OCF3.

[00330] Examples of plant growth regulators include chlormequat chloride, mepiquat chloride, calcium prohexadione, trinexapac ethyl or the gibberellin group. These include, for example, the gibberellins GA1, GA3, GA4, GA5 and GA7 and the like, and the corresponding exo-16,17-dihydrogibberellins, and also their derivatives, for example, the esters with C1-C4 carboxylic acids.

[00331] Water-soluble concentrates (SL, LS) comprise, by Petition 870250094721, dated 10 / 16 / 2025, pp. 277 / 331 102 / 155 example: (a) 0.01 to 3% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.01 to 5% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 5 to 60% by weight, in relation to the total weight of the composition, of the active substances; (d) 5 to 15% by weight, relative to the total weight of the composition, of a humectant (for example, alcohol alkoxylates); (e) 3 to 15% by weight, in relation to the total weight of the composition, of an antifreeze agent; (f) water or a mixture of water and a water-soluble solvent (e.g., an alcohol) up to 100% by weight.

[00332] Emulsions (EW, EO, ES) include, for example: (a) 0.01 to 3% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.01 to 5% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 5 to 40% by weight, in relation to the total weight of the composition, of the active substance; (d) 1 to 10% by weight, in relation to the total weight of the composition, of one or more emulsifiers (for example, calcium dodecylbenzenesulfonate and castor oil ethoxylate); (e) 3 to 15% by weight, in relation to the total weight of the composition, of an antifreeze agent; (f) 20 to 40% by weight, relative to the total weight of the composition, of a water-insoluble organic solvent (e.g., hydrocarbon) Petition 870250094721, dated 10 / 16 / 2025, pp. 278 / 331 103 / 155 aromatic); (g) water up to 100% by weight.

[00333] Suspensions (SC, OD, FS) include, for example: (a) 0.01 to 3% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.01 to 5% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 5 to 60% by weight, in relation to the total weight of the composition, of the active substance; (d) 2 to 10% by weight, in relation to the total weight of the composition, of dispersants and / or wetting agents (for example, sodium lignosulfonate and alcohol ethoxylate); (e) 0.1 to 2% by weight, relative to the total weight of the composition, of a thickener (e.g., xanthan gum); (f) 3 to 15% by weight, relative to the total weight of the composition, of an antifreeze agent; (g) water up to 100% by weight.

[00334] For FS type compositions, up to 40% by weight of binder (e.g., polyvinyl alcohol) is contained.

[00335] Gels (GW, GF) include, for example: (a) 0.01 to 3% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.01 to 5% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 5 to 50% by weight, in relation to the total weight of the composition, of the active substance; (d) 3 to 10% by weight, in relation to the total weight of the composition, Petition 870250094721, dated 10 / 16 / 2025, pp. 279 / 331 104 / 155 of one or more dispersants (e.g., sodium lignosulfonate); (e) 1 to 5% by weight, relative to the total weight of the composition, of a thickener (e.g., carboxymethylcellulose); (f) 3 to 15% by weight, relative to the total weight of the composition, of an antifreeze agent; (g) water up to 100% by weight.

[00336] Microemulsions (ME) include, for example: (a) 0.01 to 3% by weight, relative to the total weight of the composition, of an antimicrobial agent as defined above; (b) 0.01 to 5% by weight, relative to the total weight of the composition, of an alkoxylated amine (I) or a mixture of different alkoxylated amines (I), as defined above; (c) 5 to 50% by weight, in relation to the total weight of the composition, of the active substance; (d) 5 to 30% by weight, relative to the total weight of the composition, of a mixture of organic solvents (for example, fatty acid dimethylamide and cyclohexanone); (e) 10 to 25% by weight, relative to the total weight of the composition, of a mixture of surfactants (for example, alcohol ethoxylate and arylphenol ethoxylate); (f) 3 to 15% by weight, relative to the total weight of the composition, of an antifreeze agent; (g) water up to 100% by weight.

[00337] The above crop protection compositions may optionally comprise other auxiliaries, such as 0.1 to 1% by weight of other bactericides, 0.1 to 1% by weight of antifoaming agents and 0.1 to 1% by weight of dyes. Pharmaceutical compositions

[00338] Suitable pharmaceutical compositions may exist in a Petition 870250094721, dated 10 / 16 / 2025, pp. 280 / 331 105 / 155 wide variety of forms, for example, in the form of liquid preparations such as an O / W, O / W, O / W / O, W / O / W or PIT emulsion and all types of microemulsions; in the form of a non-emulsified water-based liquid, in the form of a gel, in the form of an oil, cream, milk or lotion, in the form of a spray (spray with propellant gas or spray pump) or aerosol, in the form of a foam, in the form of a paste, in the form of a wet wipe (such as for cleaning the diaper area).

[00339] Pharmaceutical compositions may include, for example, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat compositions or ointments. Personal care compositions

[00340] Preserving personal care products from microbial degradation is both imperative and challenging, as most topical cosmetics and dermatological products contain significant amounts of water, providing a highly favorable environment for microbial growth. Many other ingredients in personal care products can also be a good source of nutrients for microbes. Furthermore, the shelf life and expiration dates of personal care products are quite long compared to, for example, food products. Generally, personal care products are neither sterilized nor packaged under hermetic conditions, and therefore the presence of preservatives can hardly be dispensed with. On the other hand, the public considers preservatives in personal care products problematic.Consumers expect preservatives to be not only effective but also extremely mild throughout their shelf life. Public opinion strongly discourages the use of formaldehyde donors, halogenated organic molecules, and, more recently, parabens in personal care products. At a minimum, the amounts of these preservatives are expected to be kept to a minimum. Antimicrobials that are not. Petition 870250094721, dated 10 / 16 / 2025, pp. 281 / 331 106 / 155 or at least are less dangerous, such as 2-phenoxyethanol, are often not very effective and need to be used in fairly high concentrations to achieve an acceptable antimicrobial effect. In personal care applications, however, high concentrations are not acceptable. The present combination of antimicrobials (a) and alkoxylated amines (I) allows a substantial reduction in the amount of antimicrobial without compromising the desired antimicrobial effect.

[00341] Nevertheless, in personal care compositions, the antimicrobial is preferably 2-phenoxyethanol.

[00342] Personal care compositions can be for hygienic or cosmetic use. Examples of compositions suitable for personal care are given above.

[00343] Suitable compositions for personal care may exist in a wide variety of forms, for example, in the form of liquid preparations such as an O / W, O / W, O / W / O, W / O / W or PIT emulsion and all types of microemulsions; in the form of a non-emulsified water-based liquid, in the form of a gel, in the form of an oil, cream, milk or lotion, in the form of a spray (spray with propellant gas or spray pump) or aerosol, in the form of a foam, in the form of a paste, in the form of a wet wipe (such as for cleaning the diaper area).

[00344] Personal care compositions may include, for example, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat compositions or ointments.

[00345] Ingredients typically present in such personal care compositions and their quantities vary according to the specific formulation. Examples of such ingredients are solvents, surfactants, emulsifiers, rheology modifiers (usually thickeners), conditioners, emollients, skin care ingredients, lubricants, fillers, antioxidants, dermatologically active ingredients, Petition 870250094721, dated 10 / 16 / 2025, pp. 282 / 331 107 / 155 fragrances and water.

[00346] For example, in the form of water-and-oil emulsions (e.g., W / O, O / W, O / W / O and W / O / W emulsions or microemulsions), the preparations generally contain at least one oil component, at least one emulsifier, water and, optionally, at least one additional cosmetically acceptable adjuvant; For example, from 0.1 to 30% by weight, preferably from 0.1 to 15% by weight and especially from 0.5 to 10% by weight, based on the total weight of the composition, from 1 to 60% by weight, especially from 5 to 50% by weight and preferably from 10 to 35% by weight, based on the total weight of the composition, of at least one oily component, from 0 to 30% by weight, especially from 1 to 30% by weight and preferably from 4 to 20% by weight, based on the total weight of the composition, of at least one emulsifier, from 10 to 90% by weight, especially from 30 to 90% by weight, based on the total weight of the composition, of water, and from 0 to 88.9% by weight, especially from 1 to 50% by weight, of other cosmetically acceptable adjuvants.

[00347] Preparations intended primarily for cleaning, such as soaps, shower gels and shampoos, contain at least one or more surfactants, often of the anionic type, optionally in combination with zwitterionic surfactants; and water. In addition, they generally contain at least one of the following components: emulsifier, sequestrant, fragrance, pH modifier (usually an organic acid and / or an inorganic base), inorganic salt (mainly NaCl), colorant.

[00348] Of particular importance are cosmetic preparations for hair, especially for the purpose of anti-dandruff treatment, in particular hair washing preparations in the form of shampoos, conditioners, hair care preparations, for example, pre-treatment preparations, hair tonics, styling creams, styling gels, pomades, hair rinses, treatment masks, intensive hair treatments, hair straightening preparations, liquid preparations Petition 870250094721, dated 10 / 16 / 2025, pp. 283 / 331 108 / 155 for hair styling, hair mousses and hairsprays. Of particular interest are hair washing preparations in the form of shampoos. In addition, shower gels are of particular interest.

[00349] Shampoos, as well as shower gels, generally contain water and at least one anionic surfactant.

[00350] Suitable anionic surfactants are primarily all those described above in the context of cosmetically acceptable household care and I&I compositions. In shampoos and shower gels, it is useful to use surfactants that are good foam formers.

[00351] Examples of suitable anionic surfactants in this context are alkyl sulfates, alkyl ether sulfates, alkyl sulfonates, alkanoyl isethionates, alkyl succinates, alkyl sulfosuccinates, alkyl ether sulfosuccinates, N-alkyl sarcosinates, alkyl phosphates, alkyl ether phosphates and alkyl ether carboxylic acids and salts thereof, especially sodium, magnesium, ammonium and mono-, di- and triethanolamine salts. The alkyl and acyl groups generally contain from 8 to 18, preferably from 10 to 16 carbon atoms, and may be unsaturated. Alkyl ether sulfates, alkyl ether sulfosuccinates, alkyl ether phosphates, and alkyl ether carboxylic acids and salts thereof may contain from 1 to 20 units of ethylene oxide or propylene oxide per molecule.Typical surfactants for use in shampoo compositions include sodium oleyl succinate, ammonium lauryl sulfosuccinate, sodium lauryl sulfate, sodium lauryl ether sulfate (sodium laureth sulfate), sodium lauryl ether sulfosuccinate, ammonium lauryl sulfate, ammonium lauryl ether sulfate, sodium dodecylbenzene sulfonate, triethanolamine dodecylbenzene sulfonate, sodium cocoyl isethionate, sodium lauryl isethionate, lauryl ether carboxylic acid, and sodium N-lauryl sarcosinate. Mixtures of any of the anionic surfactants mentioned are also suitable.

[00352] The total amount of anionic surfactant in the compositions of Petition 870250094721, dated 10 / 16 / 2025, pp. 284 / 331 109 / 155 shampoo of the invention generally varies from 0.5 to 45% by weight, for example, from 1.5 to 35% by weight, based on the total weight of the composition.

[00353] The composition of shampoo or shower gel may also include non-ionic, amphoteric and / or cationic co-surfactants, which help to impart aesthetic, haptic, combing, physical or cleansing properties to the composition.

[00354] Suitable nonionic surfactants are those listed above, for example, ethoxylated fatty alcohols, mono- or di-alkyl alkanolamides, such as coco mono- or di-ethanolamide and coco monoisopropanolamide; or alkyl polyglycosides (APGs), such as Oramix NS10 ex Seppic; Plantaren 1200 and Plantaren 2000 ex Henkel. The total amount of nonionic surfactant in the shampoo or shower gel compositions of the invention generally ranges from 0.5 to 8% by weight, preferably from 2 to 5% by weight, based on the total weight of the composition.

[00355] Suitable amphoteric or zwitterionic surfactants are those listed above, for example, alkylamine oxides, alkyl betaines, alkyl amidopropyl betaines, alkyl sulfobetaines (sultains), alkyl glycinates, alkyl carboxyglycinates, alkyl amphoacetates, alkyl amphopropionates, alkyl amphoglycinates, alkyl amidopropyl hydroxysultains, acyl taurates and acyl glutamates, wherein the alkyl and acyl groups have from 8 to 19 carbon atoms. Specific examples are lauryl oxide, cocodimethyl sulfopropyl betaine, lauryl betaine, cocamidopropyl betaine and sodium cocoamphoacetate. Mixtures of the above amphoteric or zwitterionic surfactants are also suitable. The total amount of amphoteric or zwitterionic surfactant in the shampoo or shower gel compositions of the invention generally ranges from 0.5 to 8% by weight, preferably from 1 to 4% by weight, based on the total weight of the composition.

[00356] Suitable cationic polymers are those listed above. Examples are copolymers of vinyl monomers with functionalities of Petition 870250094721, dated 10 / 16 / 2025, pp. 285 / 331 110 / 155 Cationic amine or quaternary ammonium compound with water-soluble spacer monomers such as (meth)acrylamide, alkyl and dialkyl (meth)acrylamides, alkyl (meth)acrylate, vinyl caprolactone and vinyl pyrrolidine. Alkyl and dialkyl substituted monomers preferably have C1-C7 alkyl groups, more preferably C1-C3 alkyl groups. Other suitable spacers include vinyl esters, vinyl alcohol, maleic anhydride, propylene glycol and ethylene glycol. Cationic amines can be primary, secondary or tertiary, depending on the specific species and pH of the composition. In general, secondary and tertiary amines, especially tertiary ones, are preferred. Other examples include cationic polysaccharide polymers, such as cationic derivatives of cellulose, cationic derivatives of starch, and cationic derivatives of guar gum.The total amount of cationic surfactant in the shampoo or shower gel compositions of the invention generally ranges from 0.05 to 1% by weight, more preferably from 0.08 to 0.5% by weight, based on the total weight of the composition.

[00357] The total amount of surfactant (including any co-surfactant and / or any emulsifier) ​​in a shampoo or shower gel composition is generally from 1 to 50% by weight, preferably from 2 to 40% by weight, more preferably from 10 to 25% by weight, based on the total weight of the composition.

[00358] Other components that may be present in shampoo or shower gel are, for example, suspending agents such as polyacrylic acids, cross-linked acrylic acid polymers, copolymers of acrylic acid with a hydrophobic monomer, copolymers of monomers containing carboxylic acid and acrylic esters, cross-linked acrylic acid and acrylate ester copolymers, heteropolysaccharide gums and long-chain crystalline acyl derivatives, the latter preferably selected from ethylene glycol stearate, fatty acid alkanolamides having 16 to 22 carbon atoms and mixtures thereof; fragrances, Petition 870250094721, dated 10 / 16 / 2025, pp. 286 / 331 111 / 155 dyes and pigments, pH adjusting agents, pearlescent or opacifying agents, viscosity modifiers and salts, such as NaCl; in shampoos, in addition to natural hair nutrients or dermatologically active ingredients, such as vegetables, fruit extracts, caffeine, panthenol, sugar derivatives, amino acids, such as keratin or hydrolyzed glycine, vegetable oils or hydrogenated vegetables.

[00359] In ready-to-use compositions in which the antimicrobial agent (in combination with the alkoxylated amine (I)) is to exert a preservative effect, the antimicrobial agent and the alkoxylated amine (I) are naturally contained in an effective amount of preservative. This is an amount sufficient to reduce the cell population of an undesirable microorganism below a predetermined limit value to achieve storage stability over a given period of time.

[00360] Thus, an “effective amount of preservative” may be defined, for example, as an amount sufficient to reduce the cell population by, for example, at least one, preferably at least two, in particular at least three orders of logarithm of at least one of the following microorganisms: Alcaligeneses faecalis, Aspergillus niger, Burkholderia cepacia, Candida albicans, Escherichia coli, Pseudomonas aeruginosa, Pseudomonas putida and Staphylococcus aureus, and in particular at least one of the following microorganisms: Alcaligeneses faecalis, Burkholderia cepacia, Escherichia coli, Pseudomonas aeruginosa, Pseudomonas putida and Staphylococcus aureus.

[00361] Alternatively or additionally, an “effective amount of preservative” may be defined, for example, as an amount sufficient to reduce the cell population by, for example, at least one, preferably at least two, in particular at least three orders of logarithm of at least one of the following microorganisms: Aspergillus brasiliensis, Rhodotorula mucilaginosa and Yarrowia lipolytica. Petition 870250094721, dated 10 / 16 / 2025, pp. 287 / 331 112 / 155

[00362] The composition of the invention preferably has a pH of 2 to 11, more preferably from 4 to 10 and, in particular, from 4 to 9.

[00363] Next, some exemplary formulations of the invention are listed to illustrate typical compositions. (1) Multipurpose cleaner 1 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 3 3 3 3 3 Plurafac LF 400 (BASF) Alkoxylated alcohol 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 Hostapur SAS 60 (Clariant) Sodium C14-17 secondary alkyl sulfonate 14.00 14.00 14.00 14.00 14.00 14.00 14.00 14.00 14.00 14.00 Texapon® LS 35 (BASF) Sodium laurylmyristyl sulfate 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Citric acid (Merck) Citric acid adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 6.5 adjust to pH 6.5 IRAGON® Blue ABL 9 sol.1% (BASF) Acid Blue 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Cibafast® H Liquid (BASF) Sodium benzotriazolylbutylphenol sulfonate (and) buteth-3 (and) tributyl citrate 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Water and perfume Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100%. (2) Multipurpose cleaner 2 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 2 2 2 2 2 2 2 2 2 2 Solvent - - - - - 3 3 3 3 3 Plurafac PE 6800 (BASF) Alkoxylated alcohol 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 Petition 870250094721, dated 10 / 16 / 2025, pp. 288 / 331 113 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Plurafac LF 901 (BASF) Alkoxylated alcohol 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Citric acid (Merck) Citric acid adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 adjust to pH 6.5 IRAGON® Blue ABL 9 sol. 1% (BASF) Acid Blue 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Cibafast® H Liquid (BASF) Sodium benzotriazolylbutylphenol sulfonate (and) buteth3 (and) tributyl citrate 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Water and perfume Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (3) Multipurpose cleaner 3 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial Agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 3 3 3 3 3 Texapon® LS 35 (BASF) Sodium Laurylmyristyl Sulfate 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 Glucopon® 215 CS UP (BASF) Alkyl polyglucoside 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Perfume qs qs qs qs qs qs qs qs qs qs Citric acid (Merck) Citric acid adjust to pH 3.0 adjust to pH 3.0 adjust to pH 3.0 adjust to pH 3.0 adjust to pH 3.0 adjust to pH 3.0 adjust to pH 3.0 adjust to pH 3.0 adjust to pH 3.0 adjust to pH 3.0 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (4) Multipurpose cleaner 4 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 3 3 3 3 3 Plurafac LF 400 (BASF) Alkoxylated alcohol 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 Sodium cumene sulfonate (Hickson Manro) Cumene sulfonate sodium 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Petition 870250094721, dated 10 / 16 / 2025, pp. 289 / 331 114 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Marlon PS 65 (Sasol) Sodium C13-17 alkane sulfonate 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 Perfume qs qs qs qs qs qs qs qs qs qs Trissodium citrate di-hydrate (Fluka) Trissodium citrate di-hydrate 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp . (5) Multipurpose cleaner 5 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - - 3 3 3 3 3 Glucopon® 215 CS UP (BASF) Alkyl polyglucoside 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Texapon® LS 35 (BASF) Sodium laurylmyristyl sulfate 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 Perfume qs qs qs qs qs qs qs qs qs qs Trisodium citrate dihydrate (Fluka) Trisodium citrate dihydrate 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (6) Multipurpose cleaner 6 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 2 2 2 2 2 2 2 2 2 2 Solvent - - - - - 2 2 2 2 2 Texapon® LS 35 (BASF) Sodium laurylmyristyl sulfate 5 5 5 5 5 5 5 5 5 5 Glucopon® 215 CS UP (BASF) Alkyl polyglucoside 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Sodium cumene sulfonate (Hickson Manro) Sodium cumene sulfonate 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Perfume qs qs qs qs qs qs qs qs qs qs Citric acid (Merck) Citric acid adjust to pH 3 adjust to pH 3 adjust to pH 3 adjust to pH 3 adjust to pH 3 adjust to pH 3 adjust to pH 3 adjust to pH 3 adjust to pH 3 adjust to pH 3 Petition 870250094721, dated 10 / 16 / 2025, pp. 290 / 331 115 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (7) Cleaner for hard surfaces 1 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 2 2 2 2 2 2 2 2 2 2 Solvent - - - - - 2 2 2 2 2 Texapon® K12 (BASF) Sodium lauryl sulfate 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Citric acid (Merck) Citric acid 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Perfume qs qs qs qs qs qs qs qs qs Sodium hydroxide (10% solution) (Fluka) Water (and) Sodium hydroxide adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (8) Cleaner for hard surfaces 2 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 1 1 1 1 1 Lutensol AO 5 (BASF) Non-ionic surfactant 5EO 2 2 2 2 2 2 2 2 2 2 Citric acid (Merck) Citric acid 1 1 1 1 1 1 1 1 1 1 Sodium bicarbonate (Fluka) NaHCO3 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Sodium hydroxide (10% solution) (Fluka) Water (and) Sodium hydroxide adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 Water qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% Petition 870250094721, dated 10 / 16 / 2025, pp. 291 / 331 116 / 155 (9) Surface cleaning spray 1 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 2 2 2 2 2 Glucopon® 215 CS UP (BASF) Alkyl polyglucoside 3.50 3.50 3.50 3.50 3.50 3.50 3.50 3.50 3.50 3.50 Dehydol® 04 Deo (BASF) Capryleth-4 1.70 1.70 1.70 1.70 1.70 1.70 1.70 1.70 1.70 1.70 Perfume qs qs qs qs qs qs qs qs qs qs Citric acid (Merck) Citric acid 9.00 9.00 9.00 9.00 9.00 9.00 9.00 9.00 9.00 9.00 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (10) Surface cleaning spray 2 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 2 2 2 2 2 Glucopon® 215 CS UP (BASF) Alkyl polyglucoside 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 Dehydol® 04 Deo (BASF) Capryleth-4 1.70 1.70 1.70 1.70 1.70 1.70 1.70 1.70 1.70 1.70 Texapon® K12 (BASF) Sodium lauryl sulfate 2 2 2 2 2 2 2 2 2 2 Citric acid (Merck) Citric acid adjust to pH 6.0 adjust to pH 6.0 adjust to pH 6.0 adjust to pH 6.0 adjust to pH 6.0 adjust to pH 6.0 adjust to pH 6.0 adjust to pH 6.0 adjust to pH 6.0 adjust to pH 6.0 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (11) Surface cleaning spray 3 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 2 2 2 2 2 Petition 870250094721, dated 10 / 16 / 2025, pp. 292 / 331 117 / 155 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Texapon® K12 (BASF) Sodium Lauryl Sulfate 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Citric Acid (Merck) Citric Acid 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Dowanol DPM (Dow) PPG-2 Methyl Ethyl 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 Sodium hydroxide (10% solution) Water (and) Sodium hydroxide adjust to pH 7.0 adjust to pH 7.0 adjust to pH 7.0 adjust to pH 7.0 adjust to pH 7.0 adjust to pH 7.0 adjust to pH 7.0 adjust to pH 7.0 adjust to pH 7.0 (12) Surface cleaning spray 4 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 2 2 2 2 2 Texapon® K12 (BASF) Sodium lauryl sulfate 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 Propylene glycol 1,2-Propanediol 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 Citric acid solution 20% Citric acid adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (13) Surface cleaning spray 5 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 1 1 1 1 1 Propylene glycol 1,2-Propanediol 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 Glucopon® 215 CS UP (BASF) Alkyl polyglucoside 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 Perfume qs qs qs qs qs qs qs qs qs qs Citric acid Citric acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Sodium hydroxide (10% solution) Water (and) Sodium hydroxide adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 Adjust to pH 5.0 Petition 870250094721, dated 10 / 16 / 2025, pp. 293 / 331 118 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (14) Wet wipes 1 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 3 3 3 3 3 Propylene glycol 1,2-Propandiol 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 Texapon® K12 (BASF) Sodium lauryl sulfate 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Citric acid Citric acid 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Perfume qs qs qs qs qs qs qs qs qs qs Sodium hydroxide (10% solution) Water (and) Sodium hydroxide adjust to pH 5.5 adjust to pH 5.5 adjust to pH 5.5 adjust to pH 5.5 adjust to pH 5.5 adjust to pH 5.5 adjust to pH 5.5 Adjust to pH 5.5 Adjust to pH 5.5 Adjust to pH 5.5 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (15) Wet wipes 2 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 3 3 3 3 3 Propylene glycol 1,2-Propanediol 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 Glucopon® 215 CS UP (BASF) Alkyl polyglucoside 1 1 1 1 1 1 1 1 1 1 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% Citric acid Citric acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Sodium hydroxide (10% solution) Water (and) Sodium hydroxide adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 Petition 870250094721, dated 10 / 16 / 2025, pp. 294 / 331 119 / 155 (16) Wet wipes 3 (for personal care) 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 3 3 3 3 3 Glycerin Glycerin 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Tween 20 Polysorbate 20 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 Miranol C2M Na2-diacetate coconut starch 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Vitamin E Tocopherol 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Panthenol Panthenol 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% Sodium citrate Sodium citrate Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 (17) Window cleaner 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 3 3 3 3 3 Ethanol Ethyl alcohol 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 Glucopon® 215 CS UP (BASF) Alkyl polyglucoside 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Perfume qs qs qs qs qs qs qs qs qs Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% Citric acid Citric acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Sodium hydroxide (solution a 10%) Water (and) Sodium hydroxide adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 adjust to pH 5.0 (18) Toilet cleaner 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 3 3 3 3 3 Glucopon® 215 CS UP (BASF) Alkyl polyglucoside 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 Neodol 91-8E C9-11 pareth-8 1.70 1.70 1.70 1.70 1.70 1.70 1.70 1.70 1.70 1.70 Petition 870250094721, dated 10 / 16 / 2025, pp. 295 / 331 120 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w RHEOVIS® CSP (BASF) Cationic polymer 1.30 1.30 1.30 1.30 1.30 1.30 1.30 1.30 1.30 1.30 Concentrated acetic acid Acetic acid 2.40 2.40 2.40 2.40 2.40 2.40 2.40 2.40 2.40 2.40 Citric acid Citric acid 9.00 9.00 9.00 9.00 9.00 9.00 9.00 9.00 9.00 9.00 IRAGON®Blue ABL80 sun. 1% (BASF) Acid Blue 80 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (19) Shoe deodorizer 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 3 3 3 3 3 Absolute ethanol ethanol 10 10 10 10 10 10 10 10 10 10 Propylene glycol 1,2Propanediol 10 10 10 10 10 10 10 10 10 10 Marlipal 24 / 99 (Sasol) Laureth-9 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Glycerin Glycerin 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Perfume qs qs qs qs qs qs qs qs qs qs Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (20) Liquid dishwashing detergent 1 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial Agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 2 2 2 2 2 Texapon K 14 Special (BASF) Sodium Myreth Sulfate 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 Texapon® LS 35 (BASF) Laurylmyristyl Sulfate Sodium 2 2 2 2 2 2 2 2 2 2 Dehyton AB 30 (BASF) Coco Betaine 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 Plantacare 1200 UP (BASF) Lauryl Glucoside 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 SD Alcohol 39-C (Berkel) alcohol 1 1 1 1 1 1 1 1 1 1 Petition 870250094721, dated 10 / 16 / 2025, pp. 296 / 331 121 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Sodium chloride Sodium chloride 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 Perfume qs qs qs qs qs qs qs qs qs qs Trisodium citrate dihydrate Trisodium citrate dihydrate Adjusted to pH 6 Adjusted to pH 6 Adjusted to pH 6 Adjusted to pH 6 Adjusted to pH 6 Adjusted to pH 6 Adjusted to pH 6 Adjusted to pH 6 Adjusted to pH 6 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (21) Liquid dishwashing detergent 2 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 2 2 2 2 2 2 2 2 2 2 Solvent - - - - - 2 2 2 2 2 Marlon A 375 (Sasol) Sodium dodecylbenzenesulfonate 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 Plantacare 1200 UP (BASF) Lauryl Glucoside 3 3 3 3 3 3 3 3 3 3 Citric Acid Citric Acid 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Sodium Chloride Sodium Chloride 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Sodium Sulfate Sodium Sulfate 3.50 3.50 3.50 3.50 3.50 3.50 3.50 3.50 3.50 Sodium Hydroxide (30% solution) Water (and) Sodium Hydroxide adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Adjust to pH 5.0 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100%. (22) Liquid dishwashing detergent 3 1 2 3 4 5 6 7 8 9 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 2 2 2 2 2 2 2 2 2 2 Solvent - - - - - 2 2 2 2 2 Marlon A 375 (Sasol) Sodium dodecylbenzenesulfonate 5 5 5 5 5 5 5 5 5 5 Petition 870250094721, dated 10 / 16 / 2025, pp. 297 / 331 122 / 155 1 2 3 4 5 6 7 8 9 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Texapon NSO (BASF) Sodium laureth sulfate 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Citric acid Citric acid 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Sodium hydroxide (30% solution) Water (and) Sodium hydroxide adjust to pH 6.0 adjust to pH 6.0 adjust to pH 6.0 Adjust to pH 6.0 Adjust to pH 6.0 Adjust to pH 6.0 Adjust to pH 6.0 Adjust to pH 6.0 Adjust to pH 6.0 Adjust to pH 6.0 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (23) Liquid dishwashing detergent 4 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial Agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 3 3 3 3 3 3 3 3 3 3 Solvent - - - - - 2 2 2 2 2 Texapon® LS 35 (BASF) Sodium Laurylmyristyl Sulfate 2 2 2 2 2 2 2 2 2 2 Texapon® K14 Special (BASF) Sodium Myreth Sulfate 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 Plantacare® 1200 UP (BASF) Lauryl Glucoside 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 Dehyton® AB 30 (BASF) Coco Betaine 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 SD Alcohol 39C (Berkel) Alcohol 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Sodium Chloride Sodium Chloride 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Citric acid Citric acid Adjust to pH 6.5 Adjust to pH 6.5 Adjust to pH 6.5 Adjust to pH 6.5 Adjust to pH 6.5 Adjust to pH 6.5 Adjust to pH 6.5 Adjust to pH 6.5 Adjust to pH 6.5 Adjust to pH 6.55 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (24) Liquid laundry detergent 1 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 3 3 3 3 3 3 3 3 3 3 Solvent - - - - - 2 2 2 2 2 Marlon A 375 (Sasol) Sodium dodecylbenzenesulfonate 8 8 8 8 8 8 8 8 8 8 Neodol 45-7 E (Shell Chemicals) C14-15 Pareth-7 7 7 7 7 7 7 7 7 7 7 Petition 870250094721, dated 10 / 16 / 2025, pp. 298 / 331 123 / 155 1 2 3 4 5 6 7 8 9 10 Commercial name INCI name / Chemical name % w / w % w / w % w / p % w / w % w / w % w / w % w / w % w / w % w / w % w / w SD Alcohol 39C (Berkel) Alcohol 9.00 9.00 9.00 9.00 9.00 9.00 9.00 9.00 9.00 9.00 Savory base (Mettler) Sodium seboate (and) sodium cocoate 5 5 5 5 5 5 5 5 5 5 Trissodic citrate di-hydrate Trissodic citrate di-hydrate 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 Triethanolamine Triethanolamine 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Tinopal® CBS- X (BASF) Fluorescent dye (FWA) 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Perfume qs qs qs qs qs qs qs qs qs qs qs qs Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (25) Liquid detergent 2 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 2 2 2 2 2 2 2 2 2 2 Solvent - - - - - 2 2 2 2 2 Nansa SSA / A (Albright & Wilson / Rhodia) Dodecylbenzenesulfonic acid 7 7 7 7 7 7 7 7 7 7 Edenor® K12- 18 (BASF) Acid coconut grease 3 3 3 3 3 3 3 3 3 3 Neodol 23-6, 5 E (Shell Chemicals) C12-13 Pareth-7 2 2 2 2 2 2 2 2 2 2 Elfan NS 243 S (Akzo Nobel) Sodium laureth sulfate 3 EO 4- 4 4 4 4 4 4 4 4 4 Trisodium citrate dihydrate Trisodium citrate dihydrate 2 2 2 2 2 2 2 2 2 2 Sodium hydroxide (30% solution) Water (and) Sodium hydroxide adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 Water and perfume Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp100% qsp 100% qsp 100% qsp 100%. (26) Liquid laundry detergent 3 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 3 3 3 3 3 3 3 3 3 3 Solvent - - - - - 2 2 2 2 2 Marlon A 375 (Sasol) Sodium dodecylbenzenesulfonate 7 7 7 7 7 7 7 7 7 7 Petition 870250094721, dated 10 / 16 / 2025, pp. 299 / 331 124 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Marlipal O 13 / 129 (Sasol) Trideceth-12 5 5 5 5 5 5 5 5 5 5 Pentasodium triphosphate Pentasodium triphosphate 10 10 10 10 10 10 10 10 10 10 Sodium sulfate Sodium sulfate 1 1 1 1 1 1 1 1 1 1 Sodium hydroxide (10% solution) Water (and) Sodium hydroxide adjusted to pH 9 adjusted to pH 9 adjusted to pH 9 adjusted to pH 9 Adjusted to pH 9 Adjusted to pH 9 Adjusted to pH 9 Adjusted to pH 9 Adjusted to pH 9 Glycerin Glycerin 2 2 2 2 2 2 2 2 2 2 Oleic acid Oleic acid 1 1 1 1 1 1 1 1 1 1 Tylose C 10000 (Clariant) Cellulose gum 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Water and perfume Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (27) Liquid laundry detergent 4 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial Agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 3 3 3 3 3 3 3 3 3 3 Solvent - - - - - 2 2 2 2 2 Wilfarin DK1218 (Wilmar Ltd.) Antiseptic 5 5 5 5 5 5 5 5 5 5 Monoethanolamine adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted to pH 8 adjusted for pH 8 adjusted for pH 8 adjusted for pH 7.5-9.0 Maranil DBS / LC (BASF) LABS 11 11 11 11 11 11 11 11 11 11 Texapon N705 (BASF) Sulfate ether 4 4 4 4 4 4 4 4 4 4 Lutensol AO 7 (BASF) Non-ionic surfactant 2 2 2 2 2 2 2 2 2 2 Sodium citrate 1 1 1 1 1 1 1 1 1 1 Lavergy Pro 104 LS (BASF) Enzyme 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Cublen NCD 732 (Zimmer & Schwarz) Phosphonate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Water and perfume Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% q.sp 100% qsp 100% qsp 100%. Petition 870250094721, dated 10 / 16 / 2025, pages 300 / 331 125 / 155 (28) Fabric softener 1 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial Agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 3 3 3 3 3 Neodol 25-7 E (Shell Chemicals) C12-15 Pareth-7 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 Arquad 2HT-75 (Akzo Nobel) Quaternium-18 (and) isopropyl alcohol 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 Perfume + dye qs qs qs qs qs qs qs qs qs qs Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (29) Fabric softener 2 1 2 3 4 5 6 7 8 9 10 Commercial name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Formula compound (I) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Solvent - - - - - 3 3 3 3 3 Rewoquat WE 18 (Evonic) Hydroxytilamônio de seboetila di-hydrogenado 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 Neodol 25-7 E (Shell Chemicals) C12-15 Pareth-7 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 Antifoam DB 31 (Dow Corning) 0.10 0.10 qs qs qs qs qs qs qs qs Perfume + corante qs qs qs qs qs qs qs qs qs Água Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (30) Amaciante de roupas 3 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial Agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 Solvent - - - - - 3 3 3 3 3 Genapol O 100 (Clariant) Oleth-10 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 Arquad 2HT-75 (Akzo Nobel) Quaternium-18 (and) isopropyl alcohol 15.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 Petition 870250094721, dated 10 / 16 / 2025, pages 301 / 331 126 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Saturated magnesium chloride solution Magnesium chloride 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Perfume dye qs qs qs qs qs qs qs qs qs qs Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (31) Fabric softener 4 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Solvent - - - - - 3 3 3 3 3 Rewoquat WE 18 (Evonik) Seboethyl hydroxyethylammonium dihydrogenated 15.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 15.00 Genapol O 100 (Clariant) Oleth-10 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 Antifoam DB 31 (Dow Corning) 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 Saturated magnesium chloride solution Magnesium chloride 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Perfume + dye qs qs qs qs qs qs qs qs qs qs Aqua Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (32) Polymer emulsion 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 2 2 2 2 2 Polyethylene wax 30.00 30.00 30.00 30.00 30.00 30.00 30.00 30.00 30.00 30.00 Lutensol TO 10 (BASF) Ethoxylated alcohol 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 KOH KOH 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% pH 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2 Petition 870250094721, dated 10 / 16 / 2025, pp. 302 / 331 127 / 155 (33) Cellulose pulp 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Solvent - - - - - 3 3 3 3 3 Cellulose (Eifeltor Mühle) Cellulose 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Water qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% pH 7.2 7.2 7.2 7.2 7.2 7.2 7.2 7.2 7.2 7.2 (34) Fluid paste of CaCÜ3 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Solvent - - - - - 3 3 3 3 3 CaCO3 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 Dispex AA 4140 (BASF) Polyacrylate 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (35) Fluid kaolin paste 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Solvent - - - - - 3 3 3 3 3 Kaolin DSK 50 (Dorfner GmbH) Kaolin 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0 Sokalan CP 10 (BASF) Polyacrylate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (36) Starch solution 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Petition 870250094721, dated 10 / 16 / 2025, pp. 303 / 331 128 / 155 Solvent - - - - - 3 3 3 3 3 Starch CAS 900525-8 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (37) Fluid pigment paste 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial Agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Solvent - - - - - 3 3 3 3 3 Blue Pigment 015 P BL 015 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 Dispergator CC 0.5-4 0.5-4 0.5-4 0.5-4 0.5-4 0.5-4 0.5-4 0.5-4 0.5-4 0.5-4 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (38) Ink 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Solvent - - - - - 3 3 3 3 3 Natrosol 250HHR (Brenntag) Hydroxyethylcellulose 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 Rheovis PE 133 (BASF)0 Polyether 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Sodium polyphosphate (NaPO3)n 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 NaOH NaOH 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 Texamol (Alpha Chemistry) Sodium alkyl ethoxysulfate 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 Foammaster MO 2114 (BASF) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Omyacarb 5 EU (Omya) CaCO3 19.8 19.8 19.8 19.8 19.8 19.8 19.8 19.8 19.8 19.8 Socal P2 (Solvay) CaCO3 11.0 11.0 11.0 11.0 11.0 11.0 11.0 11.0 11.0 11.0 Finntalc M 30 (Elementis) Talc 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 Kronos 2119 (Kronos) TiO2 10.0 10.0 10.0 10,0 10.0 10.0 10.0 10.0 10.0 10.0 Acronal EDGE 6205 (BASF) p-Acrylate 23.0 23.0 23.0 23.0 23.0 23.0 23.0 23.0 23.0 23.0 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% Petition 870250094721, dated 10 / 16 / 2025, pp. 304 / 331 129 / 155 COMPOSITIONS FOR PERSONAL CARE (39) O / W emulsion for skin care 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Solvent - - - - - 3 3 3 3 3 Cremophor A 6 (Sigma) Ceteareth-6, stearyl alcohol 2 2 2 2 2 2 2 2 2 2 Cremophor A 25 (Sigma) 2 2 2 2 2 2 2 2 2 2 Tegosoft liquid (Evonik) Cetearyl ethyl hexanoate 5 5 5 5 5 5 5 5 5 5 Paraffinic oil Mineral oil 5 5 5 5 5 5 5 5 5 5 Lanette 16 (BASF) Cetyl alcohol 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (40) A / O Lotion 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Part A Antimicrobial agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 2 2 2 2 2 Part B Dehymuls PGPH Polyglyceryl-dipolyhydroxystearate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Lameform TGI Polyglyceryl-3-Diisostearate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Zinc Stearate Zinc Stearate 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Cosmedia Gel CC Dicaprylyl Carbonate, Steralkonium Hectorite, Propylene Carbonate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Cetiol Sensoft Propylheptyl Caprylate 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Cethiol CC Carbonate dicaprylyl 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 Cetiol C 5C Coco-Caprylate / Caprate 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Glycerin Glycerin 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 Mg2SO4 x 7H2O Magnesium sulfate 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Perfume qsqsqsqsqsqsqsqsqsqs Part C Water qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100%, Petition 870250094721, dated 10 / 16 / 2025, pp. 305 / 331 130 / 155 (41) Roll-on deodorant 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial Agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 3 3 3 3 3 Arlanol HD (Croda) Isohexadecane 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 Tegosoft CT (Evonik) Caprylic / Capric Triglyceride 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Cetiol OE (BASF) Stearyl Ether 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 Arlatone 983 (Croda) PEG-5 Glyceryl Stearate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Brij 76 NENA (Sigma) Steareth-10 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Lanette 16 (BASF) Cetyl Alcohol 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Atlas G-2330 (Croda) Sorbeth-30 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp100% NaOH (1%) Adjusted to pH 5.7 Adjusted to pH 5.7 Adjusted to pH 5.7 Adjusted to pH 5.7 Adjusted to pH 5.7 Adjusted to pH 5.7 Adjusted to pH 5.7 Adjusted to pH 5.7 Adjusted to pH 5.7. (42) Shower gel 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial Agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 2 2 2 2 2 Texapon N 70 Sodium Laureth Sulfate 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 8.5 Plantacare 818 UP CocoGlucoside 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 3.8 Lamesoft PO 65 CocoGlucoside, Glycerol Oleate 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Petition 870250094721, dated 10 / 16 / 2025, pp. 306 / 331 131 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Dehyquart CC7 BZ Polyquaternium-7 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Citric acid 50% Citric acid Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Sodium chloride Sodium chloride qsqsqsqsqsqsqsqsqsqs Water and perfume Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (43) Shampoo 1 2 3 4 5 6 7 8 9 10 Trade Name INCI Name / Chemical Name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial Agent 0.001 0.01 0.1 1 2 0.001 0.01 0.1 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 2 2 2 2 2 Texapon N 70 Sodium Laureth Sulfate 14.0 14.0 14.0 14.0 14.0 14.0 14.0 14.0 14.0 14.0 Dehyton PK 45 Cocamidopropyl Betaine 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Cetiol LDO Dicaprylyl Ether, Lauryl Alcohol 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 Euperlan PK 710 Benz Glycol Distearate, Sodium Laureth Sulfate, Cocamide MEA 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 Perfume qsqsqsqsqsqsqsqsqsGuar Hydroxypropyltrimonium Chloride 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Citric Acid Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Adjusted to pH 5-7 Sodium Chloride Sodium Chloride qsqsqsqsqsqsqsqsqsqs Water and Perfume Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100%. INDUSTRIAL FLUIDS (44) Metal machining fluid (in use) 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 3 3 3 3 3 Petition 870250094721, dated 10 / 16 / 2025, pp. 307 / 331 132 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Monoethanolamine 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 Triethanolamine 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 Aminomethylpropanol 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 Pluronic RPE 1720 (BASF) Non-ionic surfactant 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 Pluronic RPE 1740 (BASF) Non-ionic surfactant 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 Korantin LUB (BASF) Poly[oxy(methyl-1,2-etandi-yl)],aphosphono-ω-hydroxy- 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 Oleic acid 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 Erucic acid 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 Water q.s.p. 100% q.s.p. 100% q.s.p. 100% q.s.p. 100% q.s.p. 100% q.s.p. 100% q.s.p. 100% q.s.p. 100% q.s.p. 100% (45) Drilling fluid 1 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 Solvent - - - - - 3 3 3 3 3 Potassium chloride KCl 11.3 11.3 11.3 11.3 11.3 11.3 11.3 11.3 11.3 11.3 Polysaccharide 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 Xanthan gum 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Calcium carbonate CaCO3 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (46) Drilling fluid 2 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Solvent - - - - - 3 3 3 3 3 Potassium chloride KCl 11.3 11.3 11.3 11.3 11.3 11.3 11.3 11.3 11.3 11.3 Polyanionic cellulose 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 Biopolymer 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Calcium carbonate CaCO3 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 Disodium carbonate Na2CO3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Petition 870250094721, dated 10 / 16 / 2025, pp. 308 / 331 133 / 155 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Water Aqua qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (47) Oilfield intervention fluid 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Solvent - - - - - 3 3 3 3 3 Bentonite 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 Xanthan gum 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 Modified starch 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 Barium sulfate 11.2 11.2 11.2 11.2 11.2 11.2 11.2 11.2 11.2 11.2 Disodium carbonate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Seawater q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% qsp 100% (48) Cooling water 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Antimicrobial agent 0.001 0.01 0.1 0.5 1 0.001 0.01 0.1 0.5 1 Compound of Formula (I) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Solvent - - - - - 3 3 3 3 3 Ca2+ 0-0.05 0-0.05 0-0.05 0-0.05 0-0.05 0-0.05 0-0.05 0-0.05 0-0.05 0-0.05 Plurafac LF 221 (BASF) Non-ionic surfactant 0.01-0.1 0.010.1 0.010.1 0.010.1 0.010.1 0.010.1 0.010.1 0.010.1 0.010.1 0.010.1 Korantin PP (BASF) 2-propyn-1-ol 0.0010.05 0.0010.05 0.0010.05 0.0010.05 0.0010.05 0.0010.05 0.0010.05 0.0010.05 0.0010.05 0.0010.05 pH 610 pH 610 pH 610 pH 610 pH 610 pH 610 pH 610 pH 610 pH 610 pH 610 Water q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% q.s. 100% (49) Plant protection product 1 1 2 3 4 5 6 7 8 9 10 Trade name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Part A Antimicrobial agent 0.001 0.01 0.2 1 2 0.001 0.01 0.2 1 2 Compound of Formula (I) 1 1 1 1 1 1 1 1 1 1 Solvent - - - - - 2 2 2 2 2 Petition 870250094721, dated 10 / 16 / 2025, pp. 309 / 331 134 / 155 1 2 3 4 5 6 7 8 9 10 Commercial name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Part B Azoxystrobin 25 25 25 25 25 25 25 25 25 25 Agnique CP 72 L (BASF) 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 Sokalan CP 10 (BASF) 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1,2-Propane-diol 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Lutensol XP 80 (BASF) 15 15 15 15 15 15 15 15 15 15 Attagel 50 (BASF) 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Agnique DFM 111 S (BASF) 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Part C Água qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% (50) Plant protection product 2 1 2 3 4 5 6 7 8 9 10 Commercial name INCI name / Chemical name % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w % w / w Part A Antimicrobial agent 0.001 0.01 0.2 0.5 1 0.001 0.01 0.2 0.5 1 Formula Compound (I) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Solvent - - - - - 2 2 2 2 2 Part B Azoxystrobin 25 25 25 25 25 25 25 25 25 25 Agnique CP 72 L (BASF) 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 Sokalan CP 10 (BASF) 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.6 1.2-Propane-diol 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Attagel 50 (BASF) 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Agnique DFM 111 S (BASF) 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Part C Water qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100% qsp 100%

[00364] In the tables above (1) to (50), “compound of formula (I)” means alkoxylated amine of formula (I) represented above. Preferably, in the alkoxylated amine (I) R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, wherein Ra is methyl, m is 10 to 30 and en is 3 to 12; or m is 10 to 20 and en is 0. More preferably, in the alkoxylated amine (I) R1, R2 and R3 are independently -CHiCHiO-An-Bm-H, wherein Ra is methyl, m is 13 to 28 and en is 4 to 11; or m is 14 to 16 and en is 0. Specifically, in the alkoxylated amine (I) R1, Petition 870250094721, dated 10 / 16 / 2025, pp. 310 / 331 135 / 155 R2 and R3 are independently -CHiCHiO-An-Bm-H, where Ra is methyl, m is 14 to 27 and en is 5 to 10; or m is 15 and en is 0. Very specifically, in the alkoxylated amine (I) R1, R2 and R3 are independently -CHiCHiO-An-Bm-H, where Ra is methyl, m is 14 and en is 5; or m is 15 and en is 0.

[00365] In each of formulations 1 to 10 above, in each of tables 1 to 50 above, one of the following antimicrobial agents is used in each case: 2-phenoxyethanol, phenoxyisopropanol, 4,4'-dichloro-2'-hydroxydiphenyl ether, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde, 2,4-dichlorobenzyl alcohol, 1,3,5-tris-(2-hydroxyethyl)-1,3,5-hexahydrotriazine, formic acid and salts thereof, benzoic acid and salts thereof, sorbic acid and salts thereof, lactic acid and salts thereof, isothiazolinones selected from the group consisting of 1,2-benzisothiazol-3(2H)-one (BIT), 2-methyl-2-isothiazol-3-one (MIT), 2-octyl-2H-isothiazol-3-one (OIT), 5-chloro-2-methyl-2-isothiazol-3-one (CMIT) and 2-butyl-benzo[d]isothiazol-3-one (BBIT); 3-iodo-2-propynylbutylcarbamate (IPBC), benzyl alcohol, pyridine-2-thiol 1-oxide and salts thereof;2,2-dibromo-2-cyanoacetamide (DBNPA), N-(3-aminopropyl)N-dodecylpropane-1,3-diamine (Diamine), tetrakis(hydroxymethyl)phosphonium(2:1) sulfate (THPS), 2,2-dithiobis[N-methylbenzamide] (DTBMA) and 2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB). Specifically, 2-phenoxyethanol, 4,4'-dichloro 2'-hydroxydiphenylether (diclosan), 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde or 1,2benzisothiazol-3(2H)-one (BIT) are used. More specifically, 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde, or 1,2-benzisothiazol-3(2H)one (BIT) is used. Very specifically, 2-phenoxyethanol is used. In another more specific embodiment, phenoxyisopropanol is used.

[00366] Each of these antimicrobial agents is combined in each of the above formulations with one or more of the alkoxylates (I), as defined above. In particular, one of the following alkoxylated amines (I) is used as compound (I): an alkoxylated amine (I) in which R1, R2 and R3 are, Petition 870250094721, dated 10 / 16 / 2025, pp. 311 / 331 136 / 155 independently, -CHgCHgO-An-Bm-H, wherein Ra is methyl, m is 10 to 30 and en is 3 to 12; or m is 10 to 20 and en is 0. More particularly, one of the following alkoxylated amines (I) is used as compound (I): an alkoxylated amine (I) wherein R1, R2 and R3 are independently, -CH2CH2O-An-Bm-H, wherein Ra is methyl, m is 13 to 28 and en is 4 to 11; or m is 14 to 16 and n is 0. Specifically, one of the following alkoxylated amines (I) is used as compound (I): an alkoxylated amine (I) in which R1, R2 and R3 are independently -CH2CH2O-An-BmH, in which Ra is methyl, m is 14 to 27 and n is 5 to 10; or m is 15 and n is 0. Very specifically, one of the following alkoxylated amines (I) is used as compound (I): an alkoxylated amine (I) in which R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, in which Ra is methyl, m is 14 and n is 5; or m is 15 and n is 0.

[00367] Specifically, in each of the above formulations from 1 to 10 in each of the tables 1 to 50 above, 2-phenoxyethanol is used as the antimicrobial agent and one of the following alkoxylated amines (I) is used as compound (I): an alkoxylated amine (I) in which R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, in which Ra is methyl, m is 13 to 28 and en is 4 to 11; or m is 14 to 16 and en is 0. More specifically, in each of the formulations above from 1 to 10 in each of the tables 1 to 50 above, 2-phenoxyethanol is used as an antimicrobial agent and one of the following alkoxylated amines (I) is used as compound (I): an alkoxylated amine (I) in which R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, in which Ra is methyl, m is 14 to 27 and en is 5 to 10; or m is 15 and en is 0.

[00368] Specifically, in each of the formulations above from 1 to 10 in each of tables 1 to 50 above, 2-phenoxyethanol, bromo-2-nitropropane-1,3-diol, glutaraldehyde or 1,2-benzisothiazol-3(2H)-one (BIT) is used as the antimicrobial agent and one of the following alkoxylated amines (I) is used as compound (I): an alkoxylated amine (I) where R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, where Ra is methyl, m is 13 to 15 and Petition 870250094721, dated 10 / 16 / 2025, pp. 312 / 331 137 / 155 is 4 to 6. More specifically, in each of the above formulations from 1 to 10 in each of tables 1 to 50 above, bromo-2-nitropropane-1,3-diol, glutaraldehyde or 1,2-benzisothiazol-3(2H)-one (BIT) is used as the antimicrobial agent and one of the following alkoxylated amines (I) is used as compound (I): an alkoxylated amine (I) wherein R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, wherein Ra is methyl, m is 14 and n is 5.

[00369] If a solvent is used in the above formulations, it shall be as defined above. Specifically, the solvent is ethanol, n-propanol, isopropanol, ethylene glycol, propylene glycol, ethylene glycol mono-n-butyl ether, propylene glycol mono-n-butyl ether, γ-butyrolactone, γ-valerolactone, γoctalactone, γ-nonalactone, or ε-caprolactone.

[00370] In another specific embodiment, the solvent is or comprises N,N-dimethyl-lactamide, 1-butoxy-propan-2-ol, diethylene glycol mono-n-butyl ether, γ-valerolactone or a mixture thereof. If the solvent comprises N,N-dimethyl-lactamide, 1-butoxy-propan-2-ol, diethylene glycol mono-n-butyl ether, γ-valerolactone or a mixture thereof, the solvent may further comprise one or more of ethanol, n-propanol, isopropanol, ethylene glycol, propylene glycol, ethylene glycol mono-n-butyl ether and propylene glycol mono-n-butyl ether.

[00371] In the tables above, the % w / w are relative to the total weight of the respective composition.

[00372] The invention further relates to a kit of parts comprising at least two parts, wherein the first part comprises at least one antimicrobial agent as defined above; the second part comprises at least one alkoxylated amine (I) as defined above and, optionally, at least one organic solvent [obviously different from the alkoxylated amine (I) and said antimicrobial agent], preferably as defined above; and an optional third part comprises at least one organic solvent [obviously different from the alkoxylated amine (I) and said antimicrobial agent]. Petition 870250094721, dated 10 / 16 / 2025, pp. 313 / 331 138 / 155 antimicrobial agent], preferably as defined above; wherein the first part does not comprise any alkoxylated amine (I); wherein the second part does not comprise any antimicrobial agent as defined above; wherein the optional third part does not comprise any antimicrobial agent as defined above nor any alkoxylated amine (I); and wherein the first and second parts contain at least one antimicrobial agent as defined above and at least one alkoxylated amine (I) in amounts such that, when the first and second parts are mixed, the resulting total weight ratio is as defined above, namely, 100:1 to 1:10000, preferably 50:1 to 1:2000, more preferably 50:1 to 1:1000, even more preferably 50:1 to 1:500, in particular 20:1 to 1:500, more particularly 10:1 to 1:450, even more particularly 5:1 to 1:450 and, specifically, 2:1 to 1:450.

[00373] To be more specific, in the case of 2-phenoxyethanol as an antimicrobial agent, the resulting total weight ratio of the antimicrobial agent and the alkoxylated amine (I) is preferably 3:1 to 1:5, more preferably 3:1 to 1:3, even more preferably 2.5:1 to 1:2.5, in particular 2:1 to 1:2.5, specifically 1.3:1 to 1:2 and very specifically 1:1 to 1:2.

[00374] More specifically, in the case of 2-bromo-2-nitropropane1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT) as an antimicrobial agent, the resulting total weight ratio of antimicrobial agent and alkoxylated amine (I) is preferably 1:1 to 1:500, more preferably 1:1 to 1:450 and, in particular, 1:100 to 1:450.

[00375] While in the compositions described above components (a) and (b) are present as a physical mixture, in a parts kit they are Petition 870250094721, dated 10 / 16 / 2025, pp. 314 / 331 139 / 155 formulated separately, but provided in such a way that they still form a functional unit. They therefore form a true combination through an application directed to a specific purpose. The functional unit is expressed, for example, in the fact that the components contain the antimicrobial agent and the alkoxylated amine (I) in quantities such that, when mixed, they result in the desired weight ratio. Another way to express functional unity may be an instruction for use explaining the combined use of two or more parts of the kit. Another way to express functional unity may be a physical connection. For example, the different parts of the kit may be joined together by means of adhesive tape, strip or any other type of binding, or they may be gathered in a common container, such as a box, package, basket, etc., or wrapped together in a plastic film.

[00376] In a preferred embodiment, the kit of parts is a two-part kit, wherein the first part comprises at least one antimicrobial agent, as defined above; and the second part comprises at least one alkoxylated amine (I), as defined above, and at least one organic solvent [other than the alkoxylated amine (I) and said antimicrobial agent], wherein the organic solvent preferably has one of the preferred meanings above.

[00377] In a preferred alternative embodiment, the kit of parts is a three-part kit, wherein the first part comprises at least one antimicrobial agent, as defined above; the second part comprises at least one alkoxylated amine (I), as defined above; and the third part comprises at least one organic solvent [other than the alkoxylated amine (I) and said antimicrobial agent], wherein the organic solvent preferably has one of the preferred meanings above.

[00378] The invention also relates to the use of an alkoxylated amine (I), as defined above, to enhance the activity Petition 870250094721, dated 10 / 16 / 2025, pages 315 / 331 140 / 155 antimicrobial, in particular the preservative activity, of the antimicrobial agent, as defined above, and in particular to enhance the antimicrobial activity, in particular the preservative activity, of the antimicrobial agent in an aqueous liquid composition for household care, as defined above.

[00379] With regard to preferred alkoxylated amines (I), antimicrobial agents, their weight ratios, compositions in which they are used, materials for which they are used, etc., reference is made to the details above.

[00380] Preferably, the invention relates to the use of an alkoxylated amine (I), as defined above, to enhance the antimicrobial activity, in particular the preservative activity, of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol (bronopol), glutaraldehyde or 1,2-benzisothiazol-3(2H)one (BIT); specifically of 2-phenoxyethanol.

[00381] More preferably, the invention relates to the use of an alkoxylated amine (I), wherein R1, R2 and R3 are independently -CH2CH2OAn-Bm-H, wherein Ra is methyl, m is 10 to 30 and en is 3 to 12; or m is 10 to 20 and en is 0, to enhance the antimicrobial activity, in particular preservative activity, of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol (bronopol), glutaraldehyde or 1,2-benzisothiazol-3(2H)one (BIT); specifically of 2-phenoxyethanol. Even more preferably, the invention relates to the use of an alkoxylated amine (I), wherein R1, R2 and R3 are independently -CH2CH2O-A„-Bm-H, wherein Ra is methyl, m is 13 to 28 and n is 4 to 11; or m is 14 to 16 and n is 0, to enhance the antimicrobial activity, in particular preservative activity, of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol (bronopol), glutaraldehyde or 1,2-benzisothiazol-3(2H)one (BIT); specifically of 2-phenoxyethanol.In particular, the invention relates to the use of an alkoxylated amine (I), wherein R1, R2 and R3 are independently -CH2CH2O-A„-Bm-H, wherein Ra is methyl, m is 14 to 27 and n is 5 to 10; or m is 15 and n is 0, to enhance the antimicrobial activity, in particular the preservative activity, of 2-phenoxyethanol, 2. Petition 870250094721, dated 10 / 16 / 2025, pp. 316 / 331 141 / 155 bromo-2-nitropropane-1,3-diol (bronopol), glutaraldehyde or 1,2-benzisothiazol-3(2H)one (BIT); specifically 2-phenoxyethanol.

[00382] Specifically, the invention relates to the use of an alkoxylated amine (I), wherein R1, R2 and R3 are independently -CH2CH2O-AnBm-H, wherein Ra is methyl, m is 14 to 27 and en is 5 to 10; or m is 14 to 16 and en is 0, to enhance the antimicrobial activity, in particular the preservative activity, of 2-phenoxyethanol. Very specifically, the invention relates to the use of an alkoxylated amine (I), wherein R1, R2 and R3 are independently -CH2CH2OAn-Bm-H, wherein Ra is methyl, m is 14 and en is 5; or m is 15 and en is 0, to enhance the antimicrobial activity, in particular the preservative activity, of 2-phenoxyethanol.

[00383] Specifically, the invention relates to the use of an alkoxylated amine (I), wherein R1, R2 and R3 are independently -CH2CH2O-AnBm-H, wherein Ra is methyl, m is 13 to 15 and en is 4 to 6; or m is 14 to 16 and en is 0, to enhance the antimicrobial activity, in particular preservative activity, of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol (bronopol), glutaraldehyde or 1,2-benzisothiazol-3(2H)one (BIT). More specifically, the invention relates to the use of an alkoxylated amine (I), wherein R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, wherein Ra is methyl, m is 14 and en is 5, to enhance the antimicrobial activity, in particular preservative activity, of 2-bromo-2-nitropropane-1,3-diol (bronopol), glutaraldehyde or 1,2-benzisothiazol-3(2H)one (BIT).

[00384] The antimicrobial activity is particularly directed against fungi and bacteria, since these typically occur in the compositions to be preserved against attack / infestation by microbes or in substrates, surfaces or materials to be disinfected. Some examples of fungi are Aspergillus brasiliensis, Rhodotorula mucilaginosa or Yarrowia lipolytica, and some examples of bacteria are Escherichia coli, Alcaligenes faecalis, Pseudomonas aeruginosa, Staphylococcus aureus, Petition 870250094721, dated 10 / 16 / 2025, pp. 317 / 331 142 / 155 Burkholderia cepacia and Pseudomonas putida, to name just a few.

[00385] The invention is now illustrated by the following examples. EXAMPLES Alkoxylated amine (I):

[00386] Plurafac® LF 1430 from BASF (abbreviated as PLF): Alkoxylated triethanolamine with 5 average EO and average 14 PO per triethanolamine OH group; to be more precise, a compound (I) in which R1, R2e R3son -CH2CH2O-An-Bm-H, in which Raé methylated, m is 14 in is 5.

[00387] TEA-15 PO: Alkoxylated triethanolamine with 15 PO on average per triethanolamine OH group, to be more precise a compound (I) in which R1, R2e R3son -CHgCHgO-An-Bm-H, in which Raé methylated, m é 15 in is 0.

[00388] TEA-20PO / 5EO: Alkoxylated triethanolamine with 5 average EO and 20 average PO per triethanolamine OH group; to be more precise, a compound (I) in which R1, R2e R3sion -CH^CH^O-An-Bm-H, in which Raé methyl, m is 20 in is 5.

[00389] TEA-20PO / 7.5EO: Alkoxylated triethanolamine with 7.5 average EO and 20 average PO per triethanolamine OH group; to be more precise, a compound (I) in which R1, R2e R3sion -CHiCHiO-An-Bm-H, in which Raé methyl, m is 20 in is 7.5.

[00390] TEA-27PO / 10EO: Alkoxylated triethanolamine with an average of 10 EO and an average of 27 PO per OH group of triethanolamine; to be more precise, a compound (I) where R1, R2 and R3 are -CH2CH2O-An-Bm-H, where Ra is methyl, m is 27 and en is 10

[00391] Solvents: A: γ-Valerolactone B: N,N-Dimethyl-lactamide C: Butyldiglycol: diethylene glycol-mono-n-butyl ether D: Butoxy-2-propanol: 1-butoxy-2-propanol; propylene glycolmono-n-butyl ether Petition 870250094721, dated 10 / 16 / 2025, pp. 318 / 331 143 / 155

[00392] All solvents are commercially available. Example 1: Antimicrobial activity against fungi 1.1 Preservative activity in phosphate buffer solution using 2-phenoxyethanol (PE) as an antimicrobial agent in combination with PLF

[00393] A phosphate buffer solution with pH 7.0 was used.

[00394] The samples were contaminated with a fungal mixture composed of: Aspergillus brasiliensis DSM 1988 Rhodotorula mucilaginosa DSM 13621 Yarrowia lipolytica DSM 8218

[00395] Samples were inoculated with the fungal mixture on day 0 to obtain an inoculation of 1 - 3 x10E+05 CFU / ml in the test sample, composed of the phosphate buffer solution defined above, and stored at 25°C for 7 days. The CFU was determined on day 7.

[00396] Any CFU value on day 7 obtained with a sample of phosphate buffer solution of the invention containing 2-phenoxyethanol (PE) and Plurafac® LF 1430 (PLF) (phosphate buffer solution + 0.5 wt% PE + 1.0 wt% PLF) lower than the respective value of “comparative example 1” (phosphate buffer solution + 0.5 wt% PE) or “comparative example 2” (phosphate buffer solution + 1.0 wt% PLF) indicates a better performance of the inventive combination of 2-phenoxyethanol with the alkoxylated amine. All percentages are % by weight and are relative to the total weight of the respective composition (here, the sample of phosphate buffer solution). Table 1.1 d7 [CFU / ml] Phosphate buffer solution - Reference >100,000 Phosphate buffer solution + 0.5% PE - Comparison 1 62,000 Phosphate buffer solution + 1.0% PLF - Comparison 2 >100,000 Phosphate buffer solution + 0.5% PE + 1.0% PLF <10

[00397] The results in d7 show that the combination of 2-phenoxyethanol and alkoxylated amine intensifies, in a super-additive way, the activity Petition 870250094721, dated 10 / 16 / 2025, pp. 319 / 331 144 / 155 preservative of 2-phenoxyethanol alone. 1.2 Preservative activity in phosphate buffer solution using 2-phenoxyethanol (PE) as an antimicrobial agent in combination with PLF or TEA-15 PO

[00398] A phosphate buffer solution with pH 7.0 was used.

[00399] The samples were contaminated with a fungal mixture composed of: Aspergillus brasiliensis DSM 1988 Rhodotorula mucilaginosa DSM 13621 Yarrowia lipolytica DSM 8218

[00400] Samples were inoculated with the fungal mixture on day 0 and day 7 to obtain an inoculation of 1 - 3 x10E+05 CFU / ml in the test sample, composed of the phosphate buffer solution defined above, and stored at 25°C for 21 days. CFU was determined before reinoculation, on day 7, day 14 and day 21.

[00401] Any CFU value on days 7, 14 and 21 obtained with a sample of phosphate buffer solution of the invention containing 2-phenoxyethanol (PE) and Plurafac® LF 1430 (PLF) or TEA-15 PO lower than the respective value of “comparative example 1” (phosphate buffer solution + 0.5% by weight of 2-phenoxyethanol), “comparative example 2” (phosphate buffer solution + 1.0% PLF) or “comparative example 3” (phosphate buffer solution + 1.0% TEA-15 PO) indicates a better performance of the inventive combination of 2-phenoxyethanol with the alkoxylated amine. All percentages are % by weight and are relative to the total weight of the respective composition (here, the sample of phosphate buffer solution). Table 1.2 d7 [CFU / ml] d14 [CFU / ml] d21 [CFU / ml] Phosphate buffer solution - Reference >100,000 >100,000 >100,000 Phosphate buffer solution + 0.5% PE - Comparison 1 62,000 52,000 5,500 Phosphate buffer solution + 1.0% PLF - Comparison 2 >100,000 >100,000 >100,000 Petition 870250094721, dated 10 / 16 / 2025, pp. 320 / 331 145 / 155 d7 [CFU / ml] d14 [CFU / ml] d21 [CFU / ml] Phosphate buffer solution + 1.0% TEA-15 PO Comparison 3 >100,000 >100,000 >100,000 Phosphate buffer solution + 0.5% PE + 0.5% PLF <10 <10 <10 Phosphate buffer solution + 0.5% PE + 0.5% TEA-15 PO 255 ​​550 557

[00402] The results at d7, d14 and d21 show that the combination of 2-phenoxyethanol and alkoxylated amine intensifies, in a super-additive manner, the preservative activity of 2-phenoxyethanol alone. 1.3 Preservative activity: a hard surface cleaning composition using 2-phenoxyethanol (PE) as an antimicrobial agent in combination with PLF.

[00403] A pH 7.0 hard surface hand cleaner (HSC) containing the following components was used: Table 1.3 Maranil DBS / LC C10-C13-alkylbenzene sulfonate linear from BASF 1.24% Lutensol CS 6250 1-hexanol ethoxylate with 4 EO from BASF 0.6% Lutensol XP 70 C10 alcohol ethoxylate with 7 EO from BASF 0.6% Edenor K 12-18 Coconut fatty acid from BASF 0.6% Ethanol 1.0% Trisodium dicitrate adjusted to pH 7 Deionat Deionized water up to 100%

[00404] The samples were contaminated with a fungal mixture composed of: Aspergillus brasiliensis DSM 1988 Rhodotorula mucilaginosa DSM 13621 Yarrowia lipolytica DSM 8218

[00405] Samples were inoculated with the fungal mixture on days 0 and 7 to obtain an inoculation of 1 - 3 x10E+05 CFU / ml in the test sample, composed of the HSC hard surface cleaner defined above, and stored at 25°C for 14 days. CFU was determined before reinoculation, on day 7 and on day 14.

[00406] Any CFU value on day 7 or day 14 obtained with an HSC sample of the invention containing 2-phenoxyethanol (PE) and Plurafac® LF 1430 (PLF) (HSC + 1.0% PE + 1.0% PLF) lower than the respective value of Petition 870250094721, dated 10 / 16 / 2025, pp. 321 / 331 146 / 155 example “comparative 1” (HSC + 1.0% by weight of 2-phenoxyethanol) or example “comparative 2” (HSC + 2.0% by weight of PLF) indicates a better performance of the inventive combination of 2-phenoxyethanol with the alkoxylated amine. All percentages are % by weight and are relative to the total weight of the respective composition (in this case, the HSC sample). Table 1.4 d7 [CFU / ml] d14 [CFU / ml] HSC - Reference >100,000 >100,000 HSC + 1.0% PE - Comparative 1 49,500 48,000 HSC + 2.0% PLF - Comparative 2 >100,000 >100,000 HSC + 1.0% PE+ 1.0% PLF 2950 45

[00407] Results at d7 and d14 show that the combination of 2-phenoxyethanol and alkoxylated amine intensifies, in a super-additive manner, the preservative activity of 2-phenoxyethanol alone. 1.4 Preservative activity in phosphate buffer solution containing surfactants using 2-phenoxyethanol (PE) as an antimicrobial agent in combination with PLF

[00408] A phosphate buffer solution with pH 7.0 was used. As indicated in Table 1.5 below, this additionally contained 1.5% by weight of the following surfactant:

[00409] Surfactant: Lutensol XP 70 - C10 ethoxylated alcohol with 7 EO from BASF

[00410] The samples were contaminated with a fungal mixture composed of: Aspergillus brasiliensis DSM 1988 Rhodotorula mucilaginosa DSM 13621 Yarrowia lipolytica DSM 8218

[00411] Samples were inoculated with the fungal mixture on day 0 to obtain an inoculation of 1 - 3 x10E+05 CFU / ml in the test sample, composed of the phosphate buffer solution defined above, and stored at 25°C for 7 days. The CFU was determined on day 7.

[00412] Any value of CFU in d7 obtained with a sample of Petition 870250094721, dated 10 / 16 / 2025, pages 322 / 331 147 / 155 phosphate buffer solution containing surfactant containing 2-phenoxyethanol (PE) and Plurafac® LF 1430 (PLF) lower than the respective value of the comparative examples indicates a better performance of the inventive combination of 2-phenoxyethanol with the alkoxylated amine. All percentages are % by weight and are relative to the total weight of the respective composition (here, the sample of phosphate buffer solution). Table 1.5 d7 [CFU / ml] Phosphate buffer solution - Reference >100,000 Phosphate buffer solution + 0.6% PE - Comparison 1 40,000 Phosphate buffer solution + 1.0% PLF - Comparison 2 >100,000 Phosphate buffer solution + 1.5% Lutensol XP 70 - Comparison 3 >100,000 Phosphate buffer solution + 0.6% PE + 1.5% Lutensol XP 70 Comparison 4 >100,000 Phosphate buffer solution + 0.6% PE + 1.0% PLF + 1.5% Lutensol XP 70 <10

[00413] The results in d7 show that the combination of 2-phenoxyethanol and alkoxylated amine intensifies, in a super-additive manner, the preservative activity of 2-phenoxyethanol alone. Furthermore, the comparison of Comparative Example 4 with Comparative Example 1 shows that the effect of PE is neutralized by the presence of Lutensol XP 70. This neutralizing effect is completely neutralized by the presence of PLF, as demonstrated by the results obtained with the composition of the invention. 1.5 Preservative activity in phosphate buffer solution using 2-phenoxyethanol (PE) as an antimicrobial agent in combination with various alkoxylated amines

[00414] A phosphate buffer solution with pH 7.0 was used.

[00415] The samples were contaminated with a fungal mixture composed of: Aspergillus brasiliensis DSM 1988 Rhodotorula mucilaginosa DSM 13621 Yarrowia lipolytica DSM 8218

[00416] Samples were inoculated with the fungal mixture on days 0 and 7 to obtain an inoculation of 1 - 5 x10E+05 CFU / ml in the test sample, Petition 870250094721, dated 10 / 16 / 2025, pp. 323 / 331 148 / 155 composed of the phosphate buffer solution defined above, and stored at 25°C for 14 days. The CFU was determined on day 7, before reinoculation, and on day 14.

[00417] Any CFU value on days 7 and 14, obtained with a sample of the invention's phosphate buffer solution containing 2-phenoxyethanol (PE) and the indicated alkoxylated amine (phosphate buffer solution + 0.5 wt% PE + 0.5 wt% indicated alkoxylated amine), less than the respective value of example “comparative 1” (phosphate buffer solution + 0.5 wt% PE) or examples “comparative 2” to “comparative 4” (phosphate buffer solution + 1.0 wt% indicated alkoxylated amine) indicates a better performance of the inventive combination of 2-phenoxyethanol with the alkoxylated amine. All percentages are % by weight and are relative to the total weight of the respective composition (here, the sample of the phosphate buffer solution). Table 1.6 d7 [CFU / ml] d14 [CFU / ml] Phosphate buffer solution - Reference >100,000 >100,000 Phosphate buffer solution + 0.5% PE - Comparison 1 38,000 8,500 Phosphate buffer solution + 1.0% TEA-20PO / 5EO - Comparison 2 >100,000 >100,000 Phosphate buffer solution + 1.0% TEA-20PO / 7.5EO - Comparison 3 >100,000 >100,000 Phosphate buffer solution + 1.0% TEA-27PO / 10EO - Comparison 4 >100,000 >100,000 Phosphate buffer solution + 0.5% PE + 0.5% TEA-20PO / 5EO 580 3,650 Phosphate buffer solution + 0.5% PE + 0.5% TEA20PO / 7.5EO 185 1,600 Phosphate buffer solution + 0.5% PE + 0.5% TEA27PO / 10EO 140 2,550

[00418] Results at d7 and d14 show that the combination of 2-phenoxyethanol and alkoxylated amine intensifies, in a super-additive manner, the preservative activity of 2-phenoxyethanol alone. 1.6 Preservative activity in phosphate buffer solution using 2-bromo-2-nitropropane-1,3-diol (bronopol) as an antimicrobial agent in combination with PLF

[00419] A phosphate buffer solution with pH 7.0 was used.

[00420] The samples were contaminated with a fungal mixture Petition 870250094721, dated 10 / 16 / 2025, pp. 324 / 331 149 / 155 composed of: Aspergillus brasiliensis DSM 1988 Rhodotorula mucilaginosa DSM 13621 Yarrowia lipolytica DSM 8218

[00421] Samples were inoculated with the fungal mixture on days 0 and 7 to obtain an inoculation of 1 - 5 x10E+05 CFU / ml in the test sample, composed of the phosphate buffer solution defined above, and stored at 25°C for 14 days. CFU was determined on day 7, before reinoculation, and on day 14.

[00422] Any CFU value on d7 and d14 obtained with a sample of phosphate buffer solution of the invention containing bronopol and Plurafac® LF 1430 (PLF) lower than the respective value of the “comparative example 1” (phosphate buffer solution + 40 ppm bronopol) or the “comparative example 2” (phosphate buffer solution + 1.0% PLF) indicates a better performance of the inventive combination of bronopol with the alkoxylated amine. All percentages are % by weight and relative to the total weight of the respective composition (in this case, the phosphate buffer solution sample). ppm is also by weight and relative to the total weight of the respective composition (in this case, the phosphate buffer solution sample). Table 1.7 d7 [CFU / ml] d14 [CFU / ml] Phosphate buffer solution - Reference >100,000 >100,000 Phosphate buffer solution + 40 ppm bronopol - Comparison 1 >100,000 >100,000 Phosphate buffer solution + 1.0% PLF - Comparison 2 >100,000 >100,000 Phosphate buffer solution + 40 ppm bronopol + 1.0% PLF <10 <10

[00423] Results at d7 and d14 show that the combination of bronopol and alkoxylated amine intensifies, in a super-additive manner, the preservative activity of bronopol alone. 1.7 Preservative activity in phosphate buffer solution using 1,2-benzisothiazol-3(2H)-one (BIT) as an antimicrobial agent in combination with PLF Petition 870250094721, dated 10 / 16 / 2025, pages 325 / 331 150 / 155

[00424] A phosphate buffer solution with pH 7.0 was used.

[00425] The samples were contaminated with a fungal mixture composed of: Aspergillus brasiliensis DSM 1988 Rhodotorula mucilaginosa DSM 13621 Yarrowia lipolytica DSM 8218

[00426] Samples were inoculated with the fungal mixture on day 0 to obtain an inoculation of 1 - 5 x10E+05 CFU / ml in the test sample, composed of the phosphate buffer solution defined above, and stored at 25°C for 7 days. The CFU was determined on day 7.

[00427] Any CFU value on d7 obtained with a sample of phosphate buffer solution of the invention containing BIT and Plurafac® LF 1430 (PLF) lower than the respective value of “comparative example 1” (phosphate buffer solution + 25 ppm of BIT) or “comparative example 2” (phosphate buffer solution + 1.0% of PLF) indicates a better performance of the inventive combination of BIT with the alkoxylated amine. All percentages are % by weight and relative to the total weight of the respective composition (in this case, the phosphate buffer solution sample). ppm is also by weight and relative to the total weight of the respective composition (in this case, the phosphate buffer solution sample). Table 1.8 d7 [CFU / ml] Phosphate buffer solution - Reference >100,000 Phosphate buffer solution + 25 ppm BIT - Comparison 1 18,000 Phosphate buffer solution + 1.0% PLF - Comparison 2 >100,000 Phosphate buffer solution + 25 ppm BIT + 1.0% PLF 3,300

[00428] Results in d7 show that the combination of BIT and alkoxylated amine intensifies, in a super-additive manner, the preservative activity of BIT alone. 1.8 Preservative activity in PEG 6000 (50% solution in water) using 2-phenoxyethanol (PE) as an antimicrobial agent in combination with PLF and, additionally, solvent A (γ-valerolactone). Petition 870250094721, dated 10 / 16 / 2025, pp. 326 / 331 151 / 155

[00429] A 50% polyethylene glycol 6000 (PEG 6000) solution, pH 7.0, was used.

[00430] The samples were contaminated with Aspergillus brasiliensis DSM 1988.

[00431] Samples were inoculated with the fungal mixture on days 0 and 15 to obtain 1 - 3 x10E+05 CFU / ml of inoculation in the test sample, composed of the PEG solution defined above, and stored at 25°C for 7 days. CFU were determined on days 0, 2, 7, 14, 15 and 29. Table 1.9 UFC d0 [CFU / ml] d2 [CFU / ml] d7 [CFU / ml] d14 [CFU / ml] d15 [CFU / ml] d29 [CFU / ml] PEG 50% 1.9x105 4.4x104 8.4x104 3.0x105 2.6x105 8.4x104 PEG 50% + 1.0% PE Comp. 1 1.9x105 2.4x104 6.0x104 4.3x104 2.6x105 1.3x105 PEG 50% + 1.0% PLF Comp. 2 1.9x105 8.2x104 4.0x104 4.7x104 2.6x105 8.4x104 PEG 50% + 1.0% PE + 1.0% PLF 3.1x105 2.3x104 7,500 40 3.1x105 720 PEG 50% +1.0% PE + 0.5% PLF + 0.5% solvent A 3.1x105 2.1x104 <10 <10 3.1x105 <10

[00432] As the results demonstrate, the presence of solvent A intensifies and further accelerates the preservative activity of the PE + PLF combination. 1.9 Preservative activity in PEG 6000 (50% solution in water) using 2-phenoxyethanol (PE) as an antimicrobial agent in combination with PLF and, additionally, solvent B (N,N-dimethyl-lactamide) or solvent C (butyldiglycol) or solvent D (butoxy-2-propanol)

[00433] A 50% polyethylene glycol 6000 (PEG 6000) solution, pH 7.0, was used.

[00434] The samples were contaminated with Aspergillus brasiliensis DSM 1988.

[00435] Samples were inoculated with the fungal mixture on days 0 and 15 to obtain 1 - 3 x10E+05 CFU / ml of inoculation in the test sample, composed of the PEG solution defined above, and stored at 25°C for 7 Petition 870250094721, dated 10 / 16 / 2025, pp. 327 / 331 152 / 155 days. The CFU were determined on days 0, 2, 7, 14, 15 and 29. Table 2.1 UFC d0 [CFU / ml] d2 [CFU / ml] d7 [CFU / ml] d14 [CFU / ml] d15 [CFU / ml] d29 [CFU / ml] PEG 50% 1.9x105 4.4x104 8.4x104 3.0x105 2.6x105 8.4x104 PEG 50% + 1.0% PE - Comp. 1 1.9x105 2.4x104 6.0x104 4.3x104 2.6x105 1.3x105 PEG 50% + 1.0% PLF - Comp. 2 1.9x105 8.2x104 4.0x104 4.7x104 2.6x105 8.4x104 PEG 50% + 1.0% PE + 0.75% PLF 2.5x105 4.2x104 230 45 2.7x105 260 PEG 50% +1.0% PE + 0.75% PLF + 1.0% solvent B 2.5x105 9.4x103 <10 <10 2.7x105 <10 PEG 50% +1.0% PE + 0.75% PLF + 1.0% solvent C 2.5x105 3,500 <10 <10 2.7x105 <10 PEG 50% +1.0% PE + 0.75% PLF + 1.0% solvent D 2.5x105 3,100 <10 <10 2.7x105 <10

[00436] As the results demonstrate, the presence of solvent B, C or D intensifies and further accelerates the preservative activity of the PE + PLF combination. Example 2: Antimicrobial activity against bacteria 2.1 Preservative activity in phosphate buffer solution using 2-phenoxyethanol (PE) as an antimicrobial agent in combination with PLF

[00437] A phosphate buffer solution with pH 7.0 was used.

[00438] The samples were contaminated with a bacterial mixture composed of: Escherichia coli DSM 1576 Alcaligenes faecalis DSM 13644 Pseudomonas aeruginosa ATCC 15442 Staphylococcus aureus ATCC 6538 Burkholderia cepacia DSM 7288 Pseudomonas putida DSM 12735

[00439] Samples were inoculated with the bacterial mixture on day 0 to obtain an inoculation of 10E+06 to 10E+07 CFU / ml in the test samples and stored at 25°C for 7 days. The CFU was determined on day 7. Petition 870250094721, dated 10 / 16 / 2025, pp. 328 / 331 153 / 155

[00440] Any CFU value on day 7 obtained with a sample of phosphate buffer solution of the invention containing 2-phenoxyethanol (PE) and Plurafac® LF 1430 (PLF) (phosphate buffer solution + 0.5 wt% PE + 1.0 wt% PLF) lower than the respective value of “comparative example 1” (phosphate buffer solution + 0.5 wt% PE) or “comparative example 2” (phosphate buffer solution + 1.0 wt% PLF) indicates a better performance of the inventive combination of 2-phenoxyethanol with the alkoxylated amine. All percentages are % by weight and are relative to the total weight of the respective composition (here, the sample of phosphate buffer solution). Table 2.2 d7 [CFU / ml] Phosphate buffer solution - Reference >100,000 Phosphate buffer solution + 0.5% PE - Comparison 1 >100,000 Phosphate buffer solution + 1.0% PLF - Comparison 2 >100,000 Phosphate buffer solution + 0.5% PE + 1.0% PLF 3450

[00441] Results in d7 show that the combination of 2-phenoxyethanol and alkoxylated amine intensifies, in a super-additive manner, the preservative activity of 2-phenoxyethanol alone. 2.2 Preservative activity in phosphate buffer solution using 1,2-benzisothiazol-3(2H)-one (BIT) as an antimicrobial agent in combination with PLF

[00442] A phosphate buffer solution with pH 7.0 was used.

[00443] The samples were contaminated with a bacterial mixture composed of: Escherichia coli DSM 1576 Alcaligenes faecalis DSM 13644 Pseudomonas aeruginosa ATCC 15442 Staphylococcus aureus ATCC 6538 Burkholderia cepacia DSM 7288 Pseudomonas putida DSM 12735

[00444] The samples were inoculated with the bacterial mixture on the day Petition 870250094721, dated 10 / 16 / 2025, pp. 329 / 331 154 / 155 to obtain an inoculation of 10E+06 to 10E+07 CFU / ml in the test samples and stored at 25°C for 7 days. The CFU was determined on day 7.

[00445] Any CFU value on d7 obtained with a sample of phosphate buffer solution of the invention containing benzoisothiazolinone (BIT) and Plurafac® LF 1430 (PLF) (phosphate buffer solution + 75 ppm BIT + 1.0 wt% PLF) less than the respective value of “comparative example 1” (phosphate buffer solution + 75 ppm BIT) or “comparative example 2” (phosphate buffer solution + 1.0 wt% PLF) indicates a better performance of the inventive combination of BIT with the alkoxylated amine. All percentages are % by weight and relative to the total weight of the respective composition (in this case, the phosphate buffer solution sample). ppm is also by weight and relative to the total weight of the respective composition (in this case, the phosphate buffer solution sample). Table 2.3 d7 [CFU / ml] Phosphate buffer solution - Reference >100,000 Phosphate buffer solution + 75 ppm BIT - Comparison 1 31,000 Phosphate buffer solution + 1.0% PLF - Comparison 2 >100,000 Phosphate buffer solution + 75 ppm BIT + 1.0% PLF <10

[00446] Results in d7 show that the combination of BIT and alkoxylated amine intensifies, in a super-additive manner, the preservative activity of BIT alone. 2.3 Preservative activity in phosphate buffer solution using glutaraldehyde (used as a 50% solution in water) as an antimicrobial agent in combination with PLF

[00447] A phosphate buffer solution with pH 7.0 was used.

[00448] The samples were contaminated with a bacterial mixture composed of: Escherichia coli DSM 1576 Alcaligenes faecalis DSM 13644 Pseudomonas aeruginosa ATCC 15442 Staphylococcus aureus ATCC 6538 Petition 870250094721, dated 10 / 16 / 2025, pp. 330 / 331 155 / 155 Burkholderia cepacia DSM 7288 Pseudomonas putida DSM 12735

[00449] Samples were inoculated with the bacterial mixture on day 0 to obtain an inoculation of 10E+06 to 10E+07 CFU / ml in the test samples and stored at 25°C for 7 days. The CFU was determined on day 7.

[00450] Any CFU value on d7 obtained with a sample of phosphate buffer solution of the invention containing 50% glutaraldehyde and Plurafac® LF 1430 (PLF) (phosphate buffer solution + 50 ppm 50% glutaraldehyde + 1.0% by weight of PLF) lower than the respective value of “comparative example 1” (phosphate buffer solution + 50 ppm 50% glutaraldehyde) or “comparative example 2” (phosphate buffer solution + 1.0% by weight of PLF) indicates a better performance of the inventive combination of glutaraldehyde with the alkoxylated amine. All percentages are % by weight and relative to the total weight of the respective composition (in this case, the sample of phosphate buffer solution). ppm is also given by weight and is relative to the total weight of the respective composition (in this case, the phosphate buffer solution sample). Table 2.4 d7 [CFU / ml] Phosphate buffer solution - Reference >100,000 Phosphate buffer solution + 50 ppm glutaraldehyde (50% solution) Comparison 1 >100,000 Phosphate buffer solution + 1.0% PLF - Comparison 2 >100,000 Phosphate buffer solution + 50 ppm glutaraldehyde (50% solution) + 1.0% PLF <10

[00451] Results in d7 show that the combination of glutaraldehyde and alkoxylated amine intensifies, in a super-additive way, the preservative activity of glutaraldehyde alone. Petition 870250094721, dated 10 / 16 / 2025, page 331 / 331

Claims

1 / 8 CLAIMS 1. Composition, characterized in that it comprises (a) at least one antimicrobial agent selected from the group consisting of 2-phenoxyethanol, phenoxyisopropanol, 4,4'-dichloro-2'-hydroxydiphenyl ether, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde, 2,4-dichlorobenzyl alcohol, 1,3,5-tris-(2-hydroxyethyl)-1,3,5-hexahydrotriazine, formic acid and salts thereof, benzoic acid and salts thereof, sorbic acid and salts thereof, lactic acid and salts thereof, isothiazolinones selected from the group consisting of 1,2-benzisothiazol-3(2H)-one (BIT), 2-methyl-2-isothiazol-3-one (MIT), 2-octyl-2H-isothiazol-3-one (OIT), 5-chloro-2-methyl-2-isothiazol-3-one (CMIT) and 2-butyl-benzo[d]isothiazol-3-one (BBIT); 3-iodo-2-propynylbutylcarbamate (IPBC), benzyl alcohol, pyridine-2-thiol 1-oxide and salts thereof;2,2-dibromo-2-cyanoacetamide (DBNPA), N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine (Diamine), tetrakis(hydroxymethyl)phosphonium sulfate (2:1) (THPS), 2,2-dithiobis[N-methylbenzamide] (DTBMA), 2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB); and mixtures thereof; and (b) an alkoxylated amine of formula (I) NR1R2R3 (I) where R1 is -CH2CH2O-An-Bm-H; -CH2CH2O-Bm-An-H or CH2CH2O-1 '„).„-! I; where A is -CH2CH2O-; B is -CH(Ra)-CH2-O- or -CH2-CH(Ra)-O-; E is randomly assigned to A and B; Ra is C1-C16-alkyl; m is from 0 to 30; n is from 0 to 15; where the sum of m + n is from 5 to 40; and Petition 870250094721, dated 10 / 16 / 2025, p. 167 / 331 2 / 8 R2 and R3 independently have one of the definitions given for R1 or are C1-C18-alkyl.; 2. Composition according to claim 1, characterized in that the antimicrobial agent is selected from the group consisting of 2-phenoxyethanol, phenoxyisopropanol, 4,4'-dichloro-2'-hydroxydiphenyl ether, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde, benzoic acid and salts thereof and isothiazolinones selected from the group consisting of 1,2-benzisothiazol-3(2H)-one (BIT), 2-methyl-2H-isothiazol-3-one (MIT), 2-octyl-2-isothiazol-3-one (OIT), 5-chloro-2-methyl-2H-isothiazol-3-one (CMIT) and 2-butylbenzo[d]isothiazol-3-one (BBIT); and preferably from the group consisting of 2-phenoxyethanol, phenoxyisopropanol, 4,4'-dichloro-2'-hydroxydiphenyl ether, 2-bromo-2-nitropropane-1,3-diol and 1,2-benzisothiazol-3(2H)one (BIT).

3. Composition according to claim 2, characterized in that the antimicrobial agent is selected from the group consisting of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT).

4. Composition according to claim 3, characterized in that the antimicrobial agent is 2-phenoxyethanol.

5. A composition according to any of the preceding claims, characterized in that R2 and R3 independently have one of the meanings of R1.

6. Composition according to any of the preceding claims, characterized in that Ra is methyl.

7. Composition according to any of the preceding claims, characterized in that m is 10 to 30 and n is 3 to 12; or m is 10 to 25 and n is 0.

8. Composition according to any of the preceding claims, characterized in that R1 is -CHiCHiO-AnBm-H. Petition 870250094721, dated 10 / 16 / 2025, page 168 / 331 3 / 8 9. Composition according to any of the preceding claims, characterized in that the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 100:1 to 1:10000, preferably 50:1 to 1:2000, more preferably 50:1 to 1:1000, even more preferably 50:1 to 1:500, particularly 20:1 to 1:500, in particular 10:1 to 1:500, specifically 2:1 to 1:

450.

10. Composition according to claim 9, characterized in that, if the antimicrobial agent is 2-phenoxyethanol, the 2-phenoxyethanol and the alkoxylated amine are present in a total weight ratio of 3:1 to 1:3, preferably 2.5:1 to 1:2.5, and specifically 2:1 to 1:

2.

11. Composition according to claim 9, characterized in that, if the antimicrobial agent is selected from the group consisting of 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT), said antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:500, preferably 1:1 to 1:450, and more preferably 1:100 to 1:

450.

12. Composition according to any of the preceding claims, characterized in that the antimicrobial agent is selected from the group consisting of 2-phenoxyethanol, 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT); in the alkoxylated amine of formula (I), R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, where Ra is methyl, m is 10 to 30 and n is 3 to 12; or m is 10 to 20 and n is 0; and the antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 3:1 to 1:500; where preferably in the alkoxylated amine of formula (I) R1, R2 and R3 are independently -CHiCHiO-An-Bm-H, where Ra is methyl, m is 14 to 27 and en is 5 to 10; or m is 15 and en is 0; and the antimicrobial agent and the alkoxylated amine Petition 870250094721, 10 / 16 / 2025, p. 169 / 331 4 / 8 are present in a total weight ratio of 2:1 to 1:

450.

13. Composition according to claim 12, characterized in that the antimicrobial agent is 2-phenoxyethanol; in the alkoxylated amine of formula (I) R1, R2 and R3 are independently CH2CH2Ü-An-Bm-H, where Ra is methyl, m is 10 to 30, preferably 14 to 27, en is 3 to 12, preferably 5 to 10; or m is 10 to 20, preferably 15, en is 0; and 2-phenoxyethanol and the alkoxylated amine are present in a total weight ratio of 3:1 to 1:3, preferably 2.5:1 to 1:2.5, and more preferably 2:1 to 1:

2.

14. Composition according to claim 12, characterized in that the antimicrobial agent is selected from the group consisting of 2-bromo-2-nitropropane-1,3-diol, glutaraldehyde and 1,2-benzisothiazol-3(2H)one (BIT); in the alkoxylated amine of formula (I) R1, R2 and R3 are independently -CH2CH2O-An-Bm-H, wherein Ra is methyl, m is 10 to 20, preferably 14, en is 3 to 8, preferably 5; and said antimicrobial agent and the alkoxylated amine are present in a total weight ratio of 1:1 to 1:500, preferably 1:1 to 1:450, and more preferably 1:100 to 1:

450.

15. Composition according to any of the preceding claims, characterized in that it further comprises (c) at least one organic solvent selected from the group consisting of (c.1) carboxamides of formula (C-1) wherein R4 is hydrogen or C1-C8-alkyl; Petition 870250094721, 10 / 16 / 2025, p. 170 / 331 5 / 8 R5 is C1-C8-alkyl; and R6 is C1-C8-alkyl or C1-C8-hydroxyalkyl; (c.2) carboxylic esters of formula (C-2) wherein R6 is C1-C8-alkyl or C1-C8-hydroxyalkyl; and R7 is C1-C10-alkyl; (c.3) Cs-C8-alkanols; (c.4) C3-C8-alkanediols; (c.5) C1-C8-alkyl monoethers of C2-C8-alkanediols; (c.6) diethylene glycol, dipropylene glycol, a polyethylene glycol with up to 10 repeating units or a polypropylene glycol with up to 10 repeating units; (c.7) C1-C8-alkyl monoethers of diethylene glycol or dipropylene glycol; (c.8) lactones of formula (C-8) wherein R8 is C1-C5-alkyl; (c.9) dioxolanes of formula (C-9) wherein Petition 870250094721, of 10 / 16 / 2025, page.171 / 331 6 / 8 R9 and R10 are independently C1-C4-alkyl or together form an oxo group; and R11 is C1-C4-alkyl or C1-C4-hydroxyalkyl; and (c.10) mono-, di- or triesters of glycerol with C1-C4 carboxylic acids.

16. Composition according to claim 15, characterized in that the organic solvent of component (c) is selected from the group consisting of (c. 1) the carboxamide of formula (C-1), wherein R4 and R5 are methyl, and R6 is 1-hydroxyethyl; (c.5) C3-C5-alkyl monoethers of C2-C3-alkanediols, in particular 1-butoxy-propan-2-ol; (c.7) C1-C6-alkyl monoethers of diethylene glycol or dipropylene glycol, in particular, diethylene glycol mono-n-butyl ether; and (c.8) the lactone of formula (C-8), wherein R8 is methyl.

17. Composition according to claim 15 or 16, characterized in that the antimicrobial agent and the organic solvent of component (c) are present in a total weight ratio of 10:1 to 1:10, preferably 5:1 to 1:5, more preferably 3:1 to 1:3, in particular 2:1 to 1:2, specifically 2:1 to 1:

1.

18. Composition according to any of the preceding claims, characterized in that it is selected from the group consisting of antimicrobial concentrates, compositions for household care, compositions for cleaning or disinfection on an industrial scale, compositions for personal care, process water, cooling water, water in fish or shrimp tanks, water in drinking fountains, fluids for metal machining; water-based raw materials, polymer solutions, polymer dispersions, polymer emulsions, inorganic fluid pastes, organic fluid pastes, surface-active compositions; compositions for Petition 870250094721, dated 10 / 16 / 2025, page.172 / 331 7 / 8 treatment of animal skin; compositions for the treatment of leather; compositions for the treatment of textiles during the manufacturing process; compositions for the treatment of wood; compositions for the treatment of paper or precursor material during papermaking processes; compositions for crop protection; pharmaceutical compositions; inks, glues, adhesives, sealants, dyes, pigments and dispersions thereof, paints and wet wipes.

19. Kit of parts, characterized in that it comprises at least two parts, wherein the first part comprises at least one antimicrobial agent as defined in any one of claims 1 to 4; the second part comprises an alkoxylated amine as defined in any one of claims 1 or 5 to 8 and, optionally, at least one organic solvent; and an optional third part comprises at least one organic solvent; wherein the first part does not comprise an alkoxylated amine as defined in any one of claims 1 or 5 to 8; wherein the second part does not comprise any antimicrobial agent as defined in any one of claims 1 to 4; wherein the optional third part does not comprise any antimicrobial agent as defined in any one of claims 1 to 4, nor an alkoxylated amine as defined in any one of claims 1 or 5 to 8;and wherein the first and second parts contain at least one antimicrobial agent as defined in any one of claims 1 to 4 and the alkoxylated amine as defined in any one of claims 1 or 5 to 8 in amounts such that, when the first and second parts are mixed, the resulting total weight ratio is as defined in claims 9 to 11.

20. Use of an alkoxylated amine as defined in any one of claims 1 or 5 to 8, characterized in that it enhances the antimicrobial activity, in particular the preservative activity, of the antimicrobial agent, as defined in any one of claims 1 to 4.

21. Use according to claim 20 of an alkoxylated amine as defined in any one of claims 1 or 5 to 8, characterized in that it enhances the antimicrobial activity, in particular the preservative activity, of 2-phenoxyethanol.

22. Use according to claim 20 or 21, characterized in that it enhances the antimicrobial activity, in particular the preservative activity, of the antimicrobial agent in an aqueous liquid composition for household care. Petition 870250094721, dated 10 / 16 / 2025, p. 174 / 331